[
    {
        "text": "[CHEMICAL]Esmolol[\\CHEMICAL], a unique cardioselective [GENE]beta 1-adrenergic receptor[\\GENE] blocker with a half-life of 9 minutes, can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: [CHEMICAL](A) cyclosporine[\\CHEMICAL] CsA and prednisone for baseline immunosuppression (n = 9); (B) anti-Tac with CsA and prednisone as baseline immunosuppression (n = 12); and (C) anti-Tac with azathioprine and prednisone as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: (A) cyclosporine [CHEMICAL]CsA[\\CHEMICAL] and prednisone for baseline immunosuppression (n = 9); (B) anti-Tac with CsA and prednisone as baseline immunosuppression (n = 12); and (C) anti-Tac with azathioprine and prednisone as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: (A) cyclosporine CsA and [CHEMICAL]prednisone[\\CHEMICAL] for baseline immunosuppression (n = 9); (B) anti-Tac with CsA and prednisone as baseline immunosuppression (n = 12); and (C) anti-Tac with azathioprine and prednisone as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: (A) cyclosporine CsA and prednisone for baseline immunosuppression (n = 9); (B) anti-Tac with [CHEMICAL]CsA[\\CHEMICAL] and prednisone as baseline immunosuppression (n = 12); and (C) anti-Tac with azathioprine and prednisone as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: (A) cyclosporine CsA and prednisone for baseline immunosuppression (n = 9); (B) anti-Tac with CsA and [CHEMICAL]prednisone[\\CHEMICAL] as baseline immunosuppression (n = 12); and (C) anti-Tac with azathioprine and prednisone as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: (A) cyclosporine CsA and prednisone for baseline immunosuppression (n = 9); (B) anti-Tac with CsA and prednisone as baseline immunosuppression (n = 12); and (C) anti-Tac with [CHEMICAL]azathioprine[\\CHEMICAL] and prednisone as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "These two antibodies recognize closely spaced epitopes on the 55 kD chain of the IL-2 R. [GENE]IL-2 R[\\GENE] expression was examined on peripheral blood small lymphocytes in three groups of patients who received: (A) cyclosporine CsA and prednisone for baseline immunosuppression (n = 9); (B) anti-Tac with CsA and prednisone as baseline immunosuppression (n = 12); and (C) anti-Tac with azathioprine and [CHEMICAL]prednisone[\\CHEMICAL] as baseline immunosuppression (n = 5).",
        "label": 2,
        "major": -1,
        "len": 69
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, [GENE]caldesmon kinase[\\GENE] and myosin light chain kinase) of the dihydropyridine [CHEMICAL]Ca2+[\\CHEMICAL] channel blocker felodipine and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and [GENE]myosin light chain kinase[\\GENE]) of the dihydropyridine [CHEMICAL]Ca2+[\\CHEMICAL] channel blocker felodipine and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes ([GENE]cAMP phosphodiesterase[\\GENE], caldesmon kinase and myosin light chain kinase) of the dihydropyridine [CHEMICAL]Ca2+[\\CHEMICAL] channel blocker felodipine and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, [GENE]caldesmon kinase[\\GENE] and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker [CHEMICAL]felodipine[\\CHEMICAL] and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and [GENE]myosin light chain kinase[\\GENE]) of the dihydropyridine Ca2+ channel blocker [CHEMICAL]felodipine[\\CHEMICAL] and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three [GENE]calmodulin-dependent enzymes[\\GENE] (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker [CHEMICAL]felodipine[\\CHEMICAL] and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes ([GENE]cAMP phosphodiesterase[\\GENE], caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker [CHEMICAL]felodipine[\\CHEMICAL] and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, [GENE]caldesmon kinase[\\GENE] and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues ([CHEMICAL]p-chloro[\\CHEMICAL], oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and [GENE]myosin light chain kinase[\\GENE]) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues ([CHEMICAL]p-chloro[\\CHEMICAL], oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three [GENE]calmodulin-dependent enzymes[\\GENE] (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues ([CHEMICAL]p-chloro[\\CHEMICAL], oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes ([GENE]cAMP phosphodiesterase[\\GENE], caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues ([CHEMICAL]p-chloro[\\CHEMICAL], oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, [GENE]caldesmon kinase[\\GENE] and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues (p-chloro, oxidized and [CHEMICAL]t-butyl[\\CHEMICAL]) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and [GENE]myosin light chain kinase[\\GENE]) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues (p-chloro, oxidized and [CHEMICAL]t-butyl[\\CHEMICAL]) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three [GENE]calmodulin-dependent enzymes[\\GENE] (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues (p-chloro, oxidized and [CHEMICAL]t-butyl[\\CHEMICAL]) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes ([GENE]cAMP phosphodiesterase[\\GENE], caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues (p-chloro, oxidized and [CHEMICAL]t-butyl[\\CHEMICAL]) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "These observations suggest that [CHEMICAL]felodipine[\\CHEMICAL] may act directly on the [GENE]phosphodiesterase[\\GENE] as well as through calmodulin.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "These observations suggest that [CHEMICAL]felodipine[\\CHEMICAL] may act directly on the phosphodiesterase as well as through [GENE]calmodulin[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "We have examined the effects on the activities of three [GENE]calmodulin-dependent enzymes[\\GENE] (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the [CHEMICAL]dihydropyridine[\\CHEMICAL] Ca2+ channel blocker felodipine and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the dihydropyridine [GENE]Ca2+ channel[\\GENE] blocker [CHEMICAL]felodipine[\\CHEMICAL] and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "label": 4,
        "major": -1,
        "len": 39
    },
    {
        "text": "Effects of [CHEMICAL]felodipine[\\CHEMICAL] (a dihydropyridine [GENE]calcium channel[\\GENE] blocker) and analogues on calmodulin-dependent enzymes.",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "Effects of felodipine (a [CHEMICAL]dihydropyridine[\\CHEMICAL] [GENE]calcium channel[\\GENE] blocker) and analogues on calmodulin-dependent enzymes.",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Loperamide[\\CHEMICAL], an opiate analog, differently modifies the [GENE]adrenocorticotropin[\\GENE] responses to corticotropin-releasing hormone and lysine vasopressin in patients with Addison's disease.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Loperamide[\\CHEMICAL], an opiate analog, differently modifies the adrenocorticotropin responses to corticotropin-releasing hormone and [GENE]lysine vasopressin[\\GENE] in patients with Addison's disease.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Loperamide[\\CHEMICAL], an opiate analog, differently modifies the adrenocorticotropin responses to [GENE]corticotropin-releasing hormone[\\GENE] and lysine vasopressin in patients with Addison's disease.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Lorglumide[\\CHEMICAL] is therefore a useful pharmacological tool to study the functions of [GENE]CCK[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Overall, these findings suggest that [CHEMICAL]monohydroxytamoxifen[\\CHEMICAL] and LY117018 probably act through the same mechanism of action via the [GENE]estrogen receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Overall, these findings suggest that monohydroxytamoxifen and [CHEMICAL]LY117018[\\CHEMICAL] probably act through the same mechanism of action via the [GENE]estrogen receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]5-Methyl-urapidil[\\CHEMICAL] was selective for cloned [GENE]alpha 1A adrenoceptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 8
    },
    {
        "text": "Characterization of an [GENE]alpha 1D-adrenoceptor[\\GENE] mediating the contractile response of rat aorta to [CHEMICAL]noradrenaline[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "The effects of these metabolites on the expression of [GENE]uteroglobin[\\GENE] (UG) and progesterone receptor (PR) genes, both regulated by [CHEMICAL]progesterone (P4)[\\CHEMICAL], were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 (1.0 mg) for 5 consecutive days.",
        "label": 2,
        "major": -1,
        "len": 42
    },
    {
        "text": "The effects of these metabolites on the expression of uteroglobin ([GENE]UG[\\GENE]) and progesterone receptor (PR) genes, both regulated by [CHEMICAL]progesterone (P4)[\\CHEMICAL], were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 (1.0 mg) for 5 consecutive days.",
        "label": 2,
        "major": -1,
        "len": 42
    },
    {
        "text": "The effects of these metabolites on the expression of uteroglobin (UG) and [GENE]progesterone receptor[\\GENE] (PR) genes, both regulated by [CHEMICAL]progesterone (P4)[\\CHEMICAL], were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 (1.0 mg) for 5 consecutive days.",
        "label": 2,
        "major": -1,
        "len": 42
    },
    {
        "text": "The effects of these metabolites on the expression of uteroglobin (UG) and progesterone receptor ([GENE]PR[\\GENE]) genes, both regulated by [CHEMICAL]progesterone (P4)[\\CHEMICAL], were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 (1.0 mg) for 5 consecutive days.",
        "label": 2,
        "major": -1,
        "len": 42
    },
    {
        "text": "The R(-) and S(+) isomers of MDMA were significantly less efficacious at the [GENE]5-HT2A[\\GENE] receptor as compared to MDA; [CHEMICAL]S(+)MDMA[\\CHEMICAL] had no effect.",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "The [CHEMICAL]R(-) and S(+) isomers of MDMA[\\CHEMICAL] were significantly less efficacious at the [GENE]5-HT2A[\\GENE] receptor as compared to MDA; S(+)MDMA had no effect.",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "The R(-) and S(+) isomers of MDMA were significantly less efficacious at the [GENE]5-HT2A[\\GENE] receptor as compared to [CHEMICAL]MDA[\\CHEMICAL]; S(+)MDMA had no effect.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]hCOX-1[\\GENE] had a specific activity of 18.8 mumol of O2/mg with a Km of 13.8 microM for [CHEMICAL]arachidonate[\\CHEMICAL] and Vmax.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "of 1500 nmol of O2/nmol of enzyme, whereas [GENE]hCOX-2[\\GENE] had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for [CHEMICAL]arachidonate[\\CHEMICAL] and a Vmax.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "The endogenous ligand for [GENE]imidazoline receptors[\\GENE] may be a [CHEMICAL]clonidine[\\CHEMICAL]-displacing substance, a small molecule isolated from bovine brain.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[GENE]Opioid receptors[\\GENE] are the membrane proteins that mediate the pain-relieving effect of opioid drugs, such as [CHEMICAL]morphine[\\CHEMICAL] and fentanyl as well as endogenous opioid peptides enkephalins and endorphins.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "[GENE]Opioid receptors[\\GENE] are the membrane proteins that mediate the pain-relieving effect of opioid drugs, such as morphine and [CHEMICAL]fentanyl[\\CHEMICAL] as well as endogenous opioid peptides enkephalins and endorphins.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "[GENE]Dopamine D2-receptor[\\GENE] imaging with [CHEMICAL]123I-iodobenzamide[\\CHEMICAL] SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Two migraine patients were studied by in vivo SPECT using the [GENE]dopamine D2-receptor[\\GENE] specific radioligand [CHEMICAL]123I-3-iodo-6-methoxybenzamide[\\CHEMICAL] (123I-IBZM) during ergotamine abuse and after withdrawal.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Two migraine patients were studied by in vivo SPECT using the [GENE]dopamine D2-receptor[\\GENE] specific radioligand 123I-3-iodo-6-methoxybenzamide ([CHEMICAL]123I-IBZM[\\CHEMICAL]) during ergotamine abuse and after withdrawal.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]Dopamine D2-receptor[\\GENE] imaging with 123I-iodobenzamide SPECT in migraine patients abusing [CHEMICAL]ergotamine[\\CHEMICAL]: does ergotamine cross the blood brain barrier?",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Two migraine patients were studied by in vivo SPECT using the [GENE]dopamine D2-receptor[\\GENE] specific radioligand 123I-3-iodo-6-methoxybenzamide (123I-IBZM) during [CHEMICAL]ergotamine[\\CHEMICAL] abuse and after withdrawal.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Finally, a third nonadrenergic internal membrane site, labeled by [3H]IDX, was consistent with a [GENE]subtype-I2 imidazol(in)e receptor[\\GENE] site (rank order: [CHEMICAL]cirazoline[\\CHEMICAL] > IDX >> amiloride > moxonidine > clonidine).",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Finally, a third nonadrenergic internal membrane site, labeled by [3H]IDX, was consistent with a [GENE]subtype-I2 imidazol(in)e receptor[\\GENE] site (rank order: cirazoline > IDX >> [CHEMICAL]amiloride[\\CHEMICAL] > moxonidine > clonidine).",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Finally, a third nonadrenergic internal membrane site, labeled by [3H]IDX, was consistent with a [GENE]subtype-I2 imidazol(in)e receptor[\\GENE] site (rank order: cirazoline > IDX >> amiloride > [CHEMICAL]moxonidine[\\CHEMICAL] > clonidine).",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Finally, a third nonadrenergic internal membrane site, labeled by [3H]IDX, was consistent with a [GENE]subtype-I2 imidazol(in)e receptor[\\GENE] site (rank order: cirazoline > IDX >> amiloride > moxonidine > [CHEMICAL]clonidine[\\CHEMICAL]).",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "[CHEMICAL]DEX[\\CHEMICAL] enhanced the ratio [GENE]IFN-gamma[\\GENE]/IL-4 (mean +/- SEM: control, 28.7 +/- 17.6; with 10-7 M DEX, 55.0 +/- 27.5, P<0.005).",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]DEX[\\CHEMICAL] enhanced the ratio IFN-gamma/[GENE]IL-4[\\GENE] (mean +/- SEM: control, 28.7 +/- 17.6; with 10-7 M DEX, 55.0 +/- 27.5, P<0.005).",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Indoramin[\\CHEMICAL] and SNAP 1069 showed selectivity for alpha 1A and alpha 1B adrenoceptors relative to the [GENE]alpha 1D subtype[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Indoramin and [CHEMICAL]SNAP 1069[\\CHEMICAL] showed selectivity for alpha 1A and alpha 1B adrenoceptors relative to the [GENE]alpha 1D subtype[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Rec 15/2739[\\CHEMICAL], WB 4101, SL 89,0591, (+)- and (-)- tamsulosin showed selectivity for alpha 1A and alpha 1D adrenoceptors relative to the [GENE]alpha 1B subtype[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Rec 15/2739, [CHEMICAL]WB 4101[\\CHEMICAL], SL 89,0591, (+)- and (-)- tamsulosin showed selectivity for alpha 1A and alpha 1D adrenoceptors relative to the [GENE]alpha 1B subtype[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Rec 15/2739, WB 4101, [CHEMICAL]SL 89,0591[\\CHEMICAL], (+)- and (-)- tamsulosin showed selectivity for alpha 1A and alpha 1D adrenoceptors relative to the [GENE]alpha 1B subtype[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Rec 15/2739, WB 4101, SL 89,0591, [CHEMICAL](+)- and (-)- tamsulosin[\\CHEMICAL] showed selectivity for alpha 1A and alpha 1D adrenoceptors relative to the [GENE]alpha 1B subtype[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Prazosin[\\CHEMICAL] was found to be unselective; 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane (WB 4101), 5-methyl-urapidil, indoramin and (+)-niguldipine were confirmed as selective for the [GENE]alpha 1A-adrenoceptor[\\GENE], whereas spiperone was weakly alpha 1B-selective.",
        "label": 10,
        "major": -1,
        "len": 27
    },
    {
        "text": "Risperidone was equipotent to [CHEMICAL]prazosin[\\CHEMICAL] at [GENE]alpha 1A-adrenoceptors[\\GENE] in rat vas deferens and kidney.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Prazosin was found to be unselective; [CHEMICAL]2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane[\\CHEMICAL] (WB 4101), 5-methyl-urapidil, indoramin and (+)-niguldipine were confirmed as selective for the [GENE]alpha 1A-adrenoceptor[\\GENE], whereas spiperone was weakly alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Prazosin was found to be unselective; 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane ([CHEMICAL]WB 4101[\\CHEMICAL]), 5-methyl-urapidil, indoramin and (+)-niguldipine were confirmed as selective for the [GENE]alpha 1A-adrenoceptor[\\GENE], whereas spiperone was weakly alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Prazosin was found to be unselective; 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane (WB 4101), [CHEMICAL]5-methyl-urapidil[\\CHEMICAL], indoramin and (+)-niguldipine were confirmed as selective for the [GENE]alpha 1A-adrenoceptor[\\GENE], whereas spiperone was weakly alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Prazosin was found to be unselective; 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane (WB 4101), 5-methyl-urapidil, [CHEMICAL]indoramin[\\CHEMICAL] and (+)-niguldipine were confirmed as selective for the [GENE]alpha 1A-adrenoceptor[\\GENE], whereas spiperone was weakly alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Prazosin was found to be unselective; 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane (WB 4101), 5-methyl-urapidil, indoramin and [CHEMICAL](+)-niguldipine[\\CHEMICAL] were confirmed as selective for the [GENE]alpha 1A-adrenoceptor[\\GENE], whereas spiperone was weakly alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Risperidone[\\CHEMICAL] was equipotent to prazosin at [GENE]alpha 1A-adrenoceptors[\\GENE] in rat vas deferens and kidney.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "[GENE]TREK-1[\\GENE] currents are insensitive to pharmacological agents that block TWIK-1 activity such as [CHEMICAL]quinine[\\CHEMICAL] and quinidine.",
        "label": 10,
        "major": -1,
        "len": 16
    },
    {
        "text": "[GENE]TREK-1[\\GENE] currents are insensitive to pharmacological agents that block TWIK-1 activity such as quinine and [CHEMICAL]quinidine[\\CHEMICAL].",
        "label": 10,
        "major": -1,
        "len": 16
    },
    {
        "text": "TREK-1 currents are insensitive to pharmacological agents that block [GENE]TWIK-1[\\GENE] activity such as [CHEMICAL]quinine[\\CHEMICAL] and quinidine.",
        "label": 4,
        "major": -1,
        "len": 16
    },
    {
        "text": "TREK-1 currents are insensitive to pharmacological agents that block [GENE]TWIK-1[\\GENE] activity such as quinine and [CHEMICAL]quinidine[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 16
    },
    {
        "text": "Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at [GENE]dopamine D2 receptors[\\GENE], making them more resistant to displacement by endogenous [CHEMICAL]dopamine[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "For example, [CHEMICAL]clozapine[\\CHEMICAL] revealed a radioligand-independent value of 1.6 nM at the [GENE]dopamine D4 receptor[\\GENE], agreeing with the value directly measured with [3H]-clozapine at D4.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "For example, clozapine revealed a radioligand-independent value of 1.6 nM at the dopamine D4 receptor, agreeing with the value directly measured with [CHEMICAL][3H]-clozapine[\\CHEMICAL] at [GENE]D4[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "However, because [CHEMICAL]clozapine[\\CHEMICAL] competes with endogenous dopamine, the in vivo concentration of clozapine (to occupy [GENE]dopamine D4 receptors[\\GENE]) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "However, because clozapine competes with endogenous [CHEMICAL]dopamine[\\CHEMICAL], the in vivo concentration of clozapine (to occupy [GENE]dopamine D4 receptors[\\GENE]) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "However, because clozapine competes with endogenous dopamine, the in vivo concentration of [CHEMICAL]clozapine[\\CHEMICAL] (to occupy [GENE]dopamine D4 receptors[\\GENE]) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "FGFs signal through transmembrane receptor tyrosine kinases, but heparan [CHEMICAL]sulfate[\\CHEMICAL] is also required for signaling by members of the [GENE]FGF[\\GENE] family.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "We have examined the effect of dihydropyridine [GENE]Ca2+-channel[\\GENE] blockers [CHEMICAL]felodipine[\\CHEMICAL] and nicardipine on CaMPDE.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "We have examined the effect of dihydropyridine [GENE]Ca2+-channel[\\GENE] blockers felodipine and [CHEMICAL]nicardipine[\\CHEMICAL] on CaMPDE.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "We have examined the effect of [CHEMICAL]dihydropyridine[\\CHEMICAL] [GENE]Ca2+-channel[\\GENE] blockers felodipine and nicardipine on CaMPDE.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]Levodopa[\\CHEMICAL] is absorbed in the small bowel and is rapidly catabolized by [GENE]aromatic-L-amino-acid decarboxylase[\\GENE] (AADC) and catechol-O-methyltransferase (COMT).",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Levodopa[\\CHEMICAL] is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase ([GENE]AADC[\\GENE]) and catechol-O-methyltransferase (COMT).",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Levodopa[\\CHEMICAL] is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and [GENE]catechol-O-methyltransferase[\\GENE] (COMT).",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Levodopa[\\CHEMICAL] is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and catechol-O-methyltransferase ([GENE]COMT[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Both forms of the enzyme reacted with a rabbit antibody raised to the amino-terminal peptide of the liver enzyme, suggesting that [GENE]phosphodiester alpha-GlcNAcase[\\GENE] is a type I membrane-spanning glycoprotein with its [CHEMICAL]amino[\\CHEMICAL] terminus in the lumen of the Golgi apparatus.",
        "label": 1,
        "major": -1,
        "len": 40
    },
    {
        "text": "Both forms of the enzyme reacted with a rabbit antibody raised to the amino-terminal peptide of the liver enzyme, suggesting that phosphodiester alpha-GlcNAcase is a [GENE]type I membrane-spanning glycoprotein[\\GENE] with its [CHEMICAL]amino[\\CHEMICAL] terminus in the lumen of the Golgi apparatus.",
        "label": 1,
        "major": -1,
        "len": 40
    },
    {
        "text": "From these data, it is inferred that both the [GENE]SERT[\\GENE] and NET contribute to the active clearance of exogenously applied [CHEMICAL]5-HT[\\CHEMICAL] in the dentate gyrus.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "From these data, it is inferred that both the SERT and [GENE]NET[\\GENE] contribute to the active clearance of exogenously applied [CHEMICAL]5-HT[\\CHEMICAL] in the dentate gyrus.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "Along with weight loss, [CHEMICAL]orlistat[\\CHEMICAL] also favourably affects blood pressure and glucose and [GENE]insulin[\\GENE] levels in obese individuals and in obese type 2 diabetic patients.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "[CHEMICAL]LY 344864[\\CHEMICAL] appears to attenuate c-fos-like immunoreactivity via [GENE]5-HT1F[\\GENE] receptors, while sumatriptan acts via 5-HT1B receptors.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "LY 344864 appears to attenuate c-fos-like immunoreactivity via 5-HT1F receptors, while [CHEMICAL]sumatriptan[\\CHEMICAL] acts via [GENE]5-HT1B[\\GENE] receptors.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both [CHEMICAL]cAMP[\\CHEMICAL] and cGMP ([GENE]PDE10A[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "Cloning and characterization of a novel [GENE]human phosphodiesterase[\\GENE] that hydrolyzes both [CHEMICAL]cAMP[\\CHEMICAL] and cGMP (PDE10A).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and [CHEMICAL]cGMP[\\CHEMICAL] ([GENE]PDE10A[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "Cloning and characterization of a novel [GENE]human phosphodiesterase[\\GENE] that hydrolyzes both cAMP and [CHEMICAL]cGMP[\\CHEMICAL] (PDE10A).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "Recombinant [GENE]PDE10A[\\GENE] transfected and expressed in COS-7 cells hydrolyzed [CHEMICAL]cAMP[\\CHEMICAL] and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with cGMP was almost twice that with cAMP.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Recombinant [GENE]PDE10A[\\GENE] transfected and expressed in COS-7 cells hydrolyzed cAMP and [CHEMICAL]cGMP[\\CHEMICAL] with Km values of 0.26 and 7.2 microM, respectively, and Vmax with cGMP was almost twice that with cAMP.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Recombinant [GENE]PDE10A[\\GENE] transfected and expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with [CHEMICAL]cGMP[\\CHEMICAL] was almost twice that with cAMP.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Recombinant [GENE]PDE10A[\\GENE] transfected and expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with cGMP was almost twice that with [CHEMICAL]cAMP[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "To begin to examine whether these changes are mediated by alterations in gene expression for [GENE]tryptophan hydroxylase[\\GENE] (TPH), the rate-limiting enzyme in [CHEMICAL]5-HT[\\CHEMICAL] biosynthesis, we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR).",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase ([GENE]TPH[\\GENE]), the rate-limiting enzyme in [CHEMICAL]5-HT[\\CHEMICAL] biosynthesis, we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR).",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Both the phosphotriesterase and [CHEMICAL]physostigmine[\\CHEMICAL] treatments protected the brain [GENE]AChE[\\GENE] activities measured 24 h after sarin exposure.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Both the phosphotriesterase and physostigmine treatments protected the brain [GENE]AChE[\\GENE] activities measured 24 h after [CHEMICAL]sarin[\\CHEMICAL] exposure.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Our findings suggest that [CHEMICAL]torasemide[\\CHEMICAL] blocks the vasoconstrictor action of [GENE]Ang II[\\GENE] in vitro.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "Thus, our studies provide new insight into the regulation of [GENE]TH[\\GENE] by the concentration of [CHEMICAL]H4biopterin[\\CHEMICAL] which may have significant implications for the physiological regulation of catecholamine biosynthesis in neuroendocrine cells.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In addition a deletion in one of the alleles of the [GENE]deoxycytidine kinase[\\GENE] was detected in the [CHEMICAL]fludarabine[\\CHEMICAL]-resistant line.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Structure of [GENE]acetylcholinesterase[\\GENE] complexed with [CHEMICAL](-)-galanthamine[\\CHEMICAL] at 2.3 A resolution.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "Lithium's effects on [GENE]GluR3[\\GENE] desensitization are distinct from the effects of [CHEMICAL]aniracetam[\\CHEMICAL] on desensitization.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "OBJECTIVE: To determine the expression of [GENE]progesterone receptor[\\GENE] (PR) mRNA and PR protein levels in the myometrium and leiomyomata from untreated and [CHEMICAL]mifepristone[\\CHEMICAL] pretreated women with leiomyoma and to examine the mechanism of mifepristone treatment on uterine leiomyomata.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "OBJECTIVE: To determine the expression of progesterone receptor ([GENE]PR[\\GENE]) mRNA and PR protein levels in the myometrium and leiomyomata from untreated and [CHEMICAL]mifepristone[\\CHEMICAL] pretreated women with leiomyoma and to examine the mechanism of mifepristone treatment on uterine leiomyomata.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "OBJECTIVE: To determine the expression of progesterone receptor (PR) mRNA and [GENE]PR protein[\\GENE] levels in the myometrium and leiomyomata from untreated and [CHEMICAL]mifepristone[\\CHEMICAL] pretreated women with leiomyoma and to examine the mechanism of mifepristone treatment on uterine leiomyomata.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "METHODS: Expression of [GENE]PR mRNA[\\GENE] and PR protein were determined by Northern blot and HAP of single-dose saturated analysis in myometrium and leiomyomata (center and marginal area) from 27 untreated and 6 [CHEMICAL]mifepristone[\\CHEMICAL] pretreated women with leiomyomata.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "METHODS: Expression of PR mRNA and [GENE]PR protein[\\GENE] were determined by Northern blot and HAP of single-dose saturated analysis in myometrium and leiomyomata (center and marginal area) from 27 untreated and 6 [CHEMICAL]mifepristone[\\CHEMICAL] pretreated women with leiomyomata.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[Effect of [CHEMICAL]mifepristone[\\CHEMICAL] on the expression of [GENE]progesterone receptor[\\GENE] messenger RNA and protein in uterine leiomyomata].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of [CHEMICAL]felbamate[\\CHEMICAL] block of recombinant [GENE]NMDA receptors[\\GENE] composed of the NR1a subunit and various NR2 subunits.",
        "label": 4,
        "major": -1,
        "len": 37
    },
    {
        "text": "To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of [CHEMICAL]felbamate[\\CHEMICAL] block of recombinant NMDA receptors composed of the [GENE]NR1a[\\GENE] subunit and various NR2 subunits.",
        "label": 4,
        "major": -1,
        "len": 37
    },
    {
        "text": "To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of [CHEMICAL]felbamate[\\CHEMICAL] block of recombinant NMDA receptors composed of the NR1a subunit and various [GENE]NR2[\\GENE] subunits.",
        "label": 4,
        "major": -1,
        "len": 37
    },
    {
        "text": "[CHEMICAL]Felbamate[\\CHEMICAL] block of recombinant [GENE]N-methyl-D-aspartate receptors[\\GENE]: selectivity for the NR2B subunit.",
        "label": 4,
        "major": -1,
        "len": 11
    },
    {
        "text": "[CHEMICAL]Felbamate[\\CHEMICAL] block of recombinant N-methyl-D-aspartate receptors: selectivity for the [GENE]NR2B[\\GENE] subunit.",
        "label": 4,
        "major": -1,
        "len": 11
    },
    {
        "text": "We conclude that [CHEMICAL]felbamate[\\CHEMICAL] exhibits modest selectivity for [GENE]NMDA receptors[\\GENE] composed of NR1a/NR2B subunits.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "We conclude that [CHEMICAL]felbamate[\\CHEMICAL] exhibits modest selectivity for NMDA receptors composed of [GENE]NR1a[\\GENE]/NR2B subunits.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "We conclude that [CHEMICAL]felbamate[\\CHEMICAL] exhibits modest selectivity for NMDA receptors composed of NR1a/[GENE]NR2B[\\GENE] subunits.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]Orlistat[\\CHEMICAL] treatment also results in modest improvements in total cholesterol, [GENE]low-density lipoprotein[\\GENE], blood pressure, and fasting glucose and insulin concentrations.",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Orlistat[\\CHEMICAL] treatment also results in modest improvements in total cholesterol, low-density lipoprotein, blood pressure, and fasting glucose and [GENE]insulin[\\GENE] concentrations.",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "In the liver of rats given [CHEMICAL]flutamide[\\CHEMICAL] as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks, [GENE]gamma-glutamyltraspeptidase[\\GENE]-positive foci were detected only in 3 of 10 rats.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Neostigmine[\\CHEMICAL] enhances excitatory parasympathetic activity by competing with acetylcholine for attachment to [GENE]acetylcholinesterase[\\GENE] at sites of cholinergic transmission and enhancing cholinergic action.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Neostigmine enhances excitatory parasympathetic activity by competing with [CHEMICAL]acetylcholine[\\CHEMICAL] for attachment to [GENE]acetylcholinesterase[\\GENE] at sites of cholinergic transmission and enhancing cholinergic action.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "The enzyme [GENE]dimethylarginine dimethylaminohydrolase[\\GENE] (DDAH) specifically hydrolyzes these asymmetrically methylated [CHEMICAL]arginine[\\CHEMICAL] residues to citrulline and methylamines.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "The enzyme dimethylarginine dimethylaminohydrolase ([GENE]DDAH[\\GENE]) specifically hydrolyzes these asymmetrically methylated [CHEMICAL]arginine[\\CHEMICAL] residues to citrulline and methylamines.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Previously we have proposed that regulation of asymmetric [CHEMICAL]methylarginine[\\CHEMICAL] concentration by [GENE]DDAH[\\GENE] may provide a novel mechanism for the regulation of NOS activity in vivo.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "To further confirm this hypothesis, we investigated the effects of dietary treatment with [CHEMICAL]BH(4)[\\CHEMICAL] on endothelium-dependent arterial relaxation and vascular oxidative stress in the aortas of [GENE]insulin[\\GENE]-resistant rats.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The [CHEMICAL]BH(4)[\\CHEMICAL] treatment also partially improved the [GENE]insulin[\\GENE] sensitivity and blood pressure, as well as the serum triglyceride concentration, in the fructose-fed rats.",
        "label": 3,
        "major": -1,
        "len": 23
    },
    {
        "text": "BACKGROUND: [CHEMICAL]Serotonin[\\CHEMICAL][GENE]Serotonin 5-HT(4) receptors[\\GENE] are located on enteric cholinergic neurones and may regulate peristalsis.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "In the current studies, we show that two different classes (ATP-sensitive and -insensitive) of TOP2 poisons can be identified based on their differential sensitivity to the [CHEMICAL]ATP[\\CHEMICAL]-bound conformation of [GENE]TOP2[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "These results suggest that [CHEMICAL]ATP[\\CHEMICAL]-bound [GENE]TOP2[\\GENE] may be the specific target of ATP-sensitive TOP2 poisons.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "These results suggest that ATP-bound [GENE]TOP2[\\GENE] may be the specific target of [CHEMICAL]ATP[\\CHEMICAL]-sensitive TOP2 poisons.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Using Lac repressor-operator complexes as roadblocks, we show that [CHEMICAL]ATP[\\CHEMICAL]-bound [GENE]TOP2[\\GENE] acts as a circular clamp capable of entering DNA ends and sliding on unobstructed duplex DNA.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "These results suggest that [GENE]ACS1[\\GENE] and ACS4 may be linked to [CHEMICAL]triacylglycerol[\\CHEMICAL] synthesis.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "These results suggest that ACS1 and [GENE]ACS4[\\GENE] may be linked to [CHEMICAL]triacylglycerol[\\CHEMICAL] synthesis.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "The antipsychotic drugs [CHEMICAL]sertindole[\\CHEMICAL] and pimozide block [GENE]erg3[\\GENE], a human brain K(+) channel.",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "The antipsychotic drugs [CHEMICAL]sertindole[\\CHEMICAL] and pimozide block erg3, a [GENE]human brain K(+) channel[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "The antipsychotic drugs sertindole and [CHEMICAL]pimozide[\\CHEMICAL] block [GENE]erg3[\\GENE], a human brain K(+) channel.",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "The antipsychotic drugs sertindole and [CHEMICAL]pimozide[\\CHEMICAL] block erg3, a [GENE]human brain K(+) channel[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "Block of [GENE]erg3[\\GENE] by [CHEMICAL]sertindole[\\CHEMICAL] also displayed a positive voltage-dependence.",
        "label": 4,
        "major": -1,
        "len": 10
    },
    {
        "text": "We conclude that [GENE]erg3[\\GENE] can be blocked by certain antipsychotic drugs like [CHEMICAL]sertindole[\\CHEMICAL] and pimozide.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "We conclude that [GENE]erg3[\\GENE] can be blocked by certain antipsychotic drugs like sertindole and [CHEMICAL]pimozide[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "In addition to studies focused on the mechanisms of [GENE]nuclear receptor[\\GENE] function, additional work has illuminated the mechanism by which [CHEMICAL]androgens[\\CHEMICAL] are metabolized in selected tissues.",
        "label": 7,
        "major": -1,
        "len": 26
    },
    {
        "text": "By theoretical calculations we have determined most probable structure of [CHEMICAL]amiloride[\\CHEMICAL]/[GENE]uPAs[\\GENE] complexes.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "In a panel of human breast cancer and other epithelial tumor cell lines, [GENE]HER2[\\GENE]-overexpressing tumors were particularly sensitive to [CHEMICAL]ZD1839[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to [CHEMICAL]glucose[\\CHEMICAL], mitiglinide, tolbutamide, and glibenclamide in MIN6 cells after chronic mitiglinide, nateglinide, or repaglinide treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, [CHEMICAL]mitiglinide[\\CHEMICAL], tolbutamide, and glibenclamide in MIN6 cells after chronic mitiglinide, nateglinide, or repaglinide treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, [CHEMICAL]tolbutamide[\\CHEMICAL], and glibenclamide in MIN6 cells after chronic mitiglinide, nateglinide, or repaglinide treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, tolbutamide, and [CHEMICAL]glibenclamide[\\CHEMICAL] in MIN6 cells after chronic mitiglinide, nateglinide, or repaglinide treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, tolbutamide, and glibenclamide in MIN6 cells after chronic [CHEMICAL]mitiglinide[\\CHEMICAL], nateglinide, or repaglinide treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, tolbutamide, and glibenclamide in MIN6 cells after chronic mitiglinide, [CHEMICAL]nateglinide[\\CHEMICAL], or repaglinide treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, tolbutamide, and glibenclamide in MIN6 cells after chronic mitiglinide, nateglinide, or [CHEMICAL]repaglinide[\\CHEMICAL] treatment were comparable to those after chronic tolbutamide and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, tolbutamide, and glibenclamide in MIN6 cells after chronic mitiglinide, nateglinide, or repaglinide treatment were comparable to those after chronic [CHEMICAL]tolbutamide[\\CHEMICAL] and glibenclamide treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [GENE]insulin[\\GENE] responses to glucose, mitiglinide, tolbutamide, and glibenclamide in MIN6 cells after chronic mitiglinide, nateglinide, or repaglinide treatment were comparable to those after chronic tolbutamide and [CHEMICAL]glibenclamide[\\CHEMICAL] treatment.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "These results indicate that, similar to the [CHEMICAL]sulfonylureas[\\CHEMICAL], mitiglinide is highly specific to the [GENE]Kir6.2[\\GENE]/SUR1 complex, i.e., the pancreatic beta-cell K(ATP) channel, and suggest that mitiglinide may be a clinically useful anti-diabetic drug.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "These results indicate that, similar to the [CHEMICAL]sulfonylureas[\\CHEMICAL], mitiglinide is highly specific to the Kir6.2/[GENE]SUR1[\\GENE] complex, i.e., the pancreatic beta-cell K(ATP) channel, and suggest that mitiglinide may be a clinically useful anti-diabetic drug.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "These results indicate that, similar to the [CHEMICAL]sulfonylureas[\\CHEMICAL], mitiglinide is highly specific to the Kir6.2/SUR1 complex, i.e., the pancreatic beta-cell [GENE]K(ATP) channel[\\GENE], and suggest that mitiglinide may be a clinically useful anti-diabetic drug.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "These results indicate that, similar to the sulfonylureas, [CHEMICAL]mitiglinide[\\CHEMICAL] is highly specific to the Kir6.2/[GENE]SUR1[\\GENE] complex, i.e., the pancreatic beta-cell K(ATP) channel, and suggest that mitiglinide may be a clinically useful anti-diabetic drug.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "These results indicate that, similar to the sulfonylureas, [CHEMICAL]mitiglinide[\\CHEMICAL] is highly specific to the Kir6.2/SUR1 complex, i.e., the pancreatic beta-cell [GENE]K(ATP) channel[\\GENE], and suggest that mitiglinide may be a clinically useful anti-diabetic drug.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "The effects of [CHEMICAL]mitiglinide[\\CHEMICAL] (KAD-1229), a new anti-diabetic drug, on [GENE]ATP-sensitive K+ channels[\\GENE] and insulin secretion: comparison with the sulfonylureas and nateglinide.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "The effects of [CHEMICAL]mitiglinide[\\CHEMICAL] (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and [GENE]insulin[\\GENE] secretion: comparison with the sulfonylureas and nateglinide.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "The effects of mitiglinide ([CHEMICAL]KAD-1229[\\CHEMICAL]), a new anti-diabetic drug, on [GENE]ATP-sensitive K+ channels[\\GENE] and insulin secretion: comparison with the sulfonylureas and nateglinide.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "The effects of mitiglinide ([CHEMICAL]KAD-1229[\\CHEMICAL]), a new anti-diabetic drug, on ATP-sensitive K+ channels and [GENE]insulin[\\GENE] secretion: comparison with the sulfonylureas and nateglinide.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "These results indicate that, similar to the sulfonylureas, mitiglinide is highly specific to the Kir6.2/SUR1 complex, i.e., the pancreatic beta-cell [GENE]K(ATP) channel[\\GENE], and suggest that [CHEMICAL]mitiglinide[\\CHEMICAL] may be a clinically useful anti-diabetic drug.",
        "label": 5,
        "major": -1,
        "len": 33
    },
    {
        "text": "Taken together, these results reveal several differences between effects of [CHEMICAL]MDMA[\\CHEMICAL] and previously reported METH on [GENE]DAT[\\GENE] and VMAT-2; differences that may underlie the dissimilar neurotoxic profile of these agents.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Taken together, these results reveal several differences between effects of [CHEMICAL]MDMA[\\CHEMICAL] and previously reported METH on DAT and [GENE]VMAT-2[\\GENE]; differences that may underlie the dissimilar neurotoxic profile of these agents.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Taken together, these results reveal several differences between effects of MDMA and previously reported [CHEMICAL]METH[\\CHEMICAL] on [GENE]DAT[\\GENE] and VMAT-2; differences that may underlie the dissimilar neurotoxic profile of these agents.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Taken together, these results reveal several differences between effects of MDMA and previously reported [CHEMICAL]METH[\\CHEMICAL] on DAT and [GENE]VMAT-2[\\GENE]; differences that may underlie the dissimilar neurotoxic profile of these agents.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "A number of agents are being developed that target molecular abnormalities in IEN, have fewer or different side effects than [CHEMICAL]tamoxifen[\\CHEMICAL], and may be effective in [GENE]ER[\\GENE]-negative or tamoxifen-resistant disease.",
        "label": 7,
        "major": -1,
        "len": 30
    },
    {
        "text": "[GENE]MCP-1[\\GENE] and MIP-2 was tested after 1, 10, 20, 30, and 40 days post inoculation, before and after [CHEMICAL]mimosine[\\CHEMICAL] treatment.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "MCP-1 and [GENE]MIP-2[\\GENE] was tested after 1, 10, 20, 30, and 40 days post inoculation, before and after [CHEMICAL]mimosine[\\CHEMICAL] treatment.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Finally, we illustrate how [CHEMICAL]BH4[\\CHEMICAL] might transform the [GENE]NOS[\\GENE] dimer into an efficient S-nitrosoglutathione synthase,and briefly touch on some more speculative aspects of the role of BH4 in NO synthesis.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Finally, we illustrate how [CHEMICAL]BH4[\\CHEMICAL] might transform the NOS dimer into an efficient [GENE]S-nitrosoglutathione synthase[\\GENE],and briefly touch on some more speculative aspects of the role of BH4 in NO synthesis.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "The clinical profile of the [GENE]angiotensin II receptor[\\GENE] blocker [CHEMICAL]eprosartan[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 10
    },
    {
        "text": "The [CHEMICAL]4',7,8-trichloro[\\CHEMICAL] analogue (38) of mazindol was the most potent and selective ligand for HEK-[GENE]hDAT[\\GENE] cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The [CHEMICAL]4',7,8-trichloro[\\CHEMICAL] analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells ([GENE]DAT[\\GENE] K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The [CHEMICAL]4',7,8-trichloro[\\CHEMICAL] analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; [GENE]SERT[\\GENE]/DAT = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The [CHEMICAL]4',7,8-trichloro[\\CHEMICAL] analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/[GENE]DAT[\\GENE] = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The [CHEMICAL]4',7,8-trichloro[\\CHEMICAL] analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and [GENE]NET[\\GENE]/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The [CHEMICAL]4',7,8-trichloro[\\CHEMICAL] analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/[GENE]DAT[\\GENE] = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The 4',7,8-trichloro analogue (38) of [CHEMICAL]mazindol[\\CHEMICAL] was the most potent and selective ligand for HEK-[GENE]hDAT[\\GENE] cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The 4',7,8-trichloro analogue (38) of [CHEMICAL]mazindol[\\CHEMICAL] was the most potent and selective ligand for HEK-hDAT cells ([GENE]DAT[\\GENE] K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The 4',7,8-trichloro analogue (38) of [CHEMICAL]mazindol[\\CHEMICAL] was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; [GENE]SERT[\\GENE]/DAT = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The 4',7,8-trichloro analogue (38) of [CHEMICAL]mazindol[\\CHEMICAL] was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/[GENE]DAT[\\GENE] = 1283 and NET/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The 4',7,8-trichloro analogue (38) of [CHEMICAL]mazindol[\\CHEMICAL] was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and [GENE]NET[\\GENE]/DAT = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The 4',7,8-trichloro analogue (38) of [CHEMICAL]mazindol[\\CHEMICAL] was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/[GENE]DAT[\\GENE] = 38).",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "Ntp and Ctp, synthetic peptides based on the [CHEMICAL]N[\\CHEMICAL]- and C-terminal sequences of [GENE]K(IR)6.0[\\GENE], respectively, were used to probe gating of K(IR)6.0/SUR K(ATP) channels.",
        "label": 1,
        "major": -1,
        "len": 24
    },
    {
        "text": "Ntp and Ctp, synthetic peptides based on the N- and [CHEMICAL]C[\\CHEMICAL]-terminal sequences of [GENE]K(IR)6.0[\\GENE], respectively, were used to probe gating of K(IR)6.0/SUR K(ATP) channels.",
        "label": 1,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [GENE]K(IR)[\\GENE] [CHEMICAL]N[\\CHEMICAL] terminus and the TMD0-L0 segment of SUR1 are known to control the P(O(max)).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The [GENE]COX[\\GENE] pathway generates inflammatory [CHEMICAL]prostaglandins[\\CHEMICAL], while the 5-LOX pathway generates inflammatory leukotrienes.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "The COX pathway generates inflammatory prostaglandins, while the [GENE]5-LOX[\\GENE] pathway generates inflammatory [CHEMICAL]leukotrienes[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "D-Serine was previously identified in mammalian brain and was shown to be a co-agonist at the '[CHEMICAL]glycine[\\CHEMICAL]' site of the [GENE]N-methyl-D-aspartate (NMDA)-type receptors[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 23
    },
    {
        "text": "[CHEMICAL]D-Serine[\\CHEMICAL] was previously identified in mammalian brain and was shown to be a co-agonist at the 'glycine' site of the [GENE]N-methyl-D-aspartate (NMDA)-type receptors[\\GENE].",
        "label": 5,
        "major": -1,
        "len": 23
    },
    {
        "text": "[CHEMICAL]Cetrorelix[\\CHEMICAL] completely blocked the rise of levels of the two most abundant species, 5.0 kb and 4.5 kb, of the [GENE]GnRH-R[\\GENE] mRNA, during both the infantile and the juvenile periods.",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Cetrorelix[\\CHEMICAL] also abolished the developmental rise of the [GENE]gonadotropin beta[\\GENE] subunit mRNAs during the two periods of the study.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "On the other hand, high doses of [CHEMICAL]okadaic acid[\\CHEMICAL] (10 ng/mouse, i.c.v.) ), which also block [GENE]PP1[\\GENE], and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.",
        "label": 4,
        "major": -1,
        "len": 23
    },
    {
        "text": "and [CHEMICAL]cantharidin[\\CHEMICAL] (1 microg/mouse, i.c.v. ), which also block [GENE]PP1[\\GENE], and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.",
        "label": 4,
        "major": -1,
        "len": 16
    },
    {
        "text": "These differences were also present in [GENE]bovine M-CPT 1[\\GENE], whose [CHEMICAL]N[\\CHEMICAL]-terminal sequence we determined.",
        "label": 1,
        "major": -1,
        "len": 14
    },
    {
        "text": "The ratio between the GDC/[GENE]SHMT[\\GENE] and C1-THF synthase/SHMT pathways of [CHEMICAL]Ser[\\CHEMICAL] synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "The ratio between the GDC/SHMT and C1-THF synthase/[GENE]SHMT[\\GENE] pathways of [CHEMICAL]Ser[\\CHEMICAL] synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "On the other hand, the accumulation of [CHEMICAL]Ser[\\CHEMICAL] through the C1-THF synthase/[GENE]SHMT[\\GENE] pathway in glyD plants was 2.5-fold greater than that in WT plants.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis; the breakdown of formate to [CHEMICAL]CO(2)[\\CHEMICAL] by the [GENE]FDH[\\GENE] reaction is the primary and preferred fate of the organic acid in Arabidopsis.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The ratio between the [GENE]GDC[\\GENE]/SHMT and C1-THF synthase/SHMT pathways of Ser synthesis from [CHEMICAL][alpha-(13)C]Gly[\\CHEMICAL] and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "The ratio between the GDC/SHMT and [GENE]C1-THF synthase[\\GENE]/SHMT pathways of Ser synthesis from [alpha-(13)C]Gly and [CHEMICAL][(13)C]formate[\\CHEMICAL], respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the [GENE]glycine decarboxylase complex[\\GENE] (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with [CHEMICAL]glycine[\\CHEMICAL] (Gly) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex ([GENE]GDC[\\GENE], EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with [CHEMICAL]glycine[\\CHEMICAL] (Gly) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, [GENE]EC 2.1.1.10[\\GENE]) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with [CHEMICAL]glycine[\\CHEMICAL] (Gly) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and [GENE]serine hydroxymethyltransferase[\\GENE] (SHMT, EC 2.1.2.1) with [CHEMICAL]glycine[\\CHEMICAL] (Gly) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase ([GENE]SHMT[\\GENE], EC 2.1.2.1) with [CHEMICAL]glycine[\\CHEMICAL] (Gly) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, [GENE]EC 2.1.2.1[\\GENE]) with [CHEMICAL]glycine[\\CHEMICAL] (Gly) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the [GENE]glycine decarboxylase complex[\\GENE] (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine ([CHEMICAL]Gly[\\CHEMICAL]) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex ([GENE]GDC[\\GENE], EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine ([CHEMICAL]Gly[\\CHEMICAL]) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, [GENE]EC 2.1.1.10[\\GENE]) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine ([CHEMICAL]Gly[\\CHEMICAL]) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and [GENE]serine hydroxymethyltransferase[\\GENE] (SHMT, EC 2.1.2.1) with glycine ([CHEMICAL]Gly[\\CHEMICAL]) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase ([GENE]SHMT[\\GENE], EC 2.1.2.1) with glycine ([CHEMICAL]Gly[\\CHEMICAL]) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, [GENE]EC 2.1.2.1[\\GENE]) with glycine ([CHEMICAL]Gly[\\CHEMICAL]) as one-carbon (1-C) source.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "An alternative THF-dependent pathway involves the [GENE]C1-THF synthase[\\GENE]/SHMT activities with [CHEMICAL]formate[\\CHEMICAL] as 1-C source.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "An alternative THF-dependent pathway involves the C1-THF synthase/[GENE]SHMT[\\GENE] activities with [CHEMICAL]formate[\\CHEMICAL] as 1-C source.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Firstly, transgenic plants overexpressing [GENE]formate dehydrogenase[\\GENE] (FDH, EC 1.2.1.2) were used to continue our previous studies on the function of FDH in [CHEMICAL]formate[\\CHEMICAL] metabolism.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "Firstly, transgenic plants overexpressing formate dehydrogenase ([GENE]FDH[\\GENE], EC 1.2.1.2) were used to continue our previous studies on the function of FDH in [CHEMICAL]formate[\\CHEMICAL] metabolism.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "Firstly, transgenic plants overexpressing formate dehydrogenase (FDH, [GENE]EC 1.2.1.2[\\GENE]) were used to continue our previous studies on the function of FDH in [CHEMICAL]formate[\\CHEMICAL] metabolism.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "Firstly, transgenic plants overexpressing formate dehydrogenase (FDH, EC 1.2.1.2) were used to continue our previous studies on the function of [GENE]FDH[\\GENE] in [CHEMICAL]formate[\\CHEMICAL] metabolism.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis; the breakdown of [CHEMICAL]formate[\\CHEMICAL] to CO(2) by the [GENE]FDH[\\GENE] reaction is the primary and preferred fate of the organic acid in Arabidopsis.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "BACKGROUND & AIMS: Of the 2 genes (MAT1A, MAT2A) encoding methionine adenosyltransferase, the enzyme that synthesizes [CHEMICAL]S-adenosylmethionine[\\CHEMICAL], [GENE]MAT1A[\\GENE], is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "BACKGROUND & AIMS: Of the 2 genes ([GENE]MAT1A[\\GENE], MAT2A) encoding methionine adenosyltransferase, the enzyme that synthesizes [CHEMICAL]S-adenosylmethionine[\\CHEMICAL], MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "BACKGROUND & AIMS: Of the 2 genes (MAT1A, [GENE]MAT2A[\\GENE]) encoding methionine adenosyltransferase, the enzyme that synthesizes [CHEMICAL]S-adenosylmethionine[\\CHEMICAL], MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "BACKGROUND & AIMS: Of the 2 genes (MAT1A, MAT2A) encoding [GENE]methionine adenosyltransferase[\\GENE], the enzyme that synthesizes [CHEMICAL]S-adenosylmethionine[\\CHEMICAL], MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "The protein exhibited modest [CHEMICAL]H(2)O(2)[\\CHEMICAL]-dependent [GENE]peroxidase[\\GENE] activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).",
        "label": 3,
        "major": -1,
        "len": 15
    },
    {
        "text": "The protein exhibited modest H(2)O(2)-dependent [GENE]peroxidase[\\GENE] activities with [CHEMICAL]guaiacol[\\CHEMICAL], potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "The protein exhibited modest H(2)O(2)-dependent [GENE]peroxidase[\\GENE] activities with guaiacol, [CHEMICAL]potassium iodide[\\CHEMICAL], and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "The protein exhibited modest H(2)O(2)-dependent [GENE]peroxidase[\\GENE] activities with guaiacol, potassium iodide, and [CHEMICAL]2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid[\\CHEMICAL] (ABTS).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "The protein exhibited modest H(2)O(2)-dependent [GENE]peroxidase[\\GENE] activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid ([CHEMICAL]ABTS[\\CHEMICAL]).",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]Topiramate[\\CHEMICAL] also partially depressed predominantly [GENE]AMPA-receptor[\\GENE]-mediated EPSCs, but with lower efficacy.",
        "label": 4,
        "major": -1,
        "len": 11
    },
    {
        "text": "Effects of [CHEMICAL]5-aza-2'-deoxycytidine[\\CHEMICAL] on [GENE]fetal hemoglobin[\\GENE] levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Naloxone[\\CHEMICAL] (alone) treatment of rats had no effect on the levels of CREB and [GENE]p-CREB[\\GENE] protein in the nucleus accumbens.",
        "label": 10,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Naloxone[\\CHEMICAL] (alone) treatment of rats had no effect on the levels of [GENE]CREB[\\GENE] and p-CREB protein in the nucleus accumbens.",
        "label": 10,
        "major": -1,
        "len": 20
    },
    {
        "text": "The decrement of [GENE]p-CREB[\\GENE] protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of [CHEMICAL]ethanol[\\CHEMICAL] withdrawal, which recovered toward control level after 7 d of ethanol withdrawal.",
        "label": 4,
        "major": -1,
        "len": 34
    },
    {
        "text": "The decrement of [GENE]p-CREB[\\GENE] protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of ethanol withdrawal, which recovered toward control level after 7 d of [CHEMICAL]ethanol[\\CHEMICAL] withdrawal.",
        "label": 4,
        "major": -1,
        "len": 34
    },
    {
        "text": "Administration of [CHEMICAL]zuclopenthixol[\\CHEMICAL] (0.7 and 1.4 mg/kg i.p.) neither affected dopamine (DA) level nor [GENE]AChE[\\GENE] activity in rat cortex and hippocampus.",
        "label": 10,
        "major": -1,
        "len": 21
    },
    {
        "text": "This study also investigated the effect of [CHEMICAL]zuclopenthixol[\\CHEMICAL] on cortical and hippocampal monoaminergic neurotransmitters' levels together with [GENE]acetylcholinesterase[\\GENE] enzyme (AChE) activity, both of which are known to be important in control of cognitive function.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "This study also investigated the effect of [CHEMICAL]zuclopenthixol[\\CHEMICAL] on cortical and hippocampal monoaminergic neurotransmitters' levels together with acetylcholinesterase enzyme ([GENE]AChE[\\GENE]) activity, both of which are known to be important in control of cognitive function.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Synthesis and in vitro pharmacology at [CHEMICAL]AMPA[\\CHEMICAL] and kainate preferring [GENE]glutamate receptors[\\GENE] of 4-heteroarylmethylidene glutamate analogues.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Synthesis and in vitro pharmacology at AMPA and [CHEMICAL]kainate[\\CHEMICAL] preferring [GENE]glutamate receptors[\\GENE] of 4-heteroarylmethylidene glutamate analogues.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Synthesis and in vitro pharmacology at AMPA and kainate preferring [GENE]glutamate receptors[\\GENE] of [CHEMICAL]4-heteroarylmethylidene glutamate[\\CHEMICAL] analogues.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor [CHEMICAL]chloramine T[\\CHEMICAL] (CT), to destroy [GENE]plasmatic PAI-1[\\GENE] and alpha2-antiplasmin.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor [CHEMICAL]chloramine T[\\CHEMICAL] (CT), to destroy plasmatic PAI-1 and alpha2-anti[GENE]plasmin[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor chloramine T ([CHEMICAL]CT[\\CHEMICAL]), to destroy [GENE]plasmatic PAI-1[\\GENE] and alpha2-antiplasmin.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor chloramine T ([CHEMICAL]CT[\\CHEMICAL]), to destroy plasmatic PAI-1 and alpha2-anti[GENE]plasmin[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the [CHEMICAL]singlet oxygen[\\CHEMICAL] (1O2) donor chloramine T (CT), to destroy [GENE]plasmatic PAI-1[\\GENE] and alpha2-antiplasmin.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen ([CHEMICAL]1O2[\\CHEMICAL]) donor chloramine T (CT), to destroy [GENE]plasmatic PAI-1[\\GENE] and alpha2-antiplasmin.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "After 0 to 80 minutes (37 degrees C), 50-microL samples were withdrawn and added to 100 microL 1.5 M arginine, pH 8.7, and oxidized with 50 microL of 20 mM CT. For determination of [GENE]plasmin[\\GENE] activity, 10 microL thereof was incubated with 150 microL 1.5 M [CHEMICAL]arginine[\\CHEMICAL], pH 8.7, and 100 microL 20 mM CT preoxidized (15 minutes 37 degrees C) pooled normal citrate buffered EDTA-plasma for 30 minutes (37 degrees C).",
        "label": 9,
        "major": -1,
        "len": 72
    },
    {
        "text": "For determination of [[GENE]PA[\\GENE]+Pli]-activity, [CHEMICAL]arginine[\\CHEMICAL] was added after this incubation.",
        "label": 9,
        "major": -1,
        "len": 10
    },
    {
        "text": "For determination of [PA+[GENE]Pli[\\GENE]]-activity, [CHEMICAL]arginine[\\CHEMICAL] was added after this incubation.",
        "label": 9,
        "major": -1,
        "len": 10
    },
    {
        "text": "METHODS: Sedative and cardiovascular responses to [CHEMICAL]etomidate[\\CHEMICAL] and the alpha2-agonist, dexmedetomidine, were determined in mice deficient in [GENE]alpha2-receptor[\\GENE] subtypes.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "METHODS: Sedative and cardiovascular responses to etomidate and the alpha2-agonist, [CHEMICAL]dexmedetomidine[\\CHEMICAL], were determined in mice deficient in [GENE]alpha2-receptor[\\GENE] subtypes.",
        "label": 5,
        "major": -1,
        "len": 19
    },
    {
        "text": "However, [GENE]NMDA receptors[\\GENE] appear to be a key target of [CHEMICAL]memantine[\\CHEMICAL] at therapeutic concentrations.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Mechanisms of [CHEMICAL]cefadroxil[\\CHEMICAL] uptake in the choroid plexus: studies in wild-type and [GENE]PEPT2[\\GENE] knockout mice.",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "Receptor trafficking demonstrated surface expression of [GENE]beta2AR[\\GENE] with vehicle treatment and internalization following [CHEMICAL]isoproterenol[\\CHEMICAL] treatment.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Serum [CHEMICAL]carvedilol[\\CHEMICAL] concentration and its relation to change in plasma [GENE]brain natriuretic peptide[\\GENE] level in the treatment of heart failure: a preliminary study.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "The degree of improvement in heart failure was assessed from the ratio of change in the plasma [GENE]BNP[\\GENE] concentration, 2 weeks, 1 month and 3 months after the commencement of [CHEMICAL]carvedilol[\\CHEMICAL] administration.",
        "label": 2,
        "major": -1,
        "len": 32
    },
    {
        "text": "OBJECTIVE: To examine the influence of [CHEMICAL]carvedilol[\\CHEMICAL] dose and concentration in serum on plasma brain natriuretic peptide ([GENE]BNP[\\GENE]), a measure of heart failure progression.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "OBJECTIVE: To examine the influence of [CHEMICAL]carvedilol[\\CHEMICAL] dose and concentration in serum on plasma [GENE]brain natriuretic peptide[\\GENE] (BNP), a measure of heart failure progression.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "In the present study, we measured the enzyme activity of [GENE]thymidine kinase[\\GENE] (TK), thymidine phosphorylase (TP) and thymidilate synthase (TS) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of [CHEMICAL]TAS-102[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "In the present study, we measured the enzyme activity of thymidine kinase (TK), [GENE]thymidine phosphorylase[\\GENE] (TP) and thymidilate synthase (TS) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of [CHEMICAL]TAS-102[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "Antitumor activity of [CHEMICAL]TAS-102[\\CHEMICAL] appears to be associated with TK, tumor growth and [GENE]TS[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "In the present study, we measured the enzyme activity of thymidine kinase (TK), thymidine phosphorylase (TP) and [GENE]thymidilate synthase[\\GENE] (TS) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of [CHEMICAL]TAS-102[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 36
    },
    {
        "text": "In the present study, we measured the enzyme activity of thymidine kinase (TK), thymidine phosphorylase (TP) and thymidilate synthase ([GENE]TS[\\GENE]) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of [CHEMICAL]TAS-102[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 36
    },
    {
        "text": "In conclusion, TK and [CHEMICAL]TPI[\\CHEMICAL] effects on [GENE]TP[\\GENE] play important roles in the cytotoxic action of TAS-102, and it is possible to use the TK/TP ratio to predict more precisely individual resistance or sensitivity.",
        "label": 8,
        "major": -1,
        "len": 34
    },
    {
        "text": "The expression of the [CHEMICAL]NH2[\\CHEMICAL] terminally truncated [GENE]ErbB2[\\GENE] receptor (p95ErbB2) in breast cancer correlates with metastatic disease progression compared with the expression of full-length p185ErbB2.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "The expression of the [CHEMICAL]NH2[\\CHEMICAL] terminally truncated ErbB2 receptor ([GENE]p95ErbB2[\\GENE]) in breast cancer correlates with metastatic disease progression compared with the expression of full-length p185ErbB2.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "Thus, [GENE]p95ErbB2[\\GENE] represents a target for therapeutic intervention, and one that is sensitive to [CHEMICAL]GW572016[\\CHEMICAL] therapy.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Phosphatidylserine[\\CHEMICAL] (PtdSer) is made in mammalian cells by two [GENE]PtdSer synthases[\\GENE], PSS1 and PSS2.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]Phosphatidylserine[\\CHEMICAL] (PtdSer) is made in mammalian cells by two PtdSer synthases, [GENE]PSS1[\\GENE] and PSS2.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]Phosphatidylserine[\\CHEMICAL] (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and [GENE]PSS2[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]Phenytoin[\\CHEMICAL] (diphenylhydantoin, DPH) is an established [GENE]sodium channel[\\GENE] blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "label": 4,
        "major": -1,
        "len": 29
    },
    {
        "text": "Block of human NaV1.5 [GENE]sodium channels[\\GENE] by novel [CHEMICAL]alpha-hydroxyphenylamide[\\CHEMICAL] analogues of phenytoin.",
        "label": 4,
        "major": -1,
        "len": 12
    },
    {
        "text": "Block of [GENE]human NaV1.5[\\GENE] sodium channels by novel [CHEMICAL]alpha-hydroxyphenylamide[\\CHEMICAL] analogues of phenytoin.",
        "label": 4,
        "major": -1,
        "len": 12
    },
    {
        "text": "Block of human NaV1.5 [GENE]sodium channels[\\GENE] by novel alpha-hydroxyphenylamide analogues of [CHEMICAL]phenytoin[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 12
    },
    {
        "text": "Block of [GENE]human NaV1.5[\\GENE] sodium channels by novel alpha-hydroxyphenylamide analogues of [CHEMICAL]phenytoin[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 12
    },
    {
        "text": "Phenytoin ([CHEMICAL]diphenylhydantoin[\\CHEMICAL], DPH) is an established [GENE]sodium channel[\\GENE] blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "label": 4,
        "major": -1,
        "len": 29
    },
    {
        "text": "Phenytoin (diphenylhydantoin, [CHEMICAL]DPH[\\CHEMICAL]) is an established [GENE]sodium channel[\\GENE] blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "label": 4,
        "major": -1,
        "len": 29
    },
    {
        "text": "This information may be useful in the development of more potent [CHEMICAL]sodium[\\CHEMICAL][GENE]sodium channel[\\GENE] blockers.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[GENE]Voltage-gated sodium (Na) channels[\\GENE][CHEMICAL]Na[\\CHEMICAL]) channels are a critical component of electrically excitable cells.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "Block of human NaV1.5 [CHEMICAL]sodium[\\CHEMICAL][GENE]sodium channels[\\GENE] by novel alpha-hydroxyphenylamide analogues of phenytoin.",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "Block of [GENE]human NaV1.5[\\GENE] [CHEMICAL]sodium[\\CHEMICAL] channels by novel alpha-hydroxyphenylamide analogues of phenytoin.",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "[GENE]Voltage-gated sodium (Na) channels[\\GENE][CHEMICAL]sodium[\\CHEMICAL] (Na) channels are a critical component of electrically excitable cells.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Phenytoin (diphenylhydantoin, DPH) is an established [CHEMICAL]sodium[\\CHEMICAL][GENE]sodium channel[\\GENE] blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "[GENE]ABCA1[\\GENE] mediates the efflux of unesterified [CHEMICAL]cholesterol[\\CHEMICAL] and phospholipids from cells to lipid-poor apolipoprotein A-I (apoA-I).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "METHOD: The authors conducted a PET study to evaluate [GENE]D(2)[\\GENE] occupancy (using [CHEMICAL][(11)C]raclopride[\\CHEMICAL]) and 5-HT(2) occupancy (using [(18)F]setoperone) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "METHOD: The authors conducted a PET study to evaluate D(2) occupancy (using [(11)C]raclopride) and [GENE]5-HT(2)[\\GENE] occupancy (using [CHEMICAL][(18)F]setoperone[\\CHEMICAL]) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "The estimated plasma [CHEMICAL]ziprasidone[\\CHEMICAL] concentration associated with 50% maximal [GENE]5-HT(2)[\\GENE] receptor occupancy was almost four times lower than that for D(2) receptor occupancy.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "The estimated plasma [CHEMICAL]ziprasidone[\\CHEMICAL] concentration associated with 50% maximal 5-HT(2) receptor occupancy was almost four times lower than that for [GENE]D(2) receptor[\\GENE] occupancy.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "CONCLUSIONS: These data affirm that [CHEMICAL]ziprasidone[\\CHEMICAL] is similar to other novel antipsychotics in having greater [GENE]5-HT(2)[\\GENE] than D(2) receptor occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.",
        "label": 2,
        "major": -1,
        "len": 47
    },
    {
        "text": "CONCLUSIONS: These data affirm that [CHEMICAL]ziprasidone[\\CHEMICAL] is similar to other novel antipsychotics in having greater 5-HT(2) than [GENE]D(2) receptor[\\GENE] occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.",
        "label": 2,
        "major": -1,
        "len": 47
    },
    {
        "text": "The relatively high [GENE]D(2) receptor[\\GENE] occupancy, even at trough plasma levels, suggests that [CHEMICAL]ziprasidone[\\CHEMICAL] is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "The relatively high [GENE]D(2) receptor[\\GENE] occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to [CHEMICAL]risperidone[\\CHEMICAL] and olanzapine in receptor occupancy profile than to clozapine and quetiapine.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "The relatively high [GENE]D(2) receptor[\\GENE] occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to [CHEMICAL]clozapine[\\CHEMICAL] and quetiapine.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "The relatively high [GENE]D(2) receptor[\\GENE] occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and [CHEMICAL]quetiapine[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "In intact CHO-K1 cells, [CHEMICAL]I3A[\\CHEMICAL] was able to translocate different green fluorescent protein-tagged [GENE]PKC[\\GENE] isoforms, visualized by confocal microscopy, with equal or higher potency than PMA.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "In intact CHO-K1 cells, I3A was able to translocate different green fluorescent protein-tagged [GENE]PKC[\\GENE] isoforms, visualized by confocal microscopy, with equal or higher potency than [CHEMICAL]PMA[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]PKC-delta[\\GENE] in particular showed a different pattern of translocation in response to [CHEMICAL]I3A[\\CHEMICAL] and PMA.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "[GENE]PKC-delta[\\GENE] in particular showed a different pattern of translocation in response to I3A and [CHEMICAL]PMA[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Here, we report the initial characterization of [CHEMICAL]I3A[\\CHEMICAL] as a [GENE]protein kinase C[\\GENE] (PKC) ligand.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Here, we report the initial characterization of [CHEMICAL]I3A[\\CHEMICAL] as a protein kinase C ([GENE]PKC[\\GENE]) ligand.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Only five tumors failed to express TP but four of these expressed [GENE]DPD[\\GENE], suggesting [CHEMICAL]capecitabine[\\CHEMICAL] resistance.",
        "label": 10,
        "major": -1,
        "len": 16
    },
    {
        "text": "Favorable enzyme profiles (high TP and low DPD) generate high intratumor levels of [CHEMICAL]5-FU[\\CHEMICAL] that are effective against many tumors, especially those with low [GENE]TS[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Favorable enzyme profiles (high [GENE]TP[\\GENE] and low DPD) generate high intratumor levels of [CHEMICAL]5-FU[\\CHEMICAL] that are effective against many tumors, especially those with low TS.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "Favorable enzyme profiles (high TP and low [GENE]DPD[\\GENE]) generate high intratumor levels of [CHEMICAL]5-FU[\\CHEMICAL] that are effective against many tumors, especially those with low TS.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "We conclude that Met564 blocks the entry of medium- and long-chain [CHEMICAL]acyl-CoAs[\\CHEMICAL] to the catalytic site of [GENE]CrAT[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "[GENE]P2Y12[\\GENE], a new platelet ADP receptor, target of [CHEMICAL]clopidogrel[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "P2Y12, a new platelet [GENE]ADP receptor[\\GENE], target of [CHEMICAL]clopidogrel[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "Thus, the cranio-selective vasoconstriction elicited by [CHEMICAL]ergotamine[\\CHEMICAL] in dogs is predominantly mediated by 5-HT1B receptors as well as alpha2A/2C-adrenoceptor subtypes and, to a lesser extent, by [GENE]alpha1-adrenoceptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Thus, the cranio-selective vasoconstriction elicited by [CHEMICAL]ergotamine[\\CHEMICAL] in dogs is predominantly mediated by [GENE]5-HT1B[\\GENE] receptors as well as alpha2A/2C-adrenoceptor subtypes and, to a lesser extent, by alpha1-adrenoceptors.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[GENE]5-HT1B[\\GENE] receptors, alpha2A/2C- and, to a lesser extent, alpha1-adrenoceptors mediate the external carotid vasoconstriction to [CHEMICAL]ergotamine[\\CHEMICAL] in vagosympathectomised dogs.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "5-HT1B receptors, alpha2A/2C- and, to a lesser extent, [GENE]alpha1-adrenoceptors[\\GENE] mediate the external carotid vasoconstriction to [CHEMICAL]ergotamine[\\CHEMICAL] in vagosympathectomised dogs.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "In this sample of neuroleptic-refractory schizophrenic patients, [CHEMICAL]olanzapine[\\CHEMICAL] and clozapine showed a different pattern of occupancy of [GENE]D2-like receptor[\\GENE] despite a common lack of extrapyramidal side-effects.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and [CHEMICAL]clozapine[\\CHEMICAL] showed a different pattern of occupancy of [GENE]D2-like receptor[\\GENE] despite a common lack of extrapyramidal side-effects.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "We investigated the effect of the clinically used nitrates nitroglycerin (NTG), isosorbide dinitrate (ISDN), and sodium nitroprusside ([CHEMICAL]SNP[\\CHEMICAL]) on [GENE]HIF-1[\\GENE]-mediated transcriptional responses to hypoxia.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "We investigated the effect of the clinically used nitrates [CHEMICAL]nitroglycerin[\\CHEMICAL] (NTG), isosorbide dinitrate (ISDN), and sodium nitroprusside (SNP) on [GENE]HIF-1[\\GENE]-mediated transcriptional responses to hypoxia.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "We investigated the effect of the clinically used nitrates nitroglycerin ([CHEMICAL]NTG[\\CHEMICAL]), isosorbide dinitrate (ISDN), and sodium nitroprusside (SNP) on [GENE]HIF-1[\\GENE]-mediated transcriptional responses to hypoxia.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "We investigated the effect of the clinically used nitrates nitroglycerin (NTG), [CHEMICAL]isosorbide dinitrate[\\CHEMICAL] (ISDN), and sodium nitroprusside (SNP) on [GENE]HIF-1[\\GENE]-mediated transcriptional responses to hypoxia.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "We investigated the effect of the clinically used nitrates nitroglycerin (NTG), isosorbide dinitrate ([CHEMICAL]ISDN[\\CHEMICAL]), and sodium nitroprusside (SNP) on [GENE]HIF-1[\\GENE]-mediated transcriptional responses to hypoxia.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "We investigated the effect of the clinically used nitrates nitroglycerin (NTG), isosorbide dinitrate (ISDN), and [CHEMICAL]sodium nitroprusside[\\CHEMICAL] (SNP) on [GENE]HIF-1[\\GENE]-mediated transcriptional responses to hypoxia.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Using whole-cell voltage clamp, we examined [CHEMICAL]mibefradil[\\CHEMICAL] block of four [GENE]Na+ channel[\\GENE] isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve).",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Using whole-cell voltage clamp, we examined [CHEMICAL]mibefradil[\\CHEMICAL] block of four Na+ channel isoforms expressed in human embryonic kidney cells: [GENE]Nav1.5[\\GENE] (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve).",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Using whole-cell voltage clamp, we examined [CHEMICAL]mibefradil[\\CHEMICAL] block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), [GENE]Nav1.4[\\GENE] (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve).",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Using whole-cell voltage clamp, we examined [CHEMICAL]mibefradil[\\CHEMICAL] block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), [GENE]Nav1.2[\\GENE] (brain), and Nav1.7 (peripheral nerve).",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Using whole-cell voltage clamp, we examined [CHEMICAL]mibefradil[\\CHEMICAL] block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and [GENE]Nav1.7[\\GENE] (peripheral nerve).",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "State-dependent [CHEMICAL]mibefradil[\\CHEMICAL] block of [GENE]Na+ channels[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 6
    },
    {
        "text": "[CHEMICAL]Meclofenamic acid[\\CHEMICAL] and diclofenac, novel templates of [GENE]KCNQ2/Q3[\\GENE] potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Meclofenamic acid[\\CHEMICAL] and diclofenac, novel templates of KCNQ2/Q3 [GENE]potassium channel[\\GENE] openers, depress cortical neuron activity and exhibit anticonvulsant properties.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Meclofenamic acid and [CHEMICAL]diclofenac[\\CHEMICAL], novel templates of [GENE]KCNQ2/Q3[\\GENE] potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Meclofenamic acid and [CHEMICAL]diclofenac[\\CHEMICAL], novel templates of KCNQ2/Q3 [GENE]potassium channel[\\GENE] openers, depress cortical neuron activity and exhibit anticonvulsant properties.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Here, we show that [CHEMICAL]meclofenamic acid[\\CHEMICAL] (meclofenamate) and diclofenac, two related molecules previously used as anti-inflammatory drugs, act as novel [GENE]KCNQ2/Q3[\\GENE] channel openers.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Here, we show that meclofenamic acid ([CHEMICAL]meclofenamate[\\CHEMICAL]) and diclofenac, two related molecules previously used as anti-inflammatory drugs, act as novel [GENE]KCNQ2/Q3[\\GENE] channel openers.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Here, we show that meclofenamic acid (meclofenamate) and [CHEMICAL]diclofenac[\\CHEMICAL], two related molecules previously used as anti-inflammatory drugs, act as novel [GENE]KCNQ2/Q3[\\GENE] channel openers.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Comparison with the [GENE]rSDH[\\GENE]-(PLP-OMS) holo-enzyme reveals a large structural difference in active sites caused by the artifical [CHEMICAL]O-methylserine[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and [GENE]NGF-beta[\\GENE] to the baseline values.",
        "label": 3,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of [GENE]HIF-1alpha[\\GENE], VEGF, BNP, and NGF-beta to the baseline values.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of HIF-1alpha, [GENE]VEGF[\\GENE], BNP, and NGF-beta to the baseline values.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of HIF-1alpha, VEGF, [GENE]BNP[\\GENE], and NGF-beta to the baseline values.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] is associated with a reversal of abnormal regulation of [GENE]HIF-1alpha[\\GENE] and VEGF in the failing ventricular myocardium.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] is associated with a reversal of abnormal regulation of HIF-1alpha and [GENE]VEGF[\\GENE] in the failing ventricular myocardium.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "Comparison of the crystal structures of UDP-Gal- and UDP-Glc-bound [GENE]beta4Gal-T1[\\GENE] reveals that the O4 hydroxyl group in both Gal and Glc moieties forms a hydrogen bond with the side chain [CHEMICAL]carboxylate[\\CHEMICAL] group of Glu317.",
        "label": 1,
        "major": -1,
        "len": 34
    },
    {
        "text": "The orientation of the O4 hydroxyl of glucose causes a steric hindrance to the side chain [CHEMICAL]carboxylate[\\CHEMICAL] group of Glu317, accounting for the enzyme's low [GENE]Glc-T[\\GENE] activity.",
        "label": 1,
        "major": -1,
        "len": 27
    },
    {
        "text": "Comparison of the crystal structures of [CHEMICAL]UDP-Gal[\\CHEMICAL]- and UDP-Glc-bound [GENE]beta4Gal-T1[\\GENE] reveals that the O4 hydroxyl group in both Gal and Glc moieties forms a hydrogen bond with the side chain carboxylate group of Glu317.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Comparison of the crystal structures of UDP-Gal- and [CHEMICAL]UDP-Glc[\\CHEMICAL]-bound [GENE]beta4Gal-T1[\\GENE] reveals that the O4 hydroxyl group in both Gal and Glc moieties forms a hydrogen bond with the side chain carboxylate group of Glu317.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The crystal structure of [GENE]R228K[\\GENE]-Gal-T1 complexed with LA, [CHEMICAL]UDP-Gal[\\CHEMICAL], and Mn(2+) determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation, compared to that in the wild type.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The crystal structure of R228K-[GENE]Gal-T1[\\GENE] complexed with LA, [CHEMICAL]UDP-Gal[\\CHEMICAL], and Mn(2+) determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation, compared to that in the wild type.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The crystal structure of R228K-[GENE]Gal-T1[\\GENE] complexed with LA, UDP-Gal, and [CHEMICAL]Mn(2+)[\\CHEMICAL] determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation, compared to that in the wild type.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The orientation of the [CHEMICAL]O4 hydroxyl of glucose[\\CHEMICAL] causes a steric hindrance to the side chain carboxylate group of Glu317, accounting for the enzyme's low [GENE]Glc-T[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[GENE]Beta-1,4-galactosyltransferase I[\\GENE] (beta4Gal-T1) normally transfers Gal from [CHEMICAL]UDP-Gal[\\CHEMICAL] to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the [GENE]SGLT1[\\GENE]-dependent [CHEMICAL]methyl alpha-D-glucopyranoside[\\CHEMICAL] (AMG) uptake and levels of SGLT1 expression were determined.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the [GENE]SGLT1[\\GENE]-dependent methyl alpha-D-glucopyranoside ([CHEMICAL]AMG[\\CHEMICAL]) uptake and levels of SGLT1 expression were determined.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "PCR demonstrated a correlation between [GENE]dCK[\\GENE] expression and [CHEMICAL]gemcitabine[\\CHEMICAL] sensitivity, whereas expression of TS, DHFR, and GARFT was predictive of pemetrexed chemosensitivity.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We also show that an intronic polymorphism in the [GENE]SCN1A[\\GENE] gene shows significant association with maximum doses in regular usage of both [CHEMICAL]carbamazepine[\\CHEMICAL] and phenytoin (P = 0.0051 and P = 0.014, respectively).",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "We also show that an intronic polymorphism in the [GENE]SCN1A[\\GENE] gene shows significant association with maximum doses in regular usage of both carbamazepine and [CHEMICAL]phenytoin[\\CHEMICAL] (P = 0.0051 and P = 0.014, respectively).",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "We report that a known functional polymorphism in [GENE]CYP2C9[\\GENE] is highly associated with the maximum dose of [CHEMICAL]phenytoin[\\CHEMICAL] (P = 0.0066).",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "In the presence of alphaAR blockade, concentration-response curves for [CHEMICAL]isoproterenol[\\CHEMICAL], norepinephrine, and epinephrine suggested that a [GENE]beta1AR[\\GENE] was involved in this response, and the rank order of potency was isoproterenol > norepinephrine = epinephrine.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In the presence of alphaAR blockade, concentration-response curves for isoproterenol, [CHEMICAL]norepinephrine[\\CHEMICAL], and epinephrine suggested that a [GENE]beta1AR[\\GENE] was involved in this response, and the rank order of potency was isoproterenol > norepinephrine = epinephrine.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In the presence of alphaAR blockade, concentration-response curves for isoproterenol, norepinephrine, and [CHEMICAL]epinephrine[\\CHEMICAL] suggested that a [GENE]beta1AR[\\GENE] was involved in this response, and the rank order of potency was isoproterenol > norepinephrine = epinephrine.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In the presence of alphaAR blockade, concentration-response curves for isoproterenol, norepinephrine, and epinephrine suggested that a [GENE]beta1AR[\\GENE] was involved in this response, and the rank order of potency was [CHEMICAL]isoproterenol[\\CHEMICAL] > norepinephrine = epinephrine.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In the presence of alphaAR blockade, concentration-response curves for isoproterenol, norepinephrine, and epinephrine suggested that a [GENE]beta1AR[\\GENE] was involved in this response, and the rank order of potency was isoproterenol > [CHEMICAL]norepinephrine[\\CHEMICAL] = epinephrine.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In the presence of alphaAR blockade, concentration-response curves for isoproterenol, norepinephrine, and epinephrine suggested that a [GENE]beta1AR[\\GENE] was involved in this response, and the rank order of potency was isoproterenol > norepinephrine = [CHEMICAL]epinephrine[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Here we have investigated the contribution of the nitric oxide and [GENE]cyclooxygenase[\\GENE] (COX) pathways to the activity of [CHEMICAL]DEC[\\CHEMICAL] against B. malayi microfilariae in mice.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Experimental as well as clinical reports support the hypothesis that [GENE]calcium channel[\\GENE] blockers such as [CHEMICAL]verapamil[\\CHEMICAL] may be an appropriate therapeutic approach in LQTS.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "Due to its central role in the formation and stabilization of a thrombus, the [GENE]P2Y12[\\GENE] receptor is a well-established target of antithrombotic drugs like [CHEMICAL]ticlopidine[\\CHEMICAL] or clopidogrel, which have proved efficacy in many clinical trials and experimental models of thrombosis.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "Due to its central role in the formation and stabilization of a thrombus, the [GENE]P2Y12[\\GENE] receptor is a well-established target of antithrombotic drugs like ticlopidine or [CHEMICAL]clopidogrel[\\CHEMICAL], which have proved efficacy in many clinical trials and experimental models of thrombosis.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "We also studied the effects of [CHEMICAL]thalidomide[\\CHEMICAL] on [GENE]COX-1[\\GENE], COX-2 or bcl-2 expression, TNFalpha, VEGF, GSH and cytochrome c in these cells.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We also studied the effects of [CHEMICAL]thalidomide[\\CHEMICAL] on COX-1, [GENE]COX-2[\\GENE] or bcl-2 expression, TNFalpha, VEGF, GSH and cytochrome c in these cells.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We also studied the effects of [CHEMICAL]thalidomide[\\CHEMICAL] on COX-1, COX-2 or [GENE]bcl-2[\\GENE] expression, TNFalpha, VEGF, GSH and cytochrome c in these cells.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We also studied the effects of [CHEMICAL]thalidomide[\\CHEMICAL] on COX-1, COX-2 or bcl-2 expression, [GENE]TNFalpha[\\GENE], VEGF, GSH and cytochrome c in these cells.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We also studied the effects of [CHEMICAL]thalidomide[\\CHEMICAL] on COX-1, COX-2 or bcl-2 expression, TNFalpha, [GENE]VEGF[\\GENE], GSH and cytochrome c in these cells.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We also studied the effects of [CHEMICAL]thalidomide[\\CHEMICAL] on COX-1, COX-2 or bcl-2 expression, TNFalpha, VEGF, GSH and [GENE]cytochrome c[\\GENE] in these cells.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Effect of [CHEMICAL]thalidomide[\\CHEMICAL] on [GENE]COX-1[\\GENE] and COX-2 in vivo was consistent with that of in vitro.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Effect of [CHEMICAL]thalidomide[\\CHEMICAL] on COX-1 and [GENE]COX-2[\\GENE] in vivo was consistent with that of in vitro.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "[GENE]DAT[\\GENE] occupancy was determined by displacement of [CHEMICAL]8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane[\\CHEMICAL] (FECNT).",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "[GENE]DAT[\\GENE] occupancy was determined by displacement of 8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane ([CHEMICAL]FECNT[\\CHEMICAL]).",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "[GENE]DAT[\\GENE] occupancy was between 66 and 82% and <10-41% for doses of [CHEMICAL]dimethocaine[\\CHEMICAL] and procaine that maintained maximum response rates, respectively.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[GENE]DAT[\\GENE] occupancy was between 66 and 82% and <10-41% for doses of dimethocaine and [CHEMICAL]procaine[\\CHEMICAL] that maintained maximum response rates, respectively.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The present study examined the reinforcing and [GENE]DAT[\\GENE] effects of the local anesthetics [CHEMICAL]dimethocaine[\\CHEMICAL], procaine and cocaine using in vivo techniques.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The present study examined the reinforcing and [GENE]DAT[\\GENE] effects of the local anesthetics dimethocaine, [CHEMICAL]procaine[\\CHEMICAL] and cocaine using in vivo techniques.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The present study examined the reinforcing and [GENE]DAT[\\GENE] effects of the local anesthetics dimethocaine, procaine and [CHEMICAL]cocaine[\\CHEMICAL] using in vivo techniques.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "In contrast, analogs with different para-substituents on the [CHEMICAL]phenyl[\\CHEMICAL] ring had significantly different potencies for wild-type [GENE]hERG[\\GENE] block.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "A previous crystal structure of a [CHEMICAL]microcystin[\\CHEMICAL] bound to the catalytic subunit of [GENE]protein phosphatase-1[\\GENE] (PP-1c) showed distinct changes in the active site region when compared with protein phosphatase-1 structures bound to other toxins.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "A previous crystal structure of a [CHEMICAL]microcystin[\\CHEMICAL] bound to the catalytic subunit of protein phosphatase-1 ([GENE]PP-1c[\\GENE]) showed distinct changes in the active site region when compared with protein phosphatase-1 structures bound to other toxins.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "At the enzymatic activity level, doxycycline started to suppress [GENE]MMP-9[\\GENE] activity at 5 mg/kg/day (P<0.001), while [CHEMICAL]minocycline[\\CHEMICAL] had an effect at a lower dose, 1 mg/kg/day (P<0.02).",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "At the enzymatic activity level, [CHEMICAL]doxycycline[\\CHEMICAL] started to suppress [GENE]MMP-9[\\GENE] activity at 5 mg/kg/day (P<0.001), while minocycline had an effect at a lower dose, 1 mg/kg/day (P<0.02).",
        "label": 4,
        "major": -1,
        "len": 27
    },
    {
        "text": "These unexpected and intriguing complexities seem likely to have some as yet undefined role in regulating [GENE]SSAT[\\GENE] activity or stability as a part of [CHEMICAL]polyamine[\\CHEMICAL] homeostasis.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]Spermidine/spermine N1-acetyltransferase[\\GENE] (SSAT) is a key enzyme in the control of [CHEMICAL]polyamine[\\CHEMICAL] levels in human cells, as acetylation of spermidine and spermine triggers export or degradation.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]Spermidine/spermine N1-acetyltransferase[\\GENE] (SSAT) is a key enzyme in the control of polyamine levels in human cells, as acetylation of [CHEMICAL]spermidine[\\CHEMICAL] and spermine triggers export or degradation.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]Spermidine/spermine N1-acetyltransferase[\\GENE] (SSAT) is a key enzyme in the control of polyamine levels in human cells, as acetylation of spermidine and [CHEMICAL]spermine[\\CHEMICAL] triggers export or degradation.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "The [GENE]IL-2[\\GENE]/gamma(c) interface itself exhibits the smallest buried surface and the fewest [CHEMICAL]hydrogen[\\CHEMICAL] bonds in the complex, which is consistent with its promiscuous use in other cytokine receptor complexes.",
        "label": 1,
        "major": -1,
        "len": 29
    },
    {
        "text": "In addition, there was a positive correlation between the pre-withdrawal [CHEMICAL]ethanol[\\CHEMICAL] consumption and the packing density of [GENE]GS[\\GENE]-IR astrocytes.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Involvement of [GENE]EP1[\\GENE] and EP2 receptors in the regulation of the Na,K-ATPase by [CHEMICAL]prostaglandins[\\CHEMICAL] in MDCK cells.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Involvement of EP1 and [GENE]EP2 receptors[\\GENE] in the regulation of the Na,K-ATPase by [CHEMICAL]prostaglandins[\\CHEMICAL] in MDCK cells.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Involvement of EP1 and EP2 receptors in the regulation of the [GENE]Na,K-ATPase[\\GENE] by [CHEMICAL]prostaglandins[\\CHEMICAL] in MDCK cells.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Apolipoprotein E was chemically bound via linkers to [CHEMICAL]loperamide[\\CHEMICAL]-loaded [GENE]HSA[\\GENE]-NP.",
        "label": 1,
        "major": -1,
        "len": 10
    },
    {
        "text": "[GENE]Apolipoprotein E[\\GENE] was chemically bound via linkers to [CHEMICAL]loperamide[\\CHEMICAL]-loaded HSA-NP.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "From the present study, it may be concluded that mice lacking the NET may represent a good model of some aspects of depression-resistant behavior, paralleled with alterations in the expression of [GENE]adrenergic receptors[\\GENE], which result as an adaptation to elevated levels of extracellular [CHEMICAL]NE[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Rats were fed experimental diets containing SPI or [GENE]casein[\\GENE] as a [CHEMICAL]nitrogen[\\CHEMICAL] source.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "This study examined the effect of [CHEMICAL]theophylline[\\CHEMICAL] on the gene expression of secretory proteins and [GENE]phosphodiesterases[\\GENE] in the submaxillary gland.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Melatonin[\\CHEMICAL] and N-acetyl-5-hydroxytryptamine (N-acetyl-5-HT), a ligand of [GENE]MT3[\\GENE] biding site, also had no impairment on the performance, per se.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Melatonin and [CHEMICAL]N-acetyl-5-hydroxytryptamine[\\CHEMICAL] (N-acetyl-5-HT), a ligand of [GENE]MT3[\\GENE] biding site, also had no impairment on the performance, per se.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Melatonin and N-acetyl-5-hydroxytryptamine ([CHEMICAL]N-acetyl-5-HT[\\CHEMICAL]), a ligand of [GENE]MT3[\\GENE] biding site, also had no impairment on the performance, per se.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Functional divergence of a unique [CHEMICAL]C[\\CHEMICAL]-terminal domain of [GENE]leucyl-tRNA synthetase[\\GENE] to accommodate its splicing and aminoacylation roles.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "Functional divergence of a unique C-terminal domain of [CHEMICAL]leucyl[\\CHEMICAL][GENE]leucyl-tRNA synthetase[\\GENE] to accommodate its splicing and aminoacylation roles.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Leucyl[\\CHEMICAL][GENE]Leucyl-tRNA synthetase[\\GENE] (LeuRS) performs dual essential roles in group I intron RNA splicing as well as protein synthesis within the yeast mitochondria.",
        "label": 1,
        "major": -1,
        "len": 22
    },
    {
        "text": "We propose that the secondary role of [GENE]yeast mitochondrial LeuRS[\\GENE] in RNA splicing has impacted the functional evolution of this critical [CHEMICAL]C[\\CHEMICAL]-terminal domain.",
        "label": 1,
        "major": -1,
        "len": 23
    },
    {
        "text": "These data suggest that endothelial [CHEMICAL]NO[\\CHEMICAL] synthesis depends on the activity of [GENE]arginase II[\\GENE] in mitochondria and l-arginine carriers in cell membrane.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "OBJECTIVE: To compare the [GENE]cyclooxygenase[\\GENE] (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and [CHEMICAL]bromfenac sodium[\\CHEMICAL] (bromfenac).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "OBJECTIVE: To compare the cyclooxygenase ([GENE]COX[\\GENE]) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and [CHEMICAL]bromfenac sodium[\\CHEMICAL] (bromfenac).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "CONCLUSIONS: [CHEMICAL]Ketorolac[\\CHEMICAL] is relatively [GENE]COX-1[\\GENE] selective while bromfenac is potently selective for COX-2 over COX-1.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "CONCLUSIONS: Ketorolac is relatively COX-1 selective while [CHEMICAL]bromfenac[\\CHEMICAL] is potently selective for [GENE]COX-2[\\GENE] over COX-1.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "CONCLUSIONS: Ketorolac is relatively COX-1 selective while [CHEMICAL]bromfenac[\\CHEMICAL] is potently selective for COX-2 over [GENE]COX-1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "OBJECTIVE: To compare the [GENE]cyclooxygenase[\\GENE] (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and bromfenac sodium ([CHEMICAL]bromfenac[\\CHEMICAL]).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "OBJECTIVE: To compare the cyclooxygenase ([GENE]COX[\\GENE]) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and bromfenac sodium ([CHEMICAL]bromfenac[\\CHEMICAL]).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "RESULTS: [CHEMICAL]Ketorolac[\\CHEMICAL] was six times more active against [GENE]COX-1[\\GENE] (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while bromfenac was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "RESULTS: [CHEMICAL]Ketorolac[\\CHEMICAL] was six times more active against COX-1 (IC(50) = 0.02 microM) than [GENE]COX-2[\\GENE] (IC(50) = 0.12 microM) while bromfenac was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "RESULTS: Ketorolac was six times more active against COX-1 (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while [CHEMICAL]bromfenac[\\CHEMICAL] was approximately 32 times more active against [GENE]COX-2[\\GENE] (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "RESULTS: Ketorolac was six times more active against COX-1 (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while [CHEMICAL]bromfenac[\\CHEMICAL] was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than [GENE]COX-1[\\GENE] (IC(50) = 0.210 microM).",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "OBJECTIVE: To compare the [GENE]cyclooxygenase[\\GENE] (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) [CHEMICAL]ketorolac tromethamine[\\CHEMICAL] (ketorolac) and bromfenac sodium (bromfenac).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "OBJECTIVE: To compare the cyclooxygenase ([GENE]COX[\\GENE]) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) [CHEMICAL]ketorolac tromethamine[\\CHEMICAL] (ketorolac) and bromfenac sodium (bromfenac).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "OBJECTIVE: To compare the [GENE]cyclooxygenase[\\GENE] (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine ([CHEMICAL]ketorolac[\\CHEMICAL]) and bromfenac sodium (bromfenac).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "OBJECTIVE: To compare the cyclooxygenase ([GENE]COX[\\GENE]) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine ([CHEMICAL]ketorolac[\\CHEMICAL]) and bromfenac sodium (bromfenac).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "RESULTS: [CHEMICAL]Ketorolac[\\CHEMICAL] was six times more active against COX-1 (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while bromfenac was approximately 32 times more active against [GENE]COX-2[\\GENE] (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "label": 4,
        "major": -1,
        "len": 39
    },
    {
        "text": "RESULTS: [CHEMICAL]Ketorolac[\\CHEMICAL] was six times more active against COX-1 (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while bromfenac was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than [GENE]COX-1[\\GENE] (IC(50) = 0.210 microM).",
        "label": 4,
        "major": -1,
        "len": 39
    },
    {
        "text": "RESULTS: Ketorolac was six times more active against [GENE]COX-1[\\GENE] (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while [CHEMICAL]bromfenac[\\CHEMICAL] was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "label": 4,
        "major": -1,
        "len": 39
    },
    {
        "text": "RESULTS: Ketorolac was six times more active against COX-1 (IC(50) = 0.02 microM) than [GENE]COX-2[\\GENE] (IC(50) = 0.12 microM) while [CHEMICAL]bromfenac[\\CHEMICAL] was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "label": 4,
        "major": -1,
        "len": 39
    },
    {
        "text": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the [CHEMICAL]methyl[\\CHEMICAL] transfer step in [GENE]glycine N-methyltransferase[\\GENE] (GNMT).",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the [CHEMICAL]methyl[\\CHEMICAL] transfer step in glycine N-methyltransferase ([GENE]GNMT[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "The starting point for the calculations is the recent X-ray crystal structure of [GENE]GNMT[\\GENE] complexed with [CHEMICAL]SAM[\\CHEMICAL] and acetate.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "RNA interference-triggered reversal of [GENE]ABCC2[\\GENE]-dependent [CHEMICAL]cisplatin[\\CHEMICAL] resistance in human cancer cells.",
        "label": 10,
        "major": -1,
        "len": 11
    },
    {
        "text": "New data for cattle (Bos taurus) indicates a gene encoding [GENE]GnRH-II[\\GENE] decapeptide possessing [CHEMICAL]arginine[\\CHEMICAL] (codon: CGG) rather than tryptophan (TGG) at position three in the mature peptide.",
        "label": 1,
        "major": -1,
        "len": 27
    },
    {
        "text": "New data for cattle (Bos taurus) indicates a gene encoding [GENE]GnRH-II[\\GENE] decapeptide possessing arginine (codon: [CHEMICAL]CGG[\\CHEMICAL]) rather than tryptophan (TGG) at position three in the mature peptide.",
        "label": 1,
        "major": -1,
        "len": 27
    },
    {
        "text": "New data for cattle (Bos taurus) indicates a gene encoding [GENE]GnRH-II[\\GENE] decapeptide possessing arginine (codon: CGG) rather than [CHEMICAL]tryptophan[\\CHEMICAL] (TGG) at position three in the mature peptide.",
        "label": 1,
        "major": -1,
        "len": 27
    },
    {
        "text": "New data for cattle (Bos taurus) indicates a gene encoding [GENE]GnRH-II[\\GENE] decapeptide possessing arginine (codon: CGG) rather than tryptophan ([CHEMICAL]TGG[\\CHEMICAL]) at position three in the mature peptide.",
        "label": 1,
        "major": -1,
        "len": 27
    },
    {
        "text": "[GENE]BHMT[\\GENE] is expressed at high levels in rat liver and its expression is regulated by dietary [CHEMICAL]Met[\\CHEMICAL] and choline.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]BHMT[\\GENE] is expressed at high levels in rat liver and its expression is regulated by dietary Met and [CHEMICAL]choline[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]Choline dehydrogenase[\\GENE] (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in [CHEMICAL]choline[\\CHEMICAL] oxidation.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Choline dehydrogenase ([GENE]CHDH[\\GENE]) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in [CHEMICAL]choline[\\CHEMICAL] oxidation.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Choline dehydrogenase (CHDH) and [GENE]betaine-homocysteine methyltransferase[\\GENE] (BHMT) are 2 enzymes involved in [CHEMICAL]choline[\\CHEMICAL] oxidation.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase ([GENE]BHMT[\\GENE]) are 2 enzymes involved in [CHEMICAL]choline[\\CHEMICAL] oxidation.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]FK778[\\CHEMICAL], is a synthetic malononitrilamide that targets the critical enzyme of the de novo pyrimidine synthesis, [GENE]dihydroorotic acid dehydrogenase[\\GENE], and receptor-associated tyrosine kinases has completed phase II trials.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "[CHEMICAL]FK778[\\CHEMICAL], is a synthetic malononitrilamide that targets the critical enzyme of the de novo pyrimidine synthesis, dihydroorotic acid dehydrogenase, and [GENE]receptor-associated tyrosine kinases[\\GENE] has completed phase II trials.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The beneficial role of [CHEMICAL]17beta-estradiol[\\CHEMICAL] on blood pressure, cardiac hypertrophy, vascular [GENE]osteopontin[\\GENE] expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The beneficial role of 17beta-estradiol on blood pressure, cardiac hypertrophy, vascular [GENE]osteopontin[\\GENE] expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of [CHEMICAL]medroxyprogesterone acetate[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "[CHEMICAL]Rofecoxib[\\CHEMICAL] only diminished [GENE]COX-2[\\GENE] protein expression and MCP-1 gene expression in vascular atheroma.",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Rofecoxib[\\CHEMICAL] only diminished COX-2 protein expression and [GENE]MCP-1[\\GENE] gene expression in vascular atheroma.",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Dexamethasone[\\CHEMICAL] probes [GENE]glucocorticoid receptor[\\GENE] (GR) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Dexamethasone[\\CHEMICAL] probes glucocorticoid receptor ([GENE]GR[\\GENE]) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Dexamethasone probes glucocorticoid receptor (GR) function, while [CHEMICAL]prednisolone[\\CHEMICAL] probes both [GENE]GR[\\GENE] and mineralocorticoid receptor (MR) function.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Dexamethasone probes glucocorticoid receptor (GR) function, while [CHEMICAL]prednisolone[\\CHEMICAL] probes both GR and [GENE]mineralocorticoid receptor[\\GENE] (MR) function.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Dexamethasone probes glucocorticoid receptor (GR) function, while [CHEMICAL]prednisolone[\\CHEMICAL] probes both GR and mineralocorticoid receptor ([GENE]MR[\\GENE]) function.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "CONCLUSIONS: We suggest that the additional effects of [CHEMICAL]prednisolone[\\CHEMICAL] on the [GENE]MR[\\GENE] explain the different responses to these glucocorticoids in the same depressed patients.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Estrogens[\\CHEMICAL] are biosynthesised from androgens by the [GENE]CYP450[\\GENE] enzyme complex called aromatase.",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Estrogens[\\CHEMICAL] are biosynthesised from androgens by the CYP450 enzyme complex called [GENE]aromatase[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "Estrogens are biosynthesised from [CHEMICAL]androgens[\\CHEMICAL] by the CYP450 enzyme complex called [GENE]aromatase[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "The results suggest that the suppression of [GENE]TLR4[\\GENE] activity by auranofin may be the molecular mechanism through which [CHEMICAL]auranofin[\\CHEMICAL] exerts anti-rheumatic activity.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "Our results first demonstrate that [CHEMICAL]auranofin[\\CHEMICAL] suppresses the multiple steps in [GENE]TLR4[\\GENE] signaling, especially the homodimerization of TLR4.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Our results first demonstrate that [CHEMICAL]auranofin[\\CHEMICAL] suppresses the multiple steps in TLR4 signaling, especially the homodimerization of [GENE]TLR4[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "The results suggest that the suppression of [GENE]TLR4[\\GENE] activity by [CHEMICAL]auranofin[\\CHEMICAL] may be the molecular mechanism through which auranofin exerts anti-rheumatic activity.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "Therefore, if these results are confirmed, [GENE]D2 receptor[\\GENE] occupancy at the beginning of treatment with [CHEMICAL]risperidone[\\CHEMICAL] may be a predictor of subsequent clinical response.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "The objective of the study is to investigate whether [GENE]dopamine D2 receptor[\\GENE] occupancy by [CHEMICAL]risperidone[\\CHEMICAL] and plasma levels over time can account for therapeutic efficacy and the latency period to response.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "[GENE]Dopamine D2 receptor[\\GENE] occupancy by [CHEMICAL]risperidone[\\CHEMICAL]: implications for the timing and magnitude of clinical response.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "The effects of adulthood olanzapine treatment on cognitive performance and [GENE]neurotrophic factor[\\GENE] content in male and female rats neonatally treated with [CHEMICAL]quinpirole[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "The objectives of the present study were to examine the changes of histamine content, HDC activity and [GENE]HDC[\\GENE] mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to [CHEMICAL]toluene diisocyanate[\\CHEMICAL] (TDI) and to investigate the effect of dexamethasone on the above mentioned allergic parameters.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "The objectives of the present study were to examine the changes of histamine content, HDC activity and [GENE]HDC[\\GENE] mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to toluene diisocyanate ([CHEMICAL]TDI[\\CHEMICAL]) and to investigate the effect of dexamethasone on the above mentioned allergic parameters.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "The objectives of the present study were to examine the changes of histamine content, HDC activity and [GENE]HDC[\\GENE] mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to toluene diisocyanate (TDI) and to investigate the effect of [CHEMICAL]dexamethasone[\\CHEMICAL] on the above mentioned allergic parameters.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "The objectives of the present study were to examine the changes of histamine content, [GENE]HDC[\\GENE] activity and HDC mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to [CHEMICAL]toluene diisocyanate[\\CHEMICAL] (TDI) and to investigate the effect of dexamethasone on the above mentioned allergic parameters.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "The objectives of the present study were to examine the changes of histamine content, [GENE]HDC[\\GENE] activity and HDC mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to toluene diisocyanate ([CHEMICAL]TDI[\\CHEMICAL]) and to investigate the effect of dexamethasone on the above mentioned allergic parameters.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "The objectives of the present study were to examine the changes of histamine content, [GENE]HDC[\\GENE] activity and HDC mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to toluene diisocyanate (TDI) and to investigate the effect of [CHEMICAL]dexamethasone[\\CHEMICAL] on the above mentioned allergic parameters.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "Repression of [GENE]HDC[\\GENE] gene expression and HDC activity by [CHEMICAL]dexamethasone[\\CHEMICAL] may underlie its therapeutic effect in the treatment of allergy.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Dexamethasone[\\CHEMICAL] suppresses histamine synthesis by repressing both transcription and activity of [GENE]HDC[\\GENE] in allergic rats.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "Repression of HDC gene expression and [GENE]HDC[\\GENE] activity by [CHEMICAL]dexamethasone[\\CHEMICAL] may underlie its therapeutic effect in the treatment of allergy.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Dexamethasone[\\CHEMICAL] suppresses histamine synthesis by repressing both transcription and activity of [GENE]HDC[\\GENE] in allergic rats.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "However the regulatory mechanism of [CHEMICAL]histamine[\\CHEMICAL] synthesis by [GENE]HDC[\\GENE] remains to be elucidated.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "BACKGROUND: [CHEMICAL]Histamine[\\CHEMICAL] synthesized by [GENE]histidine decarboxylase[\\GENE] (HDC) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "BACKGROUND: [CHEMICAL]Histamine[\\CHEMICAL] synthesized by histidine decarboxylase ([GENE]HDC[\\GENE]) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "BACKGROUND: Histamine synthesized by [GENE]histidine decarboxylase[\\GENE] (HDC) from [CHEMICAL]L-histidine[\\CHEMICAL] is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "BACKGROUND: Histamine synthesized by histidine decarboxylase ([GENE]HDC[\\GENE]) from [CHEMICAL]L-histidine[\\CHEMICAL] is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Occupancy of dopamine D(1), D (2) and [GENE]serotonin (2A) receptors[\\GENE] in schizophrenic patients treated with [CHEMICAL]flupentixol[\\CHEMICAL] in comparison with risperidone and haloperidol.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Occupancy of dopamine D(1), D (2) and [GENE]serotonin (2A) receptors[\\GENE] in schizophrenic patients treated with flupentixol in comparison with [CHEMICAL]risperidone[\\CHEMICAL] and haloperidol.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Occupancy of dopamine D(1), D (2) and [GENE]serotonin (2A) receptors[\\GENE] in schizophrenic patients treated with flupentixol in comparison with risperidone and [CHEMICAL]haloperidol[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "CONCLUSIONS: We were able to demonstrate a moderate [GENE]5-HT(2A)[\\GENE] and D(1) occupancy under clinically relevant doses of [CHEMICAL]flupentixol[\\CHEMICAL], albeit lower than expected from in vitro data and clearly below saturation.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "CONCLUSIONS: We were able to demonstrate a moderate 5-HT(2A) and [GENE]D(1)[\\GENE] occupancy under clinically relevant doses of [CHEMICAL]flupentixol[\\CHEMICAL], albeit lower than expected from in vitro data and clearly below saturation.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Several single nucleotide polymorphisms (SNPs) in [GENE]VKORC1[\\GENE] are associated with [CHEMICAL]warfarin[\\CHEMICAL] dose across the normal dose range.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Warfarin[\\CHEMICAL] dose and the pharmacogenomics of [GENE]CYP2C9[\\GENE] and VKORC1 - rationale and perspectives.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Warfarin[\\CHEMICAL] dose and the pharmacogenomics of CYP2C9 and [GENE]VKORC1[\\GENE] - rationale and perspectives.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Development and validation of a non-radioactive [GENE]DNA polymerase[\\GENE] assay for studying cytomegalovirus resistance to [CHEMICAL]foscarnet[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "We have expressed and characterized recombinant, [CHEMICAL]N[\\CHEMICAL]-terminally His-tagged [GENE]human adenine phosphoribosyltransferase[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 11
    },
    {
        "text": "Antitumor activity of [CHEMICAL]sorafenib[\\CHEMICAL] in [GENE]FLT3[\\GENE]-driven leukemic cells.",
        "label": 4,
        "major": -1,
        "len": 8
    },
    {
        "text": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, [CHEMICAL]sorafenib[\\CHEMICAL] blocked basal and ligand dependent [GENE]FLT3[\\GENE]-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and Stat5 phosphorylation.",
        "label": 4,
        "major": -1,
        "len": 27
    },
    {
        "text": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, [CHEMICAL]sorafenib[\\CHEMICAL] blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as [GENE]extracellular signal-regulated kinase1/2[\\GENE] and Stat5 phosphorylation.",
        "label": 4,
        "major": -1,
        "len": 27
    },
    {
        "text": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, [CHEMICAL]sorafenib[\\CHEMICAL] blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and [GENE]Stat5[\\GENE] phosphorylation.",
        "label": 4,
        "major": -1,
        "len": 27
    },
    {
        "text": "This surprising correlation between the lack of OTC expression and sensitivity of ASS-positive HCC cells shows that OTC-deficient HCCs are sensitive to [GENE]rhArg[\\GENE]-mediated [CHEMICAL]arginine[\\CHEMICAL] depletion.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "Therefore, pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to [CHEMICAL]arginine[\\CHEMICAL] depletion with [GENE]arginine-depleting enzymes[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Metabolism of vitamin A, all-trans-retinol, leads to the formation of 11-cis-retinaldehyde, the visual chromophore, and [CHEMICAL]all-trans-retinoic acid[\\CHEMICAL], which is involved in the regulation of gene expression through the [GENE]retinoic acid receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Specificity of [GENE]zebrafish retinol saturase[\\GENE]: formation of [CHEMICAL]all-trans-13,14-dihydroretinol[\\CHEMICAL] and all-trans-7,8- dihydroretinol.",
        "label": 9,
        "major": -1,
        "len": 11
    },
    {
        "text": "Specificity of [GENE]zebrafish retinol saturase[\\GENE]: formation of all-trans-13,14-dihydroretinol and [CHEMICAL]all-trans-7,8- dihydroretinol[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 11
    },
    {
        "text": "Specifically, [CHEMICAL]all-trans-13,14-dihydroretinol[\\CHEMICAL] is transiently oxidized to all-trans-13,14-dihydroretinoic acid before being oxidized further by [GENE]Cyp26[\\GENE] enzymes.",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "[GENE]zRetSat A[\\GENE] also saturated the 13-14 or 7-8 double bonds of [CHEMICAL]all-trans-3,4-didehydroretinol[\\CHEMICAL] (vitamin A2), a second endogenous form of vitamin A in zebrafish.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]zRetSat A[\\GENE] also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol ([CHEMICAL]vitamin A2[\\CHEMICAL]), a second endogenous form of vitamin A in zebrafish.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "That observation, together with previous demonstrations of numerous lipid-synthesizing enzymes in myelin, suggests utilization of [CHEMICAL]acetyl[\\CHEMICAL] groups liberated by myelin-localized [GENE]ASPA[\\GENE] for lipid synthesis within the myelin sheath.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of [GENE]FADS2[\\GENE] affects the [CHEMICAL]PUFA[\\CHEMICAL] biosynthetic pathway and consequently modifies the effect of alpha-linolenic acid (ALA) on myocardial infarction (MI).",
        "label": 9,
        "major": -1,
        "len": 34
    },
    {
        "text": "OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of [GENE]FADS2[\\GENE] affects the PUFA biosynthetic pathway and consequently modifies the effect of [CHEMICAL]alpha-linolenic acid[\\CHEMICAL] (ALA) on myocardial infarction (MI).",
        "label": 9,
        "major": -1,
        "len": 34
    },
    {
        "text": "OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of [GENE]FADS2[\\GENE] affects the PUFA biosynthetic pathway and consequently modifies the effect of alpha-linolenic acid ([CHEMICAL]ALA[\\CHEMICAL]) on myocardial infarction (MI).",
        "label": 9,
        "major": -1,
        "len": 34
    },
    {
        "text": "A novel [GENE]tyrosine kinase[\\GENE] switch is a mechanism of [CHEMICAL]imatinib[\\CHEMICAL] resistance in gastrointestinal stromal tumors.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "These results suggest that [GENE]PDE4B[\\GENE] mediates the antipsychotic effects of [CHEMICAL]rolipram[\\CHEMICAL] in CAR and that the PDE4B-regulated cyclic adenosine monophosphate signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the [GENE]PDE4B[\\GENE]-regulated [CHEMICAL]cyclic adenosine monophosphate[\\CHEMICAL] signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "In large, well designed phase III trials in patients with type 2 diabetes mellitus, [CHEMICAL]sitagliptin[\\CHEMICAL] 100 or 200mg once daily alone or in combination with other antihyperglycaemics was associated with significant improvements relative to placebo in overall glycaemic control and indices for [GENE]insulin[\\GENE] response and beta-cell function.",
        "label": 2,
        "major": -1,
        "len": 47
    },
    {
        "text": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved [GENE]HbA(1c)[\\GENE] to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to [CHEMICAL]glipizide[\\CHEMICAL] when added to metformin.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, [CHEMICAL]sitagliptin[\\CHEMICAL] improved [GENE]HbA(1c)[\\GENE] to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin.",
        "label": 3,
        "major": -1,
        "len": 38
    },
    {
        "text": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved [GENE]HbA(1c)[\\GENE] to a significantly greater extent than placebo when added to [CHEMICAL]metformin[\\CHEMICAL] or pioglitazone and was noninferior to glipizide when added to metformin.",
        "label": 3,
        "major": -1,
        "len": 38
    },
    {
        "text": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved [GENE]HbA(1c)[\\GENE] to a significantly greater extent than placebo when added to metformin or [CHEMICAL]pioglitazone[\\CHEMICAL] and was noninferior to glipizide when added to metformin.",
        "label": 3,
        "major": -1,
        "len": 38
    },
    {
        "text": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved [GENE]HbA(1c)[\\GENE] to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to [CHEMICAL]metformin[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 38
    },
    {
        "text": "Overexpression of PPARdelta by adenoviral transfer rescued [GENE]14-3-3epsilon[\\GENE] proteins from elimination by [CHEMICAL]sulindac[\\CHEMICAL] or indomethacin.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Overexpression of PPARdelta by adenoviral transfer rescued [GENE]14-3-3epsilon[\\GENE] proteins from elimination by sulindac or [CHEMICAL]indomethacin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Differences in magnitude of [CHEMICAL]Na(+)[\\CHEMICAL]-dependent l-alanine uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in [GENE]ASCT2[\\GENE] protein expression, this being more abundant in WKY PTE cells.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "Differences in magnitude of Na(+)-dependent [CHEMICAL]l-alanine[\\CHEMICAL] uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in [GENE]ASCT2[\\GENE] protein expression, this being more abundant in WKY PTE cells.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "Differences in magnitude of Na(+)-dependent [CHEMICAL]l-alanine[\\CHEMICAL] uptake through [GENE]ASCT2[\\GENE] between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression, this being more abundant in WKY PTE cells.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "The acute [GENE]insulin[\\GENE] response to intravenous [CHEMICAL]glucose[\\CHEMICAL] was augmented (1,300 +/- 110 vs 790 +/- 64 pmol/l; p < 0.001).",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "These results suggest that the pro-inflammatory effect of [CHEMICAL]H(2)S[\\CHEMICAL] may be mediated by [GENE]SP[\\GENE]-NK-1R related pathway in mouse pancreatic acinar cells.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "These results suggest that the pro-inflammatory effect of [CHEMICAL]H(2)S[\\CHEMICAL] may be mediated by SP-[GENE]NK-1R[\\GENE] related pathway in mouse pancreatic acinar cells.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "Hydrogen sulphide ([CHEMICAL]H(2)S[\\CHEMICAL]) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase ([GENE]CSE[\\GENE]) and cystathionine-beta-synthase (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide ([CHEMICAL]H(2)S[\\CHEMICAL]) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and [GENE]cystathionine-beta-synthase[\\GENE] (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide ([CHEMICAL]H(2)S[\\CHEMICAL]) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase ([GENE]CBS[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide ([CHEMICAL]H(2)S[\\CHEMICAL]) is synthesized from L-cysteine via the action of [GENE]cystathionine-gamma-lyase[\\GENE] (CSE) and cystathionine-beta-synthase (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "In this study, we investigated the presence of H(2)S and the expression of [CHEMICAL]H(2)S[\\CHEMICAL] synthesizing enzymes, [GENE]CSE[\\GENE] and CBS, in isolated mouse pancreatic acini.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "In this study, we investigated the presence of H(2)S and the expression of [CHEMICAL]H(2)S[\\CHEMICAL] synthesizing enzymes, CSE and [GENE]CBS[\\GENE], in isolated mouse pancreatic acini.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Hydrogen sulphide[\\CHEMICAL] (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase ([GENE]CSE[\\GENE]) and cystathionine-beta-synthase (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Hydrogen sulphide[\\CHEMICAL] (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and [GENE]cystathionine-beta-synthase[\\GENE] (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Hydrogen sulphide[\\CHEMICAL] (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase ([GENE]CBS[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Hydrogen sulphide[\\CHEMICAL] (H(2)S) is synthesized from L-cysteine via the action of [GENE]cystathionine-gamma-lyase[\\GENE] (CSE) and cystathionine-beta-synthase (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide (H(2)S) is synthesized from [CHEMICAL]L-cysteine[\\CHEMICAL] via the action of cystathionine-gamma-lyase ([GENE]CSE[\\GENE]) and cystathionine-beta-synthase (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide (H(2)S) is synthesized from [CHEMICAL]L-cysteine[\\CHEMICAL] via the action of cystathionine-gamma-lyase (CSE) and [GENE]cystathionine-beta-synthase[\\GENE] (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide (H(2)S) is synthesized from [CHEMICAL]L-cysteine[\\CHEMICAL] via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase ([GENE]CBS[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Hydrogen sulphide (H(2)S) is synthesized from [CHEMICAL]L-cysteine[\\CHEMICAL] via the action of [GENE]cystathionine-gamma-lyase[\\GENE] (CSE) and cystathionine-beta-synthase (CBS).",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "RESULTS: Eighty percent of [GENE]CYP2C9[\\GENE]*1/*1 patients stabilized on <4.0 mg/day [CHEMICAL]warfarin[\\CHEMICAL] had at least 1 VKORC1 -1639A allele.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "RESULTS: Eighty percent of CYP2C9*1/*1 patients stabilized on <4.0 mg/day [CHEMICAL]warfarin[\\CHEMICAL] had at least 1 [GENE]VKORC1[\\GENE] -1639A allele.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Our data identify cAspAT as a new member of glyceroneogenesis, transcriptionally regulated by [CHEMICAL]TZD[\\CHEMICAL] via the control of [GENE]RORalpha[\\GENE] expression by PPARgamma in adipocytes.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Our data identify cAspAT as a new member of glyceroneogenesis, transcriptionally regulated by [CHEMICAL]TZD[\\CHEMICAL] via the control of RORalpha expression by [GENE]PPARgamma[\\GENE] in adipocytes.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Nevertheless, [GENE]PPARgamma[\\GENE] is indirectly necessary for both cAspAT basal expression and [CHEMICAL]TZD[\\CHEMICAL] responsiveness because they are, respectively, diminished and abolished by ectopic overexpression of a dominant negative PPARgamma.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "Our data identify [GENE]cAspAT[\\GENE] as a new member of glyceroneogenesis, transcriptionally regulated by [CHEMICAL]TZD[\\CHEMICAL] via the control of RORalpha expression by PPARgamma in adipocytes.",
        "label": 3,
        "major": -1,
        "len": 24
    },
    {
        "text": "In summary, our data indicates that over-expression of hGSTA4 at levels conferring high [GENE]GST[\\GENE]-[CHEMICAL]4-HNE[\\CHEMICAL] conjugating activity confers a partial growth advantage to HepG2 cells and protects against 4-HNE oxidative injury.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "The alpha class [GENE]human GSTA4-4[\\GENE] enzyme (hGSTA4-4) has a particularly high catalytic efficiency toward [CHEMICAL]4-HNE[\\CHEMICAL] conjugation.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "The alpha class human GSTA4-4 enzyme ([GENE]hGSTA4-4[\\GENE]) has a particularly high catalytic efficiency toward [CHEMICAL]4-HNE[\\CHEMICAL] conjugation.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "HepG2 cells transfected with an hGSTA4 vector construct exhibited high steady-state hGSTA4 mRNA, high [GENE]GST-4[\\GENE][CHEMICAL]4-HNE[\\CHEMICAL] catalytic activities, but lower basal glutathione (GSH) concentrations relative to insert-free vector (control) cells.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "We isolated partial cDNAs that codified for enzymes implicated in the [CHEMICAL]anthocyanin[\\CHEMICAL] biosynthesis such as [GENE]l-phenylalanine ammonia-lyase[\\GENE] (PAL) and chalcone synthase (CHS), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "We isolated partial cDNAs that codified for enzymes implicated in the [CHEMICAL]anthocyanin[\\CHEMICAL] biosynthesis such as l-phenylalanine ammonia-lyase ([GENE]PAL[\\GENE]) and chalcone synthase (CHS), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "We isolated partial cDNAs that codified for enzymes implicated in the [CHEMICAL]anthocyanin[\\CHEMICAL] biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and [GENE]chalcone synthase[\\GENE] (CHS), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "We isolated partial cDNAs that codified for enzymes implicated in the [CHEMICAL]anthocyanin[\\CHEMICAL] biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and chalcone synthase ([GENE]CHS[\\GENE]), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "We isolated partial cDNAs that codified for enzymes implicated in the [CHEMICAL]anthocyanin[\\CHEMICAL] biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and chalcone synthase (CHS), and an antioxidant enzyme such as [GENE]ascorbate peroxidase[\\GENE] (APX).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "We isolated partial cDNAs that codified for enzymes implicated in the [CHEMICAL]anthocyanin[\\CHEMICAL] biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and chalcone synthase (CHS), and an antioxidant enzyme such as ascorbate peroxidase ([GENE]APX[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "The immunosuppressive effects of T3 SCI were caused by [CHEMICAL]NE[\\CHEMICAL] acting at [GENE]beta2-adrenergic receptors[\\GENE] (beta2AR) and could be reversed using beta2AR blockers.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "The immunosuppressive effects of T3 SCI were caused by [CHEMICAL]NE[\\CHEMICAL] acting at beta2-adrenergic receptors ([GENE]beta2AR[\\GENE]) and could be reversed using beta2AR blockers.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Indoleamine 2,3-dioxygenase ([GENE]IDO[\\GENE]), a [CHEMICAL]tryptophan[\\CHEMICAL] catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "[GENE]Indoleamine 2,3-dioxygenase[\\GENE] (IDO), a [CHEMICAL]tryptophan[\\CHEMICAL] catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "CONCLUSIONS: The data advance the novel hypothesis that central sympatholysis with [CHEMICAL]dexmedetomidine[\\CHEMICAL] constitutes a highly effective countermeasure for cocaine's sympathomimetic actions on the human cardiovascular system, even in individuals carrying the [GENE]alpha2C[\\GENE]Del322-325 polymorphism.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Acetaminophen[\\CHEMICAL] plasma concentrations remained above the in vitro IC(50) for [GENE]COX-2[\\GENE] for at least 5 h postadministration.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "Ex vivo IC(50) values ([GENE]COX-1[\\GENE]: 105.2 micromol/L; COX-2: 26.3 micromol/L) of [CHEMICAL]acetaminophen[\\CHEMICAL] compared favorably with its in vitro IC(50) values.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "Ex vivo IC(50) values (COX-1: 105.2 micromol/L; [GENE]COX-2[\\GENE]: 26.3 micromol/L) of [CHEMICAL]acetaminophen[\\CHEMICAL] compared favorably with its in vitro IC(50) values.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "This short [GENE]AdSS[\\GENE] has two large deletions that map to the middle and [CHEMICAL]C[\\CHEMICAL]-terminus of the protein.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "In addition, the molecular configuration of [CHEMICAL]vardenafil[\\CHEMICAL] differs from that of sildenafil when bound to [GENE]PDE5[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "In addition, the molecular configuration of vardenafil differs from that of [CHEMICAL]sildenafil[\\CHEMICAL] when bound to [GENE]PDE5[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "In this report, we demonstrate the utility of reversed-phase protein chromatography and FT-ICR mass spectrometry in analyzing CCNU ([CHEMICAL]lomustine[\\CHEMICAL], 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea, MW: 233.7Da) modification of [GENE]stathmin[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "In this report, we demonstrate the utility of reversed-phase protein chromatography and FT-ICR mass spectrometry in analyzing CCNU (lomustine, [CHEMICAL]1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea[\\CHEMICAL], MW: 233.7Da) modification of [GENE]stathmin[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Insight into the structural basis for this improvement was gained with molecular modeling and NMR data obtained for [GENE]microtubule[\\GENE]-bound [CHEMICAL]docetaxel[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Risperidone is metabolized to its active metabolite, [CHEMICAL]9-hydroxyrisperidone[\\CHEMICAL], mainly by the [GENE]cytochrome P450[\\GENE] enzymes CYP2D6 and 3A4.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Risperidone[\\CHEMICAL] is metabolized to its active metabolite, 9-hydroxyrisperidone, mainly by the [GENE]cytochrome P450[\\GENE] enzymes CYP2D6 and 3A4.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "Tumor-growth-promoting [GENE]cyclooxygenase-2[\\GENE] [CHEMICAL]prostaglandin E2[\\CHEMICAL] pathway provides medulloblastoma therapeutic targets.",
        "label": 9,
        "major": -1,
        "len": 9
    },
    {
        "text": "METHODS: Male rats were administered [CHEMICAL]PLZ[\\CHEMICAL] (10 mg/kg) or VIG (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of [GENE]MAO[\\GENE], GABA-T and ALA-T (radiochemical assays).",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "METHODS: Male rats were administered [CHEMICAL]PLZ[\\CHEMICAL] (10 mg/kg) or VIG (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of MAO, [GENE]GABA-T[\\GENE] and ALA-T (radiochemical assays).",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "METHODS: Male rats were administered [CHEMICAL]PLZ[\\CHEMICAL] (10 mg/kg) or VIG (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of MAO, GABA-T and [GENE]ALA-T[\\GENE] (radiochemical assays).",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "METHODS: Male rats were administered PLZ (10 mg/kg) or [CHEMICAL]VIG[\\CHEMICAL] (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of [GENE]MAO[\\GENE], GABA-T and ALA-T (radiochemical assays).",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "METHODS: Male rats were administered PLZ (10 mg/kg) or [CHEMICAL]VIG[\\CHEMICAL] (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of MAO, [GENE]GABA-T[\\GENE] and ALA-T (radiochemical assays).",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "METHODS: Male rats were administered PLZ (10 mg/kg) or [CHEMICAL]VIG[\\CHEMICAL] (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of MAO, GABA-T and [GENE]ALA-T[\\GENE] (radiochemical assays).",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "[CHEMICAL]Tolvaptan[\\CHEMICAL] is a breakthrough in the therapy of hyponatremia as it directly combats elevated [GENE]AVP[\\GENE] levels associated with the syndrome of inappropriate secretion of antidiuretic hormone, congestive heart failure, and cirrhosis of the liver.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Third, [GENE]ABCA1[\\GENE]-RNAi suppressed hepatic [CHEMICAL]alpha-tocopherol[\\CHEMICAL] secretion.",
        "label": 9,
        "major": -1,
        "len": 6
    },
    {
        "text": "These results strongly suggest that [GENE]ABCA1[\\GENE] is substantially involved in hepatic [CHEMICAL]alpha-tocopherol[\\CHEMICAL] secretion.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "To confirm molecular recognition of [CHEMICAL]tinzaparin[\\CHEMICAL] by [GENE]VLA-4[\\GENE], a surface acoustic wave-biosensor was applied.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "The effects of [CHEMICAL]CDCA[\\CHEMICAL] and GW4064 on expression of [GENE]Cdx2[\\GENE] and MUC2 were abolished by guggulsterone.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The effects of [CHEMICAL]CDCA[\\CHEMICAL] and GW4064 on expression of Cdx2 and [GENE]MUC2[\\GENE] were abolished by guggulsterone.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The effects of CDCA and [CHEMICAL]GW4064[\\CHEMICAL] on expression of [GENE]Cdx2[\\GENE] and MUC2 were abolished by guggulsterone.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The effects of CDCA and [CHEMICAL]GW4064[\\CHEMICAL] on expression of Cdx2 and [GENE]MUC2[\\GENE] were abolished by guggulsterone.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The effects of CDCA and GW4064 on expression of [GENE]Cdx2[\\GENE] and MUC2 were abolished by [CHEMICAL]guggulsterone[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 16
    },
    {
        "text": "The effects of CDCA and GW4064 on expression of Cdx2 and [GENE]MUC2[\\GENE] were abolished by [CHEMICAL]guggulsterone[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Testosterone[\\CHEMICAL] (TEST) had the fastest translocation rate for the [GENE]hAR[\\GENE] of 0.0525 min(-1).",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Testosterone ([CHEMICAL]TEST[\\CHEMICAL]) had the fastest translocation rate for the [GENE]hAR[\\GENE] of 0.0525 min(-1).",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "These results led us to consider that [CHEMICAL]TAS-102[\\CHEMICAL] may also be effective for esophageal and uterine squamous cell carcinomas, as well as for gastrointestinal adenocarcinomas, even in fluoropyrimidine-resistant cases with high [GENE]TS[\\GENE] expression.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "These results led us to consider that TAS-102 may also be effective for esophageal and uterine squamous cell carcinomas, as well as for gastrointestinal adenocarcinomas, even in [CHEMICAL]fluoropyrimidine[\\CHEMICAL]-resistant cases with high [GENE]TS[\\GENE] expression.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "In contrast, thyroid papillary carcinomas, lung adenocarcinomas, hepatocellular carcinomas, pancreatic ductal carcinomas, and renal cell carcinomas, which exhibit low [GENE]TK-1[\\GENE] expression, may be resistant to [CHEMICAL]TAS-102[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]Thymidine kinase-1[\\GENE] (TK-1) and thymidylate synthase (TS) are key enzymes for salvage and de novo [CHEMICAL]pyrimidine[\\CHEMICAL] synthesis, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Thymidine kinase-1 ([GENE]TK-1)[\\GENE] and thymidylate synthase (TS) are key enzymes for salvage and de novo [CHEMICAL]pyrimidine[\\CHEMICAL] synthesis, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Thymidine kinase-1 (TK-1) and [GENE]thymidylate synthase[\\GENE] (TS) are key enzymes for salvage and de novo [CHEMICAL]pyrimidine[\\CHEMICAL] synthesis, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Thymidine kinase-1 (TK-1) and thymidylate synthase ([GENE]TS[\\GENE]) are key enzymes for salvage and de novo [CHEMICAL]pyrimidine[\\CHEMICAL] synthesis, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Immunohistochemical characterization of [CHEMICAL]pyrimidine[\\CHEMICAL] synthetic enzymes, [GENE]thymidine kinase-1[\\GENE] and thymidylate synthase, in various types of cancer.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Immunohistochemical characterization of [CHEMICAL]pyrimidine[\\CHEMICAL] synthetic enzymes, thymidine kinase-1 and [GENE]thymidylate synthase[\\GENE], in various types of cancer.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Within each pentamer most of the contacts between [GENE]S100A4[\\GENE] dimers occurs through the [CHEMICAL]TFP[\\CHEMICAL] moieties.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "The Ca(2+)-[GENE]S100A4[\\GENE]/[CHEMICAL]prochlorperazine[\\CHEMICAL] (PCP) complex exhibits a similar pentameric assembly.",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "The Ca(2+)-[GENE]S100A4[\\GENE]/prochlorperazine ([CHEMICAL]PCP[\\CHEMICAL]) complex exhibits a similar pentameric assembly.",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "Equilibrium sedimentation and cross-linking studies demonstrate the cooperative formation of a similarly sized [GENE]S100A4[\\GENE]/[CHEMICAL]TFP[\\CHEMICAL] oligomer in solution.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "The results support a role for [CHEMICAL]rasagiline[\\CHEMICAL] in protecting dopaminergic cells against free radical mediated damage and apoptosis in the presence of [GENE]alpha-synuclein[\\GENE] over-expression.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "In the absence of cTnI, docking localized [CHEMICAL]dfbp-o[\\CHEMICAL] to the same position in the hydrophobic groove of [GENE]cTnC[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "The potential role of [GENE]DAT[\\GENE] as a target for [CHEMICAL]AMPH[\\CHEMICAL] and COC has been reviewed extensively.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The potential role of [GENE]DAT[\\GENE] as a target for AMPH and [CHEMICAL]COC[\\CHEMICAL] has been reviewed extensively.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Studies over the past decades suggest that, besides [GENE]cyclooxygenases[\\GENE], [CHEMICAL]aspirin[\\CHEMICAL] acetylates other cellular proteins.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "In a recent study using protein-specific anti-acetyl lysine antibodies and immunological methods, we demonstrated the ability of [CHEMICAL]aspirin[\\CHEMICAL] to acetylate the [GENE]tumor suppressor protein p53[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 25
    },
    {
        "text": "Antibodies to either the [CHEMICAL]C[\\CHEMICAL]- or N- terminus of [GENE]VMAT-1[\\GENE] detected two proteins (73 and 55 kD) in transfected COS-1 cells.",
        "label": 1,
        "major": -1,
        "len": 21
    },
    {
        "text": "Antibodies to either the C- or [CHEMICAL]N[\\CHEMICAL]- terminus of [GENE]VMAT-1[\\GENE] detected two proteins (73 and 55 kD) in transfected COS-1 cells.",
        "label": 1,
        "major": -1,
        "len": 21
    },
    {
        "text": "The [CHEMICAL]C[\\CHEMICAL]-terminal antibodies detected both proteins in extracts of mouse medulla/pons, cortex, hypothalamus, and cerebellum but only the 73 kD protein and higher molecular weight immunoreactive proteins in mouse adrenal and rat PC12 cells, which are positive controls for [GENE]rodent VMAT-1[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 41
    },
    {
        "text": "We postulate that [CHEMICAL]vescalagin[\\CHEMICAL] is an active component in PWFE that may alleviate the [GENE]insulin[\\GENE] resistance in mouse hepatocytes.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Despite the importance of AKRs in PAHs metabolism, there are no studies that evaluate, in general human populations, the effect of [CHEMICAL]PAHs[\\CHEMICAL] on [GENE]AKRs[\\GENE] expression in peripheral blood lymphocytes (PBLs).",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Despite the importance of [GENE]AKRs[\\GENE] in [CHEMICAL]PAHs[\\CHEMICAL] metabolism, there are no studies that evaluate, in general human populations, the effect of PAHs on AKRs expression in peripheral blood lymphocytes (PBLs).",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Thiazolidinediones[\\CHEMICAL] (TZDs) are [GENE]insulin[\\GENE] sensitizers used for treatment of diabetes.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "Thiazolidinediones ([CHEMICAL]TZDs[\\CHEMICAL]) are [GENE]insulin[\\GENE] sensitizers used for treatment of diabetes.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "Thiazolidinediones (TZDs) affect osteoblast viability and biomarkers independently of the [CHEMICAL]TZD[\\CHEMICAL] effects on [GENE]aromatase[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Stable [GENE]ABCC1[\\GENE], ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of [CHEMICAL]BPDE glutathione[\\CHEMICAL] conjugates.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "Stable ABCC1, [GENE]ABCC2[\\GENE] and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of [CHEMICAL]BPDE glutathione[\\CHEMICAL] conjugates.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "Stable ABCC1, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that [GENE]ABCC1[\\GENE] mediates the basolateral and ABCC2 the apical excretion of [CHEMICAL]BPDE glutathione[\\CHEMICAL] conjugates.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "Stable ABCC1, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and [GENE]ABCC2[\\GENE] the apical excretion of [CHEMICAL]BPDE glutathione[\\CHEMICAL] conjugates.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "Swim training of monosodium L-glutamate-obese mice improves the impaired [GENE]insulin receptor[\\GENE] [CHEMICAL]tyrosine[\\CHEMICAL] phosphorylation in pancreatic islets.",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The obtained results showed that [CHEMICAL]pioglitazone[\\CHEMICAL] improved the renal function, structural changes, renal malondialdehyde (MDA), [GENE]tumor necrosis factor alpha[\\GENE] (TNF-\u03b1), nuclear factor kappa B (NF-\u03baB) genes expression in cisplatin injected rats.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that [CHEMICAL]pioglitazone[\\CHEMICAL] improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha ([GENE]TNF-\u03b1[\\GENE]), nuclear factor kappa B (NF-\u03baB) genes expression in cisplatin injected rats.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that [CHEMICAL]pioglitazone[\\CHEMICAL] improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), [GENE]nuclear factor kappa B[\\GENE] (NF-\u03baB) genes expression in cisplatin injected rats.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that [CHEMICAL]pioglitazone[\\CHEMICAL] improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), nuclear factor kappa B ([GENE]NF-\u03baB[\\GENE]) genes expression in cisplatin injected rats.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), [GENE]tumor necrosis factor alpha[\\GENE] (TNF-\u03b1), nuclear factor kappa B (NF-\u03baB) genes expression in [CHEMICAL]cisplatin[\\CHEMICAL] injected rats.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha ([GENE]TNF-\u03b1[\\GENE]), nuclear factor kappa B (NF-\u03baB) genes expression in [CHEMICAL]cisplatin[\\CHEMICAL] injected rats.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), [GENE]nuclear factor kappa B[\\GENE] (NF-\u03baB) genes expression in [CHEMICAL]cisplatin[\\CHEMICAL] injected rats.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), nuclear factor kappa B ([GENE]NF-\u03baB[\\GENE]) genes expression in [CHEMICAL]cisplatin[\\CHEMICAL] injected rats.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "The active site of the [GENE]metalloproteinase domain[\\GENE] has a consensus HEXXHXXGXXHD sequence and a [CHEMICAL]Met[\\CHEMICAL]-turn.",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "We report that [CHEMICAL]wogonoside[\\CHEMICAL] triggered the formation of [GENE]microtubule-associated protein-light chain 3[\\GENE] (MAP-LC3) positive autophagosomes and the accumulation of acidic vesicular and autolysosomes in MDA-MB-231 cells.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "We report that [CHEMICAL]wogonoside[\\CHEMICAL] triggered the formation of microtubule-associated protein-light chain 3 ([GENE]MAP-LC3[\\GENE]) positive autophagosomes and the accumulation of acidic vesicular and autolysosomes in MDA-MB-231 cells.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The results showed that [CHEMICAL]wogonoside[\\CHEMICAL] promotes the expression of [GENE]LC3-II[\\GENE] and Beclin-1.",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "The results showed that [CHEMICAL]wogonoside[\\CHEMICAL] promotes the expression of LC3-II and [GENE]Beclin-1[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "When further examined for its anticancer mechanism, [CHEMICAL]SB365[\\CHEMICAL] effectively suppressed the [GENE]AKT[\\GENE]/mTOR pathway both in vitro and in vivo.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "When further examined for its anticancer mechanism, [CHEMICAL]SB365[\\CHEMICAL] effectively suppressed the AKT/[GENE]mTOR[\\GENE] pathway both in vitro and in vivo.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]DBDCT[\\CHEMICAL] also caused the phosphorylation of [GENE]JNK[\\GENE] and p38(MAPK).",
        "label": 3,
        "major": -1,
        "len": 9
    },
    {
        "text": "[CHEMICAL]DBDCT[\\CHEMICAL] also caused the phosphorylation of JNK and [GENE]p38[\\GENE](MAPK).",
        "label": 3,
        "major": -1,
        "len": 9
    },
    {
        "text": "[CHEMICAL]DBDCT[\\CHEMICAL] also caused the phosphorylation of JNK and p38([GENE]MAPK[\\GENE]).",
        "label": 3,
        "major": -1,
        "len": 9
    },
    {
        "text": "Based on these studies, the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal [GENE]AChE[\\GENE] expression and activity - was significantly higher following exposure to [CHEMICAL]paraoxon[\\CHEMICAL] concentrations as low as 31.2 nM.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "Based on these studies, the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal [GENE]AChE[\\GENE] expression and activity - was significantly higher following exposure to [CHEMICAL]paraoxon[\\CHEMICAL] concentrations as low as 31.2 nM.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "We examined the ability of the [GENE]EPAC[\\GENE]-selective [CHEMICAL]cAMP[\\CHEMICAL] analog 8-pCPT-2'-O-Me-cAMP-AM to potentiate the action of these drugs and the mechanism that might account for it.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "We examined the ability of the [GENE]EPAC[\\GENE]-selective cAMP analog [CHEMICAL]8-pCPT-2'-O-Me-cAMP-AM[\\CHEMICAL] to potentiate the action of these drugs and the mechanism that might account for it.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "F344 [GENE]gpt[\\GENE] delta rats were subjected to repeated oral administration of [CHEMICAL]MEG[\\CHEMICAL] at dosages of 0, 10, 30, or 100mg/kg (a carcinogenic dose) for 13 weeks.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Histone deacetylase 3 (Hdac3) is a nuclear enzyme that removes [CHEMICAL]acetyl[\\CHEMICAL] groups from lysine residues in [GENE]histones[\\GENE] and other proteins to epigenetically regulate gene expression.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "Histone deacetylase 3 (Hdac3) is a nuclear enzyme that removes acetyl groups from [CHEMICAL]lysine[\\CHEMICAL] residues in [GENE]histones[\\GENE] and other proteins to epigenetically regulate gene expression.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "Our study aims to explore the potent effects of AC, as a marker component of Aconitum, on [GENE]CYP3A[\\GENE] using the probe [CHEMICAL]buspirone[\\CHEMICAL] in rats.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[GENE]CYP3A[\\GENE] activity and protein levels in rat liver microsomes pretreated with oral AC were also measured using in vitro [CHEMICAL]buspirone[\\CHEMICAL] metabolism and Western blot.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Apoptosis initiation of [CHEMICAL]\u03b2-ionone[\\CHEMICAL] in SGC-7901 gastric carcinoma cancer cells via a [GENE]PI3K[\\GENE]-AKT pathway.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Apoptosis initiation of [CHEMICAL]\u03b2-ionone[\\CHEMICAL] in SGC-7901 gastric carcinoma cancer cells via a PI3K-[GENE]AKT[\\GENE] pathway.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "To investigate the effects of [CHEMICAL]\u03b2-ionone[\\CHEMICAL] on apoptosis initiation and its possible mechanisms of action, we qualified cell apoptosis, proteins related to apoptosis and a [GENE]phosphatidylinositol 3-kinase[\\GENE] (PI3K)-AKT pathway in human gastric adenocarcinoma cancer SGC-7901 cells.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "To investigate the effects of [CHEMICAL]\u03b2-ionone[\\CHEMICAL] on apoptosis initiation and its possible mechanisms of action, we qualified cell apoptosis, proteins related to apoptosis and a phosphatidylinositol 3-kinase ([GENE]PI3K[\\GENE])-AKT pathway in human gastric adenocarcinoma cancer SGC-7901 cells.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "To investigate the effects of [CHEMICAL]\u03b2-ionone[\\CHEMICAL] on apoptosis initiation and its possible mechanisms of action, we qualified cell apoptosis, proteins related to apoptosis and a phosphatidylinositol 3-kinase (PI3K)-[GENE]AKT[\\GENE] pathway in human gastric adenocarcinoma cancer SGC-7901 cells.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "The concentration response to [CHEMICAL]levcromakalim[\\CHEMICAL] (LEVC), a [GENE]K(ATP) channel[\\GENE] opener, was significantly shifted to the left in the inflamed smooth-muscle cells.",
        "label": 3,
        "major": -1,
        "len": 21
    },
    {
        "text": "The concentration response to levcromakalim ([CHEMICAL]LEVC[\\CHEMICAL]), a [GENE]K(ATP) channel[\\GENE] opener, was significantly shifted to the left in the inflamed smooth-muscle cells.",
        "label": 3,
        "major": -1,
        "len": 21
    },
    {
        "text": "In vivo and in vitro characterization of [CHEMICAL]naltrindole[\\CHEMICAL]-derived ligands at the [GENE]\u03ba-opioid receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "The [GENE]mitochondrial respiratory chain complex IV[\\GENE] (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular [CHEMICAL]oxygen[\\CHEMICAL], yielding water.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The mitochondrial respiratory chain complex IV ([GENE]cytochrome c oxidase[\\GENE]) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular [CHEMICAL]oxygen[\\CHEMICAL], yielding water.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The 3D-structure of [GENE]HmTx[\\GENE] consists of three conserved alpha-helices: h1 ([CHEMICAL]Lys[\\CHEMICAL]24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The 3D-structure of [GENE]HmTx[\\GENE] consists of three conserved alpha-helices: h1 (Lys24-[CHEMICAL]His[\\CHEMICAL]34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The 3D-structure of [GENE]HmTx[\\GENE] consists of three conserved alpha-helices: h1 (Lys24-His34), h2 ([CHEMICAL]Cys[\\CHEMICAL]59-Asp71), and h3 (Ala80-Phe89).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The 3D-structure of [GENE]HmTx[\\GENE] consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-[CHEMICAL]Asp[\\CHEMICAL]71), and h3 (Ala80-Phe89).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The 3D-structure of [GENE]HmTx[\\GENE] consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 ([CHEMICAL]Ala[\\CHEMICAL]80-Phe89).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "The 3D-structure of [GENE]HmTx[\\GENE] consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-[CHEMICAL]Phe[\\CHEMICAL]89).",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "These results show that the robust effects of [CHEMICAL]TCDD[\\CHEMICAL] on the mRNA expression of [GENE]Snrpn[\\GENE], Peg3 and Igf2r genes in the sperm and of Igf2r in the muscle and liver are unrelated to changes in methylation in their respective genes.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "These results show that the robust effects of [CHEMICAL]TCDD[\\CHEMICAL] on the mRNA expression of Snrpn, [GENE]Peg3[\\GENE] and Igf2r genes in the sperm and of Igf2r in the muscle and liver are unrelated to changes in methylation in their respective genes.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "These results show that the robust effects of [CHEMICAL]TCDD[\\CHEMICAL] on the mRNA expression of Snrpn, Peg3 and [GENE]Igf2r[\\GENE] genes in the sperm and of Igf2r in the muscle and liver are unrelated to changes in methylation in their respective genes.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "These results show that the robust effects of [CHEMICAL]TCDD[\\CHEMICAL] on the mRNA expression of Snrpn, Peg3 and Igf2r genes in the sperm and of [GENE]Igf2r[\\GENE] in the muscle and liver are unrelated to changes in methylation in their respective genes.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "[GENE]GABA type A receptors[\\GENE] (GABA(A)-R) are important for [CHEMICAL]ethanol[\\CHEMICAL] actions and it is of interest to link individual subunits with specific ethanol behaviors.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "GABA type A receptors ([GENE]GABA(A)-R[\\GENE]) are important for [CHEMICAL]ethanol[\\CHEMICAL] actions and it is of interest to link individual subunits with specific ethanol behaviors.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "All together, they indicate that aversive property of ethanol is dependent on [CHEMICAL]ethanol[\\CHEMICAL] action on [GENE]\u03b12-containing GABA(A)-R[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "[GENE]Albumin[\\GENE] nanoparticles were surface-coated with bifunctional [CHEMICAL]polyethylene glycol[\\CHEMICAL] 3500 (PEG) and a nanobody-the single variable domain of an antibody-(Ega1) against the epidermal growth factor receptor (EGFR).",
        "label": 1,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]Albumin[\\GENE] nanoparticles were surface-coated with bifunctional polyethylene glycol 3500 ([CHEMICAL]PEG[\\CHEMICAL]) and a nanobody-the single variable domain of an antibody-(Ega1) against the epidermal growth factor receptor (EGFR).",
        "label": 1,
        "major": -1,
        "len": 26
    },
    {
        "text": "The [GENE]Ves a 1[\\GENE] structure, which is composed of seven \u03b1-helixes and eleven \u03b2-strands, contains the \u03b2-strand/\u025bSer/\u03b1-helix structural motif, which contains the [CHEMICAL]Gly[\\CHEMICAL]-X-Ser-X-Gly consensus sequence.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "The [GENE]Ves a 1[\\GENE] structure, which is composed of seven \u03b1-helixes and eleven \u03b2-strands, contains the \u03b2-strand/\u025bSer/\u03b1-helix structural motif, which contains the Gly-X-[CHEMICAL]Ser[\\CHEMICAL]-X-Gly consensus sequence.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "The [GENE]Ves a 1[\\GENE] structure, which is composed of seven \u03b1-helixes and eleven \u03b2-strands, contains the \u03b2-strand/\u025bSer/\u03b1-helix structural motif, which contains the Gly-X-Ser-X-[CHEMICAL]Gly[\\CHEMICAL] consensus sequence.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "Moreover, the observed insertion of [CHEMICAL]proline[\\CHEMICAL] into the lid domain of the [GENE]Ves a 1[\\GENE] structure is rare.",
        "label": 1,
        "major": -1,
        "len": 18
    },
    {
        "text": "We therefore propose that this [CHEMICAL]proline[\\CHEMICAL] residue might be involved in the stability and activity of [GENE]Ves a 1s[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 19
    },
    {
        "text": "Based on these suggestions, the rational redesign of [CHEMICAL]furanopyrimidine[\\CHEMICAL] 24 (clog\u2009P=7.41; [GENE]Aurora\u2005A[\\GENE] IC(50) =43\u2005nM; HCT-116 IC(50) =400\u2005nM) led to the identification of quinazoline 67 (clog\u2009P=5.28; Aurora\u2005A IC(50) =25\u2005nM; HCT-116 IC(50) =23\u2005nM).",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Based on these suggestions, the rational redesign of furanopyrimidine 24 (clog\u2009P=7.41; Aurora\u2005A IC(50) =43\u2005nM; HCT-116 IC(50) =400\u2005nM) led to the identification of [CHEMICAL]quinazoline[\\CHEMICAL] 67 (clog\u2009P=5.28; [GENE]Aurora\u2005A[\\GENE] IC(50) =25\u2005nM; HCT-116 IC(50) =23\u2005nM).",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Three different 3D-QSAR models were built and validated by using a set of 66 [CHEMICAL]pyrazole[\\CHEMICAL] (Model\u2005I) and furanopyrimidine (Model\u2005II) compounds with IC(50) values toward [GENE]Aurora kinase\u2005A[\\GENE] ranging from 33\u2005nM to 10.5\u2005\u03bcM.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Three different 3D-QSAR models were built and validated by using a set of 66 pyrazole (Model\u2005I) and [CHEMICAL]furanopyrimidine[\\CHEMICAL] (Model\u2005II) compounds with IC(50) values toward [GENE]Aurora kinase\u2005A[\\GENE] ranging from 33\u2005nM to 10.5\u2005\u03bcM.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Around five times as potent as the lead with an IC(50) of 33 \u03bcM for disruption of the [GENE]Myc[\\GENE]-Max heterodimer, [CHEMICAL]JY-3-094[\\CHEMICAL] demonstrated excellent selectivity over Max-Max homodimers, with no apparent effect at 100 \u03bcM.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Around five times as potent as the lead with an IC(50) of 33 \u03bcM for disruption of the Myc-[GENE]Max[\\GENE] heterodimer, [CHEMICAL]JY-3-094[\\CHEMICAL] demonstrated excellent selectivity over Max-Max homodimers, with no apparent effect at 100 \u03bcM.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Around five times as potent as the lead with an IC(50) of 33 \u03bcM for disruption of the Myc-Max heterodimer, [CHEMICAL]JY-3-094[\\CHEMICAL] demonstrated excellent selectivity over [GENE]Max[\\GENE]-Max homodimers, with no apparent effect at 100 \u03bcM.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Around five times as potent as the lead with an IC(50) of 33 \u03bcM for disruption of the Myc-Max heterodimer, [CHEMICAL]JY-3-094[\\CHEMICAL] demonstrated excellent selectivity over Max-[GENE]Max[\\GENE] homodimers, with no apparent effect at 100 \u03bcM.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Results demonstrate that predominantly FUT7, and to a lesser extent FUT4, forms the selectin-ligand at the [CHEMICAL]N[\\CHEMICAL] terminus of leukocyte [GENE]P-selectin glycoprotein ligand-1[\\GENE] (PSGL-1) in humans and mice.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "[CHEMICAL]MDMA[\\CHEMICAL] catechol metabolites were neurotoxic to SH-SY5Y neurons, leading to [GENE]caspase 3[\\GENE]-independent cell death in a concentration- and time-dependent manner.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "MDMA [CHEMICAL]catechol[\\CHEMICAL] metabolites were neurotoxic to SH-SY5Y neurons, leading to [GENE]caspase 3[\\GENE]-independent cell death in a concentration- and time-dependent manner.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The protein is formed by an [CHEMICAL]N[\\CHEMICAL][GENE]N-terminal helicase-like domain[\\GENE], a C-terminal DNA polymerase domain, and a large central domain that spans between the two.",
        "label": 1,
        "major": -1,
        "len": 24
    },
    {
        "text": "The protein is formed by an N-terminal helicase-like domain, a [CHEMICAL]C[\\CHEMICAL][GENE]C-terminal DNA polymerase domain[\\GENE], and a large central domain that spans between the two.",
        "label": 1,
        "major": -1,
        "len": 24
    },
    {
        "text": "The purpose of this study is to determine the effects on [GENE]insulin[\\GENE] sensitivity of a [CHEMICAL]carbohydrate[\\CHEMICAL]-rich diet (CARB; similar to the Dietary Approaches to Stop Hypertension [DASH] diet), a protein-rich diet (PROT; protein predominantly from plant sources), and an unsaturated fat-rich diet (UNSAT; predominantly monounsaturated).",
        "label": 2,
        "major": -1,
        "len": 45
    },
    {
        "text": "The Effects of [CHEMICAL]Carbohydrate[\\CHEMICAL], Unsaturated Fat, and Protein Intake on Measures of [GENE]Insulin[\\GENE] Sensitivity: Results from the OmniHeart Trial.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "This study also provides insight into the anticancer effects of [CHEMICAL]VK2[\\CHEMICAL] and suggests that [GENE]Bak[\\GENE] may be a potential target of cancer therapy.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "The CBC physically associates with these complexes to recruit them during transcription and mediates phosphorylation at [CHEMICAL]Ser[\\CHEMICAL]-2 of the C-terminal domain (CTD) of [GENE]RNA polymerase II[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 26
    },
    {
        "text": "The CBC physically associates with these complexes to recruit them during transcription and mediates phosphorylation at Ser-2 of the [CHEMICAL]C[\\CHEMICAL]-terminal domain (CTD) of [GENE]RNA polymerase II[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 26
    },
    {
        "text": "Incubation of purified [GENE]Pin1[\\GENE] with HNE followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues [CHEMICAL]His[\\CHEMICAL]-157 and Cys-113.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "Incubation of purified [GENE]Pin1[\\GENE] with HNE followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues His-157 and [CHEMICAL]Cys[\\CHEMICAL]-113.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "Furthermore, orbitrap MS data support the adduction of [CHEMICAL]Cys[\\CHEMICAL]-113 in the [GENE]Pin1[\\GENE] active site upon HNE treatment of MDA-MB-231 cells.",
        "label": 1,
        "major": -1,
        "len": 20
    },
    {
        "text": "[GENE]Pin1[\\GENE] was adducted in MDA-MB-231 breast cancer cells treated with [CHEMICAL]8-alkynyl-HNE[\\CHEMICAL] as judged by click chemistry conjugation with biotin followed by streptavidin-based pulldown and Western blotting with anti-Pin1 antibody.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Furthermore, orbitrap MS data support the adduction of Cys-113 in the [GENE]Pin1[\\GENE] active site upon [CHEMICAL]HNE[\\CHEMICAL] treatment of MDA-MB-231 cells.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Recent studies indicate that [GENE]Pin1[\\GENE] is an important molecular target for the chemopreventive effects of green tea [CHEMICAL]polyphenols[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "The [CHEMICAL]bupropion[\\CHEMICAL] metabolic ratio appears to detect known differences in [GENE]CYP2B6[\\GENE] activity associated with genetic polymorphism, across different ethnic groups.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "Western blot analyses showed significant effects of [CHEMICAL]Pb[\\CHEMICAL] exposure on [GENE]DNMT1[\\GENE], DNMT3a, and MeCP2 expression, with effects often seen at the lowest level of exposure and modified by sex and developmental window of Pb exposure.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Western blot analyses showed significant effects of [CHEMICAL]Pb[\\CHEMICAL] exposure on DNMT1, [GENE]DNMT3a[\\GENE], and MeCP2 expression, with effects often seen at the lowest level of exposure and modified by sex and developmental window of Pb exposure.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Western blot analyses showed significant effects of [CHEMICAL]Pb[\\CHEMICAL] exposure on DNMT1, DNMT3a, and [GENE]MeCP2[\\GENE] expression, with effects often seen at the lowest level of exposure and modified by sex and developmental window of Pb exposure.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "We begin by capturing [GENE]RISC[\\GENE] using a complementary [CHEMICAL]2'-O-methyl[\\CHEMICAL] oligonucleotide tethered to beads.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "There was no significant difference in [GENE]TLR4[\\GENE], NF-\u03baB, and IL-27 mRNA and proteins between [CHEMICAL]curcumin[\\CHEMICAL]-treated and sulfasalazine-treated groups.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "There was no significant difference in TLR4, [GENE]NF-\u03baB[\\GENE], and IL-27 mRNA and proteins between [CHEMICAL]curcumin[\\CHEMICAL]-treated and sulfasalazine-treated groups.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "There was no significant difference in TLR4, NF-\u03baB, and [GENE]IL-27[\\GENE] mRNA and proteins between [CHEMICAL]curcumin[\\CHEMICAL]-treated and sulfasalazine-treated groups.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "There was no significant difference in [GENE]TLR4[\\GENE], NF-\u03baB, and IL-27 mRNA and proteins between curcumin-treated and [CHEMICAL]sulfasalazine[\\CHEMICAL]-treated groups.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "There was no significant difference in TLR4, [GENE]NF-\u03baB[\\GENE], and IL-27 mRNA and proteins between curcumin-treated and [CHEMICAL]sulfasalazine[\\CHEMICAL]-treated groups.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "There was no significant difference in TLR4, NF-\u03baB, and [GENE]IL-27[\\GENE] mRNA and proteins between curcumin-treated and [CHEMICAL]sulfasalazine[\\CHEMICAL]-treated groups.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "The effects of [CHEMICAL]jaspamide[\\CHEMICAL] on human cardiomyocyte function and [GENE]cardiac ion channel[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "The primary aim of these studies was to test the hypothesis that [GENE]HSD11B1[\\GENE]-derived [CHEMICAL]cortisol[\\CHEMICAL] has a biological role in endometrial function and conceptus development during early pregnancy in sheep.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "These results suggest that [GENE]HSD11B1[\\GENE]-derived [CHEMICAL]cortisol[\\CHEMICAL] mediates, in part, actions of ovarian progesterone and the conceptus on endometrial function and support the hypothesis that IFNT, PG, and cortisol coordinately regulate endometrial functions important for conceptus elongation and implantation during early pregnancy in sheep.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "The [CHEMICAL]acyl esters[\\CHEMICAL] could be correlated with expression of [GENE]alcohol acyl-transferase EEB1[\\GENE] and the acyl esterase IAH1.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "The [CHEMICAL]acyl esters[\\CHEMICAL] could be correlated with expression of alcohol acyl-transferase EEB1 and the [GENE]acyl esterase IAH1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Meanwhile, the serum level of KC (a functional homolog of IL-8 and the main proinflammatory alpha chemokine in mice) in [GENE]apoE[\\GENE](-/-) mice was up to 357pg/ml in [CHEMICAL]SFO[\\CHEMICAL]-HD treated group.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "Meanwhile, the serum level of KC (a functional homolog of [GENE]IL-8[\\GENE] and the main proinflammatory alpha chemokine in mice) in apoE(-/-) mice was up to 357pg/ml in [CHEMICAL]SFO[\\CHEMICAL]-HD treated group.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "Meanwhile, the serum level of KC (a functional homolog of IL-8 and the main proinflammatory [GENE]alpha chemokine[\\GENE] in mice) in apoE(-/-) mice was up to 357pg/ml in [CHEMICAL]SFO[\\CHEMICAL]-HD treated group.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "[GENE]NF-\u03baB[\\GENE]-associated mechanisms underlying the response of embryonic cells to [CHEMICAL]Doxorubicin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma [GENE]insulin[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] treatment showed a significant decline in the levels of blood glucose, [GENE]glycosylated hemoglobin[\\GENE] (HbA1c), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "label": 4,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin ([GENE]HbA1c[\\GENE]), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "label": 4,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), [GENE]NF-kB[\\GENE] p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "label": 4,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB [GENE]p65[\\GENE] unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "label": 4,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and [GENE]IL-1\u03b2[\\GENE] (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "label": 4,
        "major": -1,
        "len": 33
    },
    {
        "text": "Thus, [GENE]COL8A2[\\GENE] was identified as the key protein involved in the enhancement of cell adhesion of [CHEMICAL]atRA[\\CHEMICAL] under serum-free conditions.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "In this study, we assessed the antitumor activity of [CHEMICAL]PTE[\\CHEMICAL] against human osteosarcoma cells and explored the role of [GENE]JAK2[\\GENE]/STAT3 and apoptosis-related signaling pathways on the activity of PTE.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "In this study, we assessed the antitumor activity of [CHEMICAL]PTE[\\CHEMICAL] against human osteosarcoma cells and explored the role of JAK2/[GENE]STAT3[\\GENE] and apoptosis-related signaling pathways on the activity of PTE.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "In this study, we assessed the antitumor activity of PTE against human osteosarcoma cells and explored the role of [GENE]JAK2[\\GENE]/STAT3 and apoptosis-related signaling pathways on the activity of [CHEMICAL]PTE[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "In this study, we assessed the antitumor activity of PTE against human osteosarcoma cells and explored the role of JAK2/[GENE]STAT3[\\GENE] and apoptosis-related signaling pathways on the activity of [CHEMICAL]PTE[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Results of studies to evaluate the effect of Mn and DA on cell viability in control and DAT-transfected HEK cells reveal that [CHEMICAL]Mn[\\CHEMICAL] is equally toxic to both cell lines whereas DA was only toxic to cells containing [GENE]DAT[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "Effects of [CHEMICAL]2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine[\\CHEMICAL] (PhIP) on histopathology, oxidative stress, and expression of [GENE]c-fos[\\GENE], c-jun and p16 in rat stomachs.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Effects of [CHEMICAL]2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine[\\CHEMICAL] (PhIP) on histopathology, oxidative stress, and expression of c-fos, [GENE]c-jun[\\GENE] and p16 in rat stomachs.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Effects of [CHEMICAL]2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine[\\CHEMICAL] (PhIP) on histopathology, oxidative stress, and expression of c-fos, c-jun and [GENE]p16[\\GENE] in rat stomachs.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Effects of 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine ([CHEMICAL]PhIP[\\CHEMICAL]) on histopathology, oxidative stress, and expression of [GENE]c-fos[\\GENE], c-jun and p16 in rat stomachs.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Effects of 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine ([CHEMICAL]PhIP[\\CHEMICAL]) on histopathology, oxidative stress, and expression of c-fos, [GENE]c-jun[\\GENE] and p16 in rat stomachs.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Effects of 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine ([CHEMICAL]PhIP[\\CHEMICAL]) on histopathology, oxidative stress, and expression of c-fos, c-jun and [GENE]p16[\\GENE] in rat stomachs.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Moreover, activities of [GENE]caspase-3[\\GENE] and caspase-9 enzymes were also significantly higher in both kinds of cells exposed to [CHEMICAL]SiO(2)[\\CHEMICAL] NPs.",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "Moreover, activities of caspase-3 and [GENE]caspase-9[\\GENE] enzymes were also significantly higher in both kinds of cells exposed to [CHEMICAL]SiO(2)[\\CHEMICAL] NPs.",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "The mouse [GENE]CYP2J[\\GENE] subfamily includes members that have wide tissue distribution and are active in the metabolism of [CHEMICAL]arachidonic acid[\\CHEMICAL] (AA), linoleic acid (LA), and other lipids and xenobiotics.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "The mouse [GENE]CYP2J[\\GENE] subfamily includes members that have wide tissue distribution and are active in the metabolism of arachidonic acid (AA), [CHEMICAL]linoleic acid[\\CHEMICAL] (LA), and other lipids and xenobiotics.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "In the present study, the extent to which six substituted [CHEMICAL]quercetin[\\CHEMICAL] derivatives (1-6) affected the function of [GENE]OATP1B1[\\GENE] and OATP1B3 was investigated.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "In the present study, the extent to which six substituted [CHEMICAL]quercetin[\\CHEMICAL] derivatives (1-6) affected the function of OATP1B1 and [GENE]OATP1B3[\\GENE] was investigated.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Cytotoxicity assays demonstrated that [CHEMICAL]epigallocatechin 3-O-gallate[\\CHEMICAL] (EGCG) and most of compounds 1-6 killed preferentially [GENE]OATP[\\GENE]-expressing CHO cells.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "Cytotoxicity assays demonstrated that epigallocatechin 3-O-gallate ([CHEMICAL]EGCG[\\CHEMICAL]) and most of compounds 1-6 killed preferentially [GENE]OATP[\\GENE]-expressing CHO cells.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "EGCG, 1, and 3 were the most potent cytotoxic compounds, with [CHEMICAL]EGCG[\\CHEMICAL] and 3 selectively killing [GENE]OATP1B3[\\GENE]-expressing cells.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "The expression pattern of [GENE]Sim2[\\GENE] and Drebrin correspond to 50mmol/L [CHEMICAL]glucose[\\CHEMICAL] (hyperglycaemia) was also found in primary cultured neurons.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "The expression pattern of Sim2 and [GENE]Drebrin[\\GENE] correspond to 50mmol/L [CHEMICAL]glucose[\\CHEMICAL] (hyperglycaemia) was also found in primary cultured neurons.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Moreover, [CHEMICAL]curcumin[\\CHEMICAL] alleviated [GENE]Sim2[\\GENE] expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia.",
        "label": 3,
        "major": -1,
        "len": 15
    },
    {
        "text": "Moreover, [CHEMICAL]curcumin[\\CHEMICAL] alleviated Sim2 expression, and reversely raised [GENE]Drebrin[\\GENE] expression in neurons treated with hyperglycaemia.",
        "label": 3,
        "major": -1,
        "len": 15
    },
    {
        "text": "In preclinical studies, the [GENE]mammalian target of rapamycin[\\GENE] (mTOR) in the medial prefrontal cortex and the eukaryotic elongation factor (eEF2) in the hippocampus have been proposed as critical mediators of [CHEMICAL]ketamine[\\CHEMICAL]'s rapid antidepressant actions.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In preclinical studies, the mammalian target of rapamycin ([GENE]mTOR[\\GENE]) in the medial prefrontal cortex and the eukaryotic elongation factor (eEF2) in the hippocampus have been proposed as critical mediators of [CHEMICAL]ketamine[\\CHEMICAL]'s rapid antidepressant actions.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In preclinical studies, the mammalian target of rapamycin (mTOR) in the medial prefrontal cortex and the [GENE]eukaryotic elongation factor[\\GENE] (eEF2) in the hippocampus have been proposed as critical mediators of [CHEMICAL]ketamine[\\CHEMICAL]'s rapid antidepressant actions.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "In preclinical studies, the mammalian target of rapamycin (mTOR) in the medial prefrontal cortex and the eukaryotic elongation factor ([GENE]eEF2[\\GENE]) in the hippocampus have been proposed as critical mediators of [CHEMICAL]ketamine[\\CHEMICAL]'s rapid antidepressant actions.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2-deficient cells, we found that upon [CHEMICAL]CPT[\\CHEMICAL] exposure, the [GENE]RNA polymerase II large subunit[\\GENE] (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2\u03b2-deficient cells.",
        "label": 4,
        "major": -1,
        "len": 49
    },
    {
        "text": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2-deficient cells, we found that upon [CHEMICAL]CPT[\\CHEMICAL] exposure, the RNA polymerase II large subunit ([GENE]RNAP LS[\\GENE]) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2\u03b2-deficient cells.",
        "label": 4,
        "major": -1,
        "len": 49
    },
    {
        "text": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2-deficient cells, we found that upon [CHEMICAL]CPT[\\CHEMICAL] exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas [GENE]RNAP LS[\\GENE] remained depleted without recovery in Top2\u03b2-deficient cells.",
        "label": 4,
        "major": -1,
        "len": 49
    },
    {
        "text": "However, [CHEMICAL]NCFP[\\CHEMICAL] provides greater [GENE]mGlu5[\\GENE] subtype selectivity than does CPPHA, making it more suitable for studies of effects on mGlu5 in CNS preparations.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "However, [CHEMICAL]NCFP[\\CHEMICAL] provides greater mGlu5 subtype selectivity than does CPPHA, making it more suitable for studies of effects on [GENE]mGlu5[\\GENE] in CNS preparations.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "However, NCFP provides greater [GENE]mGlu5[\\GENE] subtype selectivity than does [CHEMICAL]CPPHA[\\CHEMICAL], making it more suitable for studies of effects on mGlu5 in CNS preparations.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Dietary [CHEMICAL]EPA[\\CHEMICAL]/DHA treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving [GENE]insulin[\\GENE] sensitivity.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "Dietary EPA/[CHEMICAL]DHA[\\CHEMICAL] treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving [GENE]insulin[\\GENE] sensitivity.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "We investigated the association of [GENE]HSD11B2[\\GENE] variant with [CHEMICAL]glucose[\\CHEMICAL] homeostasis.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "There was a significant overlap (42 genes) between the 3 and 30 ppb differentially expressed gene lists, with two of these genes ([GENE]CYP17A1[\\GENE] and SAMHD1) present in all three [CHEMICAL]atrazine[\\CHEMICAL] treatments.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "There was a significant overlap (42 genes) between the 3 and 30 ppb differentially expressed gene lists, with two of these genes (CYP17A1 and [GENE]SAMHD1[\\GENE]) present in all three [CHEMICAL]atrazine[\\CHEMICAL] treatments.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "These results suggest that the enantioselective disposition of [CHEMICAL]sibutramine[\\CHEMICAL] and its active metabolites are influenced by the altered genetic and environmental factors of [GENE]CYP2B6[\\GENE] and CYP3A activity in vivo.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "These results suggest that the enantioselective disposition of [CHEMICAL]sibutramine[\\CHEMICAL] and its active metabolites are influenced by the altered genetic and environmental factors of CYP2B6 and [GENE]CYP3A[\\GENE] activity in vivo.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The baseline HbA1c and [GENE]glycated albumin[\\GENE] levels were identified as factors that predicted the response to add-on therapy with [CHEMICAL]sitagliptin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The baseline [GENE]HbA1c[\\GENE] and glycated albumin levels were identified as factors that predicted the response to add-on therapy with [CHEMICAL]sitagliptin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Methods: The stability of six [CHEMICAL]acyl glucuronides[\\CHEMICAL] in the presence of [GENE]hCES1[\\GENE], hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37\u00b0C) were investigated.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "Methods: The stability of six [CHEMICAL]acyl glucuronides[\\CHEMICAL] in the presence of hCES1, [GENE]hCES2[\\GENE], and buffer alone (100 mM potassium phosphate, pH 7.4, 37\u00b0C) were investigated.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "A multivariable model adjusted for age, sex, population group, immigrant status, BMI, season of vitamin D measurement, [GENE]LDL[\\GENE] and HDL cholesterol, triglycerides, estimated glomerular filtration rate, history of hypertension or cardiovascular disease, Charlson comorbidity index, smoking, and socioeconomic status revealed an inverse association between [CHEMICAL]25-OHD[\\CHEMICAL] and the risk of progression to IFG and diabetes.",
        "label": 2,
        "major": -1,
        "len": 54
    },
    {
        "text": "A multivariable model adjusted for age, sex, population group, immigrant status, BMI, season of vitamin D measurement, LDL and [GENE]HDL[\\GENE] cholesterol, triglycerides, estimated glomerular filtration rate, history of hypertension or cardiovascular disease, Charlson comorbidity index, smoking, and socioeconomic status revealed an inverse association between [CHEMICAL]25-OHD[\\CHEMICAL] and the risk of progression to IFG and diabetes.",
        "label": 2,
        "major": -1,
        "len": 54
    },
    {
        "text": "We conclude that there are prejunctional [GENE]A1Rs[\\GENE] in arteries and both pre- and postjunctional A1Rs in veins; thus, [CHEMICAL]adenosine[\\CHEMICAL] selectively constricts the veins.",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "We conclude that there are prejunctional A1Rs in arteries and both pre- and postjunctional [GENE]A1Rs[\\GENE] in veins; thus, [CHEMICAL]adenosine[\\CHEMICAL] selectively constricts the veins.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Furthermore, the up-regulation of [GENE]IL-12[\\GENE] and TNF-\u03b1 was found in the [CHEMICAL]procyanidin[\\CHEMICAL] trimers-treated cells in the presence of OVA.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "Furthermore, the up-regulation of IL-12 and [GENE]TNF-\u03b1[\\GENE] was found in the [CHEMICAL]procyanidin[\\CHEMICAL] trimers-treated cells in the presence of OVA.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "Apple [CHEMICAL]polyphenols[\\CHEMICAL] suppress antigen presentation of [GENE]ovalbumin[\\GENE] by THP-1-derived dendritic cells.",
        "label": 4,
        "major": -1,
        "len": 11
    },
    {
        "text": "It has been reported that oligomeric [CHEMICAL]procyanidins[\\CHEMICAL] of lotus seedpod (LSOPC) is effective in the alleviation of Alzheimer's disease and diabetes through its antioxidant and [GENE]insulin[\\GENE]-potentiating activities.",
        "label": 3,
        "major": -1,
        "len": 27
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban ([GENE]PLB[\\GENE]), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), [GENE]phospho-PLB[\\GENE], and calsequestrin 2 are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and [GENE]calsequestrin 2[\\GENE] are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins [GENE]sarcoendoplasmic reticulum ATPase 2a[\\GENE] (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins sarcoendoplasmic reticulum ATPase 2a ([GENE]SERCA2a[\\GENE]), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), [GENE]sodium calcium exchanger-1[\\GENE], phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "The [CHEMICAL]calcium[\\CHEMICAL] homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, [GENE]phospholamban[\\GENE] (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "label": 9,
        "major": -1,
        "len": 24
    },
    {
        "text": "We examined the effects of anthocyanidins ([CHEMICAL]cyanidin[\\CHEMICAL], delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins ([CHEMICAL]cyanidin[\\CHEMICAL], delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins ([CHEMICAL]cyanidin[\\CHEMICAL], delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, [CHEMICAL]delphinidin[\\CHEMICAL], malvidin, peonidin, petunidin, pelargonidin) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, [CHEMICAL]delphinidin[\\CHEMICAL], malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, [CHEMICAL]delphinidin[\\CHEMICAL], malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, [CHEMICAL]malvidin[\\CHEMICAL], peonidin, petunidin, pelargonidin) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, [CHEMICAL]malvidin[\\CHEMICAL], peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, [CHEMICAL]malvidin[\\CHEMICAL], peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, [CHEMICAL]peonidin[\\CHEMICAL], petunidin, pelargonidin) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, [CHEMICAL]peonidin[\\CHEMICAL], petunidin, pelargonidin) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, [CHEMICAL]peonidin[\\CHEMICAL], petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, [CHEMICAL]petunidin[\\CHEMICAL], pelargonidin) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, [CHEMICAL]petunidin[\\CHEMICAL], pelargonidin) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, [CHEMICAL]petunidin[\\CHEMICAL], pelargonidin) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, [CHEMICAL]pelargonidin[\\CHEMICAL]) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, [CHEMICAL]pelargonidin[\\CHEMICAL]) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, [CHEMICAL]pelargonidin[\\CHEMICAL]) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of [CHEMICAL]anthocyanidins[\\CHEMICAL] (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the [GENE]aryl hydrocarbon receptor[\\GENE] (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of [CHEMICAL]anthocyanidins[\\CHEMICAL] (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor ([GENE]AhR[\\GENE])-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the effects of [CHEMICAL]anthocyanidins[\\CHEMICAL] (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-[GENE]CYP1A1[\\GENE] signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "It remains to be fully elucidated whether use of [CHEMICAL]metformin[\\CHEMICAL], an [GENE]insulin[\\GENE] sensitizer, and/or sulfonylureas, insulin secretagogues, affect cancer incidence in subjects with T2DM.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "It remains to be fully elucidated whether use of metformin, an insulin sensitizer, and/or [CHEMICAL]sulfonylureas[\\CHEMICAL], [GENE]insulin[\\GENE] secretagogues, affect cancer incidence in subjects with T2DM.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "The objective of the current study was to investigate the effect of [CHEMICAL]vanadium[\\CHEMICAL] (V(5+)) on [GENE]Cyp1[\\GENE] expression and activity in C57BL/6 mice liver and isolated hepatocytes.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The objective of the current study was to investigate the effect of vanadium ([CHEMICAL]V(5+)[\\CHEMICAL]) on [GENE]Cyp1[\\GENE] expression and activity in C57BL/6 mice liver and isolated hepatocytes.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Ferredoxin 1 ([GENE]FDX1[\\GENE]; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including [CHEMICAL]steroid[\\CHEMICAL] hormone synthesis in mammalian tissues.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Ferredoxin 1 (FDX1; [GENE]adrenodoxin[\\GENE]) is an iron-sulfur protein that is involved in various metabolic processes, including [CHEMICAL]steroid[\\CHEMICAL] hormone synthesis in mammalian tissues.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Ferredoxin 1[\\GENE] (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including [CHEMICAL]steroid[\\CHEMICAL] hormone synthesis in mammalian tissues.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Ferredoxin 1 ([GENE]FDX1[\\GENE]; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including [CHEMICAL]steroid hormone[\\CHEMICAL] synthesis in mammalian tissues.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Ferredoxin 1 (FDX1; [GENE]adrenodoxin[\\GENE]) is an iron-sulfur protein that is involved in various metabolic processes, including [CHEMICAL]steroid hormone[\\CHEMICAL] synthesis in mammalian tissues.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Ferredoxin 1[\\GENE] (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including [CHEMICAL]steroid hormone[\\CHEMICAL] synthesis in mammalian tissues.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Cycloxygenase-2[\\GENE] (COX-2)-derived [CHEMICAL]prostaglandin E2[\\CHEMICAL] (PGE2) has been shown to be important in esophageal tumorigenesis.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Cycloxygenase-2 ([GENE]COX-2[\\GENE])-derived [CHEMICAL]prostaglandin E2[\\CHEMICAL] (PGE2) has been shown to be important in esophageal tumorigenesis.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[GENE]Cycloxygenase-2[\\GENE] (COX-2)-derived prostaglandin E2 ([CHEMICAL]PGE2[\\CHEMICAL]) has been shown to be important in esophageal tumorigenesis.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Cycloxygenase-2 ([GENE]COX-2[\\GENE])-derived prostaglandin E2 ([CHEMICAL]PGE2[\\CHEMICAL]) has been shown to be important in esophageal tumorigenesis.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "[GENE]Cytochrome P450 epoxygenase 2J2[\\GENE] (CYP2J2) metabolizes arachidonic acids to form epoxyeicosatrienoic acids ([CHEMICAL]EETs[\\CHEMICAL]), which possess various beneficial effects on the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Cytochrome P450 epoxygenase 2J2 ([GENE]CYP2J2[\\GENE]) metabolizes arachidonic acids to form epoxyeicosatrienoic acids ([CHEMICAL]EETs[\\CHEMICAL]), which possess various beneficial effects on the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Cytochrome P450 epoxygenase 2J2[\\GENE] (CYP2J2) metabolizes arachidonic acids to form [CHEMICAL]epoxyeicosatrienoic acids[\\CHEMICAL] (EETs), which possess various beneficial effects on the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Cytochrome P450 epoxygenase 2J2 ([GENE]CYP2J2[\\GENE]) metabolizes arachidonic acids to form [CHEMICAL]epoxyeicosatrienoic acids[\\CHEMICAL] (EETs), which possess various beneficial effects on the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Cytochrome P450 epoxygenase 2J2[\\GENE] (CYP2J2) metabolizes [CHEMICAL]arachidonic acids[\\CHEMICAL] to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Cytochrome P450 epoxygenase 2J2 ([GENE]CYP2J2[\\GENE]) metabolizes [CHEMICAL]arachidonic acids[\\CHEMICAL] to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Western blotting demonstrated that [CHEMICAL]DMBT[\\CHEMICAL] effectively suppressed the expression of [GENE]VEGF[\\GENE], p-VEGFR-2, p-EGFR, and p-Akt.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "Western blotting demonstrated that [CHEMICAL]DMBT[\\CHEMICAL] effectively suppressed the expression of VEGF, [GENE]p-VEGFR-2[\\GENE], p-EGFR, and p-Akt.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "Western blotting demonstrated that [CHEMICAL]DMBT[\\CHEMICAL] effectively suppressed the expression of VEGF, p-VEGFR-2, [GENE]p-EGFR[\\GENE], and p-Akt.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "Western blotting demonstrated that [CHEMICAL]DMBT[\\CHEMICAL] effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and [GENE]p-Akt[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "A clear relationship between [GENE]PTP1B[\\GENE] phosphorylation levels at [CHEMICAL]Ser[\\CHEMICAL] 50 and its negative effect on insulin signaling is shown.",
        "label": 1,
        "major": -1,
        "len": 19
    },
    {
        "text": "We studied accumulation of lipid metabolites [[CHEMICAL]triglycerides[\\CHEMICAL] (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides ([CHEMICAL]TAGs[\\CHEMICAL]), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), [CHEMICAL]diglycerides[\\CHEMICAL] (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides ([CHEMICAL]DAGs[\\CHEMICAL])] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and [CHEMICAL]ceramides[\\CHEMICAL] in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [[CHEMICAL]triglycerides[\\CHEMICAL] (TAGs), diglycerides (DAGs)] and ceramides in relation to [GENE]insulin[\\GENE] signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [[CHEMICAL]triglycerides[\\CHEMICAL] (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides ([CHEMICAL]TAGs[\\CHEMICAL]), diglycerides (DAGs)] and ceramides in relation to [GENE]insulin[\\GENE] signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides ([CHEMICAL]TAGs[\\CHEMICAL]), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), [CHEMICAL]diglycerides[\\CHEMICAL] (DAGs)] and ceramides in relation to [GENE]insulin[\\GENE] signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), [CHEMICAL]diglycerides[\\CHEMICAL] (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides ([CHEMICAL]DAGs[\\CHEMICAL])] and ceramides in relation to [GENE]insulin[\\GENE] signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides ([CHEMICAL]DAGs[\\CHEMICAL])] and ceramides in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and [CHEMICAL]ceramides[\\CHEMICAL] in relation to [GENE]insulin[\\GENE] signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and [CHEMICAL]ceramides[\\CHEMICAL] in relation to insulin signaling and expression and phosphorylation of [GENE]PTP1B[\\GENE] by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 \u03bcM).",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "Co-IP and coimmunolocalization confirmed that Creb1 associated with Mecp2 and cotransfection with [GENE]glut3[\\GENE]-[CHEMICAL](m)CpG[\\CHEMICAL] in HT22 cells enhanced glut3 transcription.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "The most potent in\u2005vitro DASI discovered is an [CHEMICAL]imidazole[\\CHEMICAL] derivative with IC50 values against [GENE]aromatase[\\GENE] and steroid sulfatase in a JEG-3 cell preparation of 0.2 and 2.5\u2005nM, respectively.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "The most potent in\u2005vitro DASI discovered is an [CHEMICAL]imidazole[\\CHEMICAL] derivative with IC50 values against aromatase and [GENE]steroid sulfatase[\\GENE] in a JEG-3 cell preparation of 0.2 and 2.5\u2005nM, respectively.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "[CHEMICAL]Oxysterols[\\CHEMICAL] interfere with [GENE]ERK[\\GENE], hedgehog and wnt pathways of proliferation and differentiation.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Oxysterols[\\CHEMICAL] interfere with ERK, [GENE]hedgehog[\\GENE] and wnt pathways of proliferation and differentiation.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Oxysterols[\\CHEMICAL] interfere with ERK, hedgehog and [GENE]wnt[\\GENE] pathways of proliferation and differentiation.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "HbA1c level in DM12W group was higher than in DM4W group, [GENE]HbA1c[\\GENE] level in [CHEMICAL]EtOH[\\CHEMICAL]+DM8W group was lower than in DM8W group.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "This paper aims to review briefly the literature on the [CHEMICAL]5-HT[\\CHEMICAL] hypothesis of depression with a major focus on the possible role of [GENE]SERT[\\GENE] in this disorder, while highlighting how recent data are more oriented on dimensional rather than nosological involvement of this structure in different conditions spanning from normality to pathology.",
        "label": 2,
        "major": -1,
        "len": 52
    },
    {
        "text": "To evaluate whether [CHEMICAL]fisetin[\\CHEMICAL] regulates [GENE]mTORC1[\\GENE] signaling, we investigated the phosphorylation and kinase activity of the 70-kDa ribosomal protein S6 kinase 1 (S6K1) and mTORC1 in 3T3-L1 preadipocytes.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "To evaluate whether [CHEMICAL]fisetin[\\CHEMICAL] regulates mTORC1 signaling, we investigated the phosphorylation and [GENE]kinase[\\GENE] activity of the 70-kDa ribosomal protein S6 kinase 1 (S6K1) and mTORC1 in 3T3-L1 preadipocytes.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "To evaluate whether [CHEMICAL]fisetin[\\CHEMICAL] regulates mTORC1 signaling, we investigated the phosphorylation and kinase activity of the [GENE]70-kDa ribosomal protein S6 kinase 1[\\GENE] (S6K1) and mTORC1 in 3T3-L1 preadipocytes.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "To evaluate whether [CHEMICAL]fisetin[\\CHEMICAL] regulates mTORC1 signaling, we investigated the phosphorylation and kinase activity of the 70-kDa ribosomal protein S6 kinase 1 ([GENE]S6K1[\\GENE]) and mTORC1 in 3T3-L1 preadipocytes.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "To evaluate whether [CHEMICAL]fisetin[\\CHEMICAL] regulates mTORC1 signaling, we investigated the phosphorylation and kinase activity of the 70-kDa ribosomal protein S6 kinase 1 (S6K1) and [GENE]mTORC1[\\GENE] in 3T3-L1 preadipocytes.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "To further our understanding of how [CHEMICAL]fisetin[\\CHEMICAL] negatively regulates mTORC1 signaling, we analyzed the phosphorylation of [GENE]S6K1[\\GENE], mTOR and Akt in fisetin-treated TSC2-knockdown cells.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "To further our understanding of how [CHEMICAL]fisetin[\\CHEMICAL] negatively regulates mTORC1 signaling, we analyzed the phosphorylation of S6K1, [GENE]mTOR[\\GENE] and Akt in fisetin-treated TSC2-knockdown cells.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "To further our understanding of how [CHEMICAL]fisetin[\\CHEMICAL] negatively regulates mTORC1 signaling, we analyzed the phosphorylation of S6K1, mTOR and [GENE]Akt[\\GENE] in fisetin-treated TSC2-knockdown cells.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Fisetin[\\CHEMICAL] regulates obesity by targeting [GENE]mTORC1[\\GENE] signaling.",
        "label": 2,
        "major": -1,
        "len": 7
    },
    {
        "text": "To further our understanding of how [CHEMICAL]fisetin[\\CHEMICAL] negatively regulates [GENE]mTORC1[\\GENE] signaling, we analyzed the phosphorylation of S6K1, mTOR and Akt in fisetin-treated TSC2-knockdown cells.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "We also observed that [CHEMICAL]fisetin[\\CHEMICAL] efficiently suppressed the phosphorylation of [GENE]Akt[\\GENE], S6K1 and mTORC1 in adipose tissue.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "We also observed that [CHEMICAL]fisetin[\\CHEMICAL] efficiently suppressed the phosphorylation of Akt, [GENE]S6K1[\\GENE] and mTORC1 in adipose tissue.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "We also observed that [CHEMICAL]fisetin[\\CHEMICAL] efficiently suppressed the phosphorylation of Akt, S6K1 and [GENE]mTORC1[\\GENE] in adipose tissue.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "Results: Our results demonstrate that treatment with [CHEMICAL]LBH589[\\CHEMICAL] leads to [GENE]NIS[\\GENE] RNA expression as shown by RT-PCR and luciferase assay, and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors.",
        "label": 3,
        "major": -1,
        "len": 36
    },
    {
        "text": "Finally, molecular modeling and (1)H- and (13)C-NMR studies performed on compounds 6c,d, 9c, and 10b allowed the right conformation of [CHEMICAL]nitrooxyalkyl ester and ether[\\CHEMICAL] side chain of these molecules within the [GENE]COX-2[\\GENE] active site to be assessed.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "We confirm the correlation between higher [GENE]hCTR1[\\GENE] levels and higher [CHEMICAL]Pt[\\CHEMICAL]-drug uptake in tumor cells sensitive to the drug.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "The [GENE]CYP2B6*6[\\GENE] Allele Significantly Alters the N-demethylation of [CHEMICAL]Ketamine[\\CHEMICAL] Enantiomers In Vitro.",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Ketamine[\\CHEMICAL] is primarily metabolized to norketamine by hepatic [GENE]cytochrome P450 (CYP) 2B6[\\GENE] and CYP3A4-mediated N-demethylation.",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]Ketamine[\\CHEMICAL] is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and [GENE]CYP3A4[\\GENE]-mediated N-demethylation.",
        "label": 9,
        "major": -1,
        "len": 15
    },
    {
        "text": "The activities of UGTs 1A3, 1A8, 1A9, 2B4 and 2B7 were low, whereas [GENE]UGT1A1[\\GENE] and UGT2B17 exhibited no [CHEMICAL]HFC[\\CHEMICAL] glucuronidation activity.",
        "label": 10,
        "major": -1,
        "len": 21
    },
    {
        "text": "The activities of UGTs 1A3, 1A8, 1A9, 2B4 and 2B7 were low, whereas UGT1A1 and [GENE]UGT2B17[\\GENE] exhibited no [CHEMICAL]HFC[\\CHEMICAL] glucuronidation activity.",
        "label": 10,
        "major": -1,
        "len": 21
    },
    {
        "text": "A high throughput assay for the glucuronidation of [CHEMICAL]7-hydroxy-4-trifluoromethylcoumarin[\\CHEMICAL] by recombinant [GENE]human UDP-glucuronosyltransferases[\\GENE] and liver microsomes.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both [CHEMICAL]HFC[\\CHEMICAL] and UDP-glucuronic acid than the other [GENE]UGTs[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]UGT1A6[\\GENE] exhibited a significantly higher Vmax and Km values toward both [CHEMICAL]HFC[\\CHEMICAL] and UDP-glucuronic acid than the other UGTs.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and [CHEMICAL]UDP[\\CHEMICAL]-glucuronic acid than the other [GENE]UGTs[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]UGT1A6[\\GENE] exhibited a significantly higher Vmax and Km values toward both HFC and [CHEMICAL]UDP[\\CHEMICAL]-glucuronic acid than the other UGTs.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-[CHEMICAL]glucuronic acid[\\CHEMICAL] than the other [GENE]UGTs[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]UGT1A6[\\GENE] exhibited a significantly higher Vmax and Km values toward both HFC and UDP-[CHEMICAL]glucuronic acid[\\CHEMICAL] than the other UGTs.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of [CHEMICAL]7-hydroxy-4-trifluoromethylcoumarin[\\CHEMICAL] (HFC) for several [GENE]UGTs[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of 7-hydroxy-4-trifluoromethylcoumarin ([CHEMICAL]HFC[\\CHEMICAL]) for several [GENE]UGTs[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "We have used this method to screen 11 recombinant [GENE]human UGTs[\\GENE] for [CHEMICAL]HFC[\\CHEMICAL] glucuronidation activity and studied the reaction kinetics with the most active enzymes.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "[GENE]PIP5K1B[\\GENE] encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate [CHEMICAL]phosphatidylinositol-4,5-bisphosphate[\\CHEMICAL] [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes [GENE]phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I[\\GENE] (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate [CHEMICAL]phosphatidylinositol-4,5-bisphosphate[\\CHEMICAL] [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I ([GENE]pip5k1\u03b2[\\GENE]), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate [CHEMICAL]phosphatidylinositol-4,5-bisphosphate[\\CHEMICAL] [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]PIP5K1B[\\GENE] encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [[CHEMICAL]PI(4,5)P2[\\CHEMICAL]].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes [GENE]phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I[\\GENE] (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [[CHEMICAL]PI(4,5)P2[\\CHEMICAL]].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I ([GENE]pip5k1\u03b2[\\GENE]), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [[CHEMICAL]PI(4,5)P2[\\CHEMICAL]].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]PIP5K1B[\\GENE] encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates [CHEMICAL]phosphatidylinositol 4-phosphate[\\CHEMICAL] [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes [GENE]phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I[\\GENE] (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates [CHEMICAL]phosphatidylinositol 4-phosphate[\\CHEMICAL] [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I ([GENE]pip5k1\u03b2[\\GENE]), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates [CHEMICAL]phosphatidylinositol 4-phosphate[\\CHEMICAL] [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]PIP5K1B[\\GENE] encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [[CHEMICAL]PI(4)P[\\CHEMICAL]] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes [GENE]phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I[\\GENE] (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [[CHEMICAL]PI(4)P[\\CHEMICAL]] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I ([GENE]pip5k1\u03b2[\\GENE]), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [[CHEMICAL]PI(4)P[\\CHEMICAL]] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Meanwhile, autophagy was detected as early as 12\u00a0h after an exposure to low-dose [CHEMICAL]dioscin[\\CHEMICAL], as indicated by an up-regulated expression of [GENE]LC3-II[\\GENE] and beclin-1 proteins.",
        "label": 3,
        "major": -1,
        "len": 25
    },
    {
        "text": "Meanwhile, autophagy was detected as early as 12\u00a0h after an exposure to low-dose [CHEMICAL]dioscin[\\CHEMICAL], as indicated by an up-regulated expression of LC3-II and [GENE]beclin-1[\\GENE] proteins.",
        "label": 3,
        "major": -1,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Furanodiene[\\CHEMICAL] Presents Synergistic Anti-proliferative Activity With Paclitaxel Via Altering Cell Cycle and [GENE]Integrin[\\GENE] Signaling in 95-D Lung Cancer Cells.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Furanodiene Presents Synergistic Anti-proliferative Activity With [CHEMICAL]Paclitaxel[\\CHEMICAL] Via Altering Cell Cycle and [GENE]Integrin[\\GENE] Signaling in 95-D Lung Cancer Cells.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]Saccharomyces cerevisiae \u03c455[\\GENE], a subunit of the RNA polymerase III-specific general transcription factor TFIIIC, comprises an [CHEMICAL]N[\\CHEMICAL]-terminal histidine phosphatase domain (\u03c455-HPD) whose catalytic activity and cellular function is poorly understood.",
        "label": 1,
        "major": -1,
        "len": 30
    },
    {
        "text": "[GENE]Saccharomyces cerevisiae \u03c455[\\GENE], a subunit of the RNA polymerase III-specific general transcription factor TFIIIC, comprises an N-terminal [CHEMICAL]histidine[\\CHEMICAL] phosphatase domain (\u03c455-HPD) whose catalytic activity and cellular function is poorly understood.",
        "label": 1,
        "major": -1,
        "len": 30
    },
    {
        "text": "We examined the specificity and initial sites of recruitment of Arf-dependent adaptors (AP-1 and GGAs) in response to the Golgi or endosomal localization of specific cargo proteins (furin, mannose-6-phosphate receptor (M6PR) and M6PR lacking a [CHEMICAL]C[\\CHEMICAL]-terminal domain [GENE]M6PR\u0394C[\\GENE]).",
        "label": 1,
        "major": -1,
        "len": 38
    },
    {
        "text": "[CHEMICAL]Doxorubicin[\\CHEMICAL] is mainly excreted into the bile via [GENE]P-glycoprotein[\\GENE] (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Doxorubicin[\\CHEMICAL] is mainly excreted into the bile via P-glycoprotein ([GENE]P-gp[\\GENE]) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Doxorubicin[\\CHEMICAL] is mainly excreted into the bile via P-glycoprotein (P-gp) and [GENE]multidrug resistance-associated protein 2[\\GENE] (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Doxorubicin[\\CHEMICAL] is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 ([GENE]Mrp2[\\GENE]) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Doxorubicin[\\CHEMICAL] is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via [GENE]cytochrome P450 (CYP) 3A[\\GENE] subfamily.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "6-DHSG was metabolised by GSH to form a GSH conjugate ([CHEMICAL]GS-6-DHSG[\\CHEMICAL]) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of [GENE]glutathione-S-transferase[\\GENE] (GST).",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "6-DHSG was metabolised by GSH to form a GSH conjugate ([CHEMICAL]GS-6-DHSG[\\CHEMICAL]) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase ([GENE]GST[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]6-DHSG[\\CHEMICAL] was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of [GENE]glutathione-S-transferase[\\GENE] (GST).",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]6-DHSG[\\CHEMICAL] was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase ([GENE]GST[\\GENE]).",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "[GENE]Cyclooxygenase(COX)-2[\\GENE]-derived [CHEMICAL]prostanoids[\\CHEMICAL] can influence several processes that are linked to carcinogenesis.",
        "label": 9,
        "major": -1,
        "len": 11
    },
    {
        "text": "Such model of [GENE]Nox4[\\GENE] activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme, i.e., its potential redox regulation, and could also define new therapeutic targets in diseases in which [CHEMICAL]quinones[\\CHEMICAL] and Nox4 are implicated.",
        "label": 3,
        "major": -1,
        "len": 45
    },
    {
        "text": "In this study, using reverse transcriptase PCR (RT-PCR) and ELISA, we showed that [CHEMICAL]TCDD[\\CHEMICAL] up-regulated the expression and secretion of [GENE]tumor necrosis factor-alpha[\\GENE] (TNF-\u03b1) in a time-dependent manner in cultured HAPI microglial cells.",
        "label": 3,
        "major": -1,
        "len": 33
    },
    {
        "text": "In this study, using reverse transcriptase PCR (RT-PCR) and ELISA, we showed that [CHEMICAL]TCDD[\\CHEMICAL] up-regulated the expression and secretion of tumor necrosis factor-alpha ([GENE]TNF-\u03b1[\\GENE]) in a time-dependent manner in cultured HAPI microglial cells.",
        "label": 3,
        "major": -1,
        "len": 33
    },
    {
        "text": "This initial action was accompanied by up-regulation of [GENE]cyclooxygenase-2[\\GENE] (COX-2), an important inflammation marker within 1h after [CHEMICAL]TCDD[\\CHEMICAL] treatment.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "This initial action was accompanied by up-regulation of cyclooxygenase-2 ([GENE]COX-2[\\GENE]), an important inflammation marker within 1h after [CHEMICAL]TCDD[\\CHEMICAL] treatment.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "Anti-inflammatory effect of [CHEMICAL]prunetin[\\CHEMICAL] via the suppression of [GENE]NF-\u03baB[\\GENE] pathway.",
        "label": 4,
        "major": -1,
        "len": 10
    },
    {
        "text": "The results showed that most of the synthesized compounds exhibited nanomolar potency against [GENE]CEase[\\GENE], much better than the parent [CHEMICAL]flavonoids[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "It is also concluded that [CHEMICAL]pyrethroid[\\CHEMICAL] group of insecticide may cause hematological, biochemical, [GENE]cytokine[\\GENE] disturbances and possible mutagenic damage to the tissues.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "We found that in vitro [CHEMICAL]rapamycin[\\CHEMICAL] also regulates the [GENE]proteasome[\\GENE], an essential intracellular protease of the ubiquitin-proteasome pathway.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "We found that in vitro [CHEMICAL]rapamycin[\\CHEMICAL] also regulates the proteasome, an essential intracellular protease of the [GENE]ubiquitin[\\GENE]-proteasome pathway.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "We found that in vitro [CHEMICAL]rapamycin[\\CHEMICAL] also regulates the proteasome, an essential intracellular protease of the ubiquitin-[GENE]proteasome[\\GENE] pathway.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "In the current study, SHR, Wistar-Kyoto (WKY) and Wistar (WIS) rats received a therapeutically relevant dose of [CHEMICAL]methylphenidate[\\CHEMICAL] (1.5mg/kg, p.o.) or vehicle during adolescence and then OFC and mPFC [GENE]DAT[\\GENE] function and cellular expression were assessed during adulthood.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "Our previous results showed that [CHEMICAL]methylphenidate[\\CHEMICAL] treatment in adolescent SHR enhanced cocaine self-administration during adulthood, and alterations in [GENE]DAT[\\GENE] function in prefrontal cortex play a role in this response.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Interestingly, the [CHEMICAL]CP[c]Ph[\\CHEMICAL] dependent up-regulation of [GENE]CYP1A[\\GENE] mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes.",
        "label": 3,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL]CP[c]Ph[\\CHEMICAL] has, comparably to B[a]P, a potential to repress expression of [GENE]tumor suppressor p53[\\GENE], in the head kidney of rainbow trout.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "CP[c]Ph has, comparably to [CHEMICAL]B[a]P[\\CHEMICAL], a potential to repress expression of [GENE]tumor suppressor p53[\\GENE], in the head kidney of rainbow trout.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "In this paper the effect of shRNA LRRK2 knock-down on [CHEMICAL]Mn[\\CHEMICAL] toxicity was examined in control and [GENE]DAT[\\GENE] transfected HEK293 cells.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The results showed that administration of [CHEMICAL]AlCl3[\\CHEMICAL] resulted in a significant elevation in the levels of AchE activity, [GENE]CRP[\\GENE], NF-\u03baB, and MCP-1 accompanied with a significant depletion in the Ach level.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The results showed that administration of [CHEMICAL]AlCl3[\\CHEMICAL] resulted in a significant elevation in the levels of AchE activity, CRP, [GENE]NF-\u03baB[\\GENE], and MCP-1 accompanied with a significant depletion in the Ach level.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The results showed that administration of [CHEMICAL]AlCl3[\\CHEMICAL] resulted in a significant elevation in the levels of AchE activity, CRP, NF-\u03baB, and [GENE]MCP-1[\\GENE] accompanied with a significant depletion in the Ach level.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The results showed that administration of [CHEMICAL]AlCl3[\\CHEMICAL] resulted in a significant elevation in the levels of [GENE]AchE[\\GENE] activity, CRP, NF-\u03baB, and MCP-1 accompanied with a significant depletion in the Ach level.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "Cosinor analysis indicated no diurnal rhythm of [GENE]Ppar\u03b3[\\GENE] expression in the livers of diabetic [CHEMICAL]STZ[\\CHEMICAL] or Iddm rats or in those of insulin-substituted Iddm rats.",
        "label": 10,
        "major": -1,
        "len": 25
    },
    {
        "text": "We investigated the diurnal expression of [GENE]clock[\\GENE] genes and clock-controlled genes (CCGs) in 3-hour intervals for a 24-h period in the livers of male [CHEMICAL]streptozotocin[\\CHEMICAL] (STZ)-treated rats, male spontaneous type 1 diabetic LEW.1AR1-iddm (Iddm) rats, and Iddm rats treated for 10 days with insulin.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "We investigated the diurnal expression of clock genes and [GENE]clock-controlled genes[\\GENE] (CCGs) in 3-hour intervals for a 24-h period in the livers of male [CHEMICAL]streptozotocin[\\CHEMICAL] (STZ)-treated rats, male spontaneous type 1 diabetic LEW.1AR1-iddm (Iddm) rats, and Iddm rats treated for 10 days with insulin.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "We investigated the diurnal expression of clock genes and clock-controlled genes ([GENE]CCGs[\\GENE]) in 3-hour intervals for a 24-h period in the livers of male [CHEMICAL]streptozotocin[\\CHEMICAL] (STZ)-treated rats, male spontaneous type 1 diabetic LEW.1AR1-iddm (Iddm) rats, and Iddm rats treated for 10 days with insulin.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "We investigated the diurnal expression of [GENE]clock[\\GENE] genes and clock-controlled genes (CCGs) in 3-hour intervals for a 24-h period in the livers of male streptozotocin ([CHEMICAL]STZ[\\CHEMICAL])-treated rats, male spontaneous type 1 diabetic LEW.1AR1-iddm (Iddm) rats, and Iddm rats treated for 10 days with insulin.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "We investigated the diurnal expression of clock genes and [GENE]clock-controlled genes[\\GENE] (CCGs) in 3-hour intervals for a 24-h period in the livers of male streptozotocin ([CHEMICAL]STZ[\\CHEMICAL])-treated rats, male spontaneous type 1 diabetic LEW.1AR1-iddm (Iddm) rats, and Iddm rats treated for 10 days with insulin.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "We investigated the diurnal expression of clock genes and clock-controlled genes ([GENE]CCGs[\\GENE]) in 3-hour intervals for a 24-h period in the livers of male streptozotocin ([CHEMICAL]STZ[\\CHEMICAL])-treated rats, male spontaneous type 1 diabetic LEW.1AR1-iddm (Iddm) rats, and Iddm rats treated for 10 days with insulin.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Diabetic [CHEMICAL]STZ[\\CHEMICAL] and Iddm rats, as well as insulin-substituted Iddm rats, exhibited a significant diurnal expression pattern of [GENE]clock[\\GENE] genes as determined by Cosinor analysis; however, the MESOR (midline estimating statistic of rhythm) of Bmal1, Per2, and Clock transcript expression was altered in Iddm and insulin-substituted Iddm rats.",
        "label": 2,
        "major": -1,
        "len": 48
    },
    {
        "text": "CRE and EB treatment also recovered [GENE]TH[\\GENE] immunopositive fibers and cells, respectively, from [CHEMICAL]MPTP[\\CHEMICAL] toxicity.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Using electrophysiologic techniques, the present study assessed the in vivo action of [CHEMICAL]brexpiprazole[\\CHEMICAL] on [GENE]serotonin (5-HT) receptor[\\GENE] subtypes 5-HT1A, 5-HT1B, and 5-HT2A; dopamine (DA) D2 autoreceptors, and alpha1- and alpha2-adrenergic receptors.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using electrophysiologic techniques, the present study assessed the in vivo action of [CHEMICAL]brexpiprazole[\\CHEMICAL] on serotonin (5-HT) receptor subtypes [GENE]5-HT1A[\\GENE], 5-HT1B, and 5-HT2A; dopamine (DA) D2 autoreceptors, and alpha1- and alpha2-adrenergic receptors.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using electrophysiologic techniques, the present study assessed the in vivo action of [CHEMICAL]brexpiprazole[\\CHEMICAL] on serotonin (5-HT) receptor subtypes 5-HT1A, [GENE]5-HT1B[\\GENE], and 5-HT2A; dopamine (DA) D2 autoreceptors, and alpha1- and alpha2-adrenergic receptors.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using electrophysiologic techniques, the present study assessed the in vivo action of [CHEMICAL]brexpiprazole[\\CHEMICAL] on serotonin (5-HT) receptor subtypes 5-HT1A, 5-HT1B, and [GENE]5-HT2A[\\GENE]; dopamine (DA) D2 autoreceptors, and alpha1- and alpha2-adrenergic receptors.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using electrophysiologic techniques, the present study assessed the in vivo action of [CHEMICAL]brexpiprazole[\\CHEMICAL] on serotonin (5-HT) receptor subtypes 5-HT1A, 5-HT1B, and 5-HT2A; [GENE]dopamine (DA) D2 autoreceptors[\\GENE], and alpha1- and alpha2-adrenergic receptors.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "The specificity of [CHEMICAL]progestagens[\\CHEMICAL] for the [GENE]progesterone receptors[\\GENE] in the cytosol fraction of MCF-7 cells was similar to that for progesterone receptors in human and rabbit myometrial cytosol but different from that for the progesterone receptor in rat myometrial cytosol.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "The specificity of [CHEMICAL]progestagens[\\CHEMICAL] for the progesterone receptors in the cytosol fraction of MCF-7 cells was similar to that for [GENE]progesterone receptors[\\GENE] in human and rabbit myometrial cytosol but different from that for the progesterone receptor in rat myometrial cytosol.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "The specificity of [CHEMICAL]progestagens[\\CHEMICAL] for the progesterone receptors in the cytosol fraction of MCF-7 cells was similar to that for progesterone receptors in human and rabbit myometrial cytosol but different from that for the [GENE]progesterone receptor[\\GENE] in rat myometrial cytosol.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "Mechanism of [CHEMICAL]iodide[\\CHEMICAL]-dependent catalatic activity of [GENE]thyroid peroxidase[\\GENE] and lactoperoxidase.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "Mechanism of [CHEMICAL]iodide[\\CHEMICAL]-dependent catalatic activity of thyroid peroxidase and [GENE]lactoperoxidase[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "On the basis of these observations and other findings, we have proposed a scheme which offers a possible explanation for [CHEMICAL]iodide[\\CHEMICAL]-dependent catalatic activity of [GENE]thyroid peroxidase[\\GENE] and lactoperoxidase.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "On the basis of these observations and other findings, we have proposed a scheme which offers a possible explanation for [CHEMICAL]iodide[\\CHEMICAL]-dependent catalatic activity of thyroid peroxidase and [GENE]lactoperoxidase[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "Compound I of the peroxidases is represented as EO, and oxidation of I- by [GENE]EO[\\GENE] is postulated to form enzyme-bound [CHEMICAL]hypoiodite[\\CHEMICAL], represented in our scheme as [EOI]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the peroxidases is represented as EO, and oxidation of I- by [GENE]EO[\\GENE] is postulated to form enzyme-bound hypoiodite, represented in our scheme as [[CHEMICAL]EOI[\\CHEMICAL]]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the [GENE]peroxidases[\\GENE] is represented as EO, and oxidation of I- by EO is postulated to form enzyme-bound [CHEMICAL]hypoiodite[\\CHEMICAL], represented in our scheme as [EOI]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the peroxidases is represented as [GENE]EO[\\GENE], and oxidation of I- by EO is postulated to form enzyme-bound [CHEMICAL]hypoiodite[\\CHEMICAL], represented in our scheme as [EOI]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the peroxidases is represented as [GENE]EO[\\GENE], and oxidation of I- by EO is postulated to form enzyme-bound hypoiodite, represented in our scheme as [[CHEMICAL]EOI[\\CHEMICAL]]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the [GENE]peroxidases[\\GENE] is represented as EO, and oxidation of I- by EO is postulated to form enzyme-bound hypoiodite, represented in our scheme as [[CHEMICAL]EOI[\\CHEMICAL]]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the [GENE]peroxidases[\\GENE] is represented as EO, and oxidation of [CHEMICAL]I-[\\CHEMICAL] by EO is postulated to form enzyme-bound hypoiodite, represented in our scheme as [EOI]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the peroxidases is represented as [GENE]EO[\\GENE], and oxidation of [CHEMICAL]I-[\\CHEMICAL] by EO is postulated to form enzyme-bound hypoiodite, represented in our scheme as [EOI]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Compound I of the peroxidases is represented as EO, and oxidation of [CHEMICAL]I-[\\CHEMICAL] by [GENE]EO[\\GENE] is postulated to form enzyme-bound hypoiodite, represented in our scheme as [EOI]-.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "We suggest that the latter can react with [CHEMICAL]H2O2[\\CHEMICAL] in a [GENE]catalase[\\GENE]-like reaction, with evolution of O2.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "We suggest that the latter can react with H2O2 in a [GENE]catalase[\\GENE]-like reaction, with evolution of [CHEMICAL]O2[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "Both the phosphotriesterase and [CHEMICAL]physostigmine[\\CHEMICAL] treatments protected the brain [GENE]AChE[\\GENE] activities measured 24 h after sarin exposure.",
        "label": 3,
        "major": -1,
        "len": 17
    },
    {
        "text": "Both the phosphotriesterase and physostigmine treatments protected the brain [GENE]AChE[\\GENE] activities measured 24 h after [CHEMICAL]sarin[\\CHEMICAL] exposure.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "Carrier-free radioiodinated [CHEMICAL][125I]IAS[\\CHEMICAL] was used to photolabel epitope-tagged [GENE]human beta 2AR[\\GENE] in membranes prepared from stably transfected HEK 293 cells.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "These suggest that the repeated administration of low-doses of [CHEMICAL]METH[\\CHEMICAL] causes quantitative changes of the signaling of [GENE]alpha(2A)-AR[\\GENE] in the mouse hippocampus.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Here, we show that [GENE]rTRPV1[\\GENE], rTRPV2, rTRPV3, and mTRPV4, as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, [GENE]rTRPV2[\\GENE], rTRPV3, and mTRPV4, as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, [GENE]rTRPV3[\\GENE], and mTRPV4, as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, rTRPV3, and [GENE]mTRPV4[\\GENE], as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, rTRPV3, and mTRPV4, as well as [GENE]hTRPM8[\\GENE], and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, rTRPV3, and mTRPV4, as well as hTRPM8, and [GENE]rTRPM3[\\GENE], which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Acute [CHEMICAL]arsenic[\\CHEMICAL] treatment alters [GENE]cytochrome P450[\\GENE] expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Our results demonstrated that acute [CHEMICAL]As(III)[\\CHEMICAL] treatment (12.5\u2009mg/kg) altered [GENE]CYP[\\GENE] epoxygenases, CYP \u03c9-hydroxylases and EPHX2 mRNA levels that were isozyme and tissue specific.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Our results demonstrated that acute [CHEMICAL]As(III)[\\CHEMICAL] treatment (12.5\u2009mg/kg) altered CYP [GENE]epoxygenases[\\GENE], CYP \u03c9-hydroxylases and EPHX2 mRNA levels that were isozyme and tissue specific.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Our results demonstrated that acute [CHEMICAL]As(III)[\\CHEMICAL] treatment (12.5\u2009mg/kg) altered CYP epoxygenases, [GENE]CYP[\\GENE] \u03c9-hydroxylases and EPHX2 mRNA levels that were isozyme and tissue specific.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Our results demonstrated that acute [CHEMICAL]As(III)[\\CHEMICAL] treatment (12.5\u2009mg/kg) altered CYP epoxygenases, CYP [GENE]\u03c9-hydroxylases[\\GENE] and EPHX2 mRNA levels that were isozyme and tissue specific.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Our results demonstrated that acute [CHEMICAL]As(III)[\\CHEMICAL] treatment (12.5\u2009mg/kg) altered CYP epoxygenases, CYP \u03c9-hydroxylases and [GENE]EPHX2[\\GENE] mRNA levels that were isozyme and tissue specific.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Sustained resistance to acute [CHEMICAL]MPTP[\\CHEMICAL] toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of [GENE]parkin[\\GENE] protein.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "These results confirm and strengthen the idea of alpha [CHEMICAL]N-acetyl[\\CHEMICAL] beta-endorphin-(1-31) acting as a non-competitive regulator of [GENE]mu opioid[\\GENE]- and alpha 2-adrenoceptor-mediated supraspinal antinociception.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "These results confirm and strengthen the idea of alpha [CHEMICAL]N-acetyl[\\CHEMICAL] beta-endorphin-(1-31) acting as a non-competitive regulator of mu opioid- and [GENE]alpha 2-adrenoceptor[\\GENE]-mediated supraspinal antinociception.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "In the insulin-hypoglycemia test (0.15 IU/kg BW), neither the [GENE]ACTH[\\GENE] peak nor the area under the curve of ACTH was affected by [CHEMICAL]loperamide[\\CHEMICAL].",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "In the insulin-hypoglycemia test (0.15 IU/kg BW), neither the ACTH peak nor the area under the curve of [GENE]ACTH[\\GENE] was affected by [CHEMICAL]loperamide[\\CHEMICAL].",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "In seven normal subjects, basal [GENE]ACTH[\\GENE] plasma levels were significantly suppressed 3 h after [CHEMICAL]loperamide[\\CHEMICAL] administration (16 mg, orally) from 5 +/- 1 to 2 +/- 0 pmol/L (P less than 0.0001).",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "Chronic effect of [CHEMICAL][D-Pen2,D-Pen5]enkephalin[\\CHEMICAL] on [GENE]rat brain opioid receptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "), whereas [CHEMICAL]amitriptyline[\\CHEMICAL] is essentially inactive on [GENE]5-HT3[\\GENE] receptors.",
        "label": 10,
        "major": -1,
        "len": 9
    },
    {
        "text": "The second part of this study consisted of looking for possible changes in central [GENE]5-HT receptors[\\GENE] 24 h after either a single or a repeated (for 14 days) treatment with [CHEMICAL]amoxapine[\\CHEMICAL] (10 mg/kg i.p.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The second part of this study consisted of looking for possible changes in central [GENE]5-HT receptors[\\GENE] 24 h after either a single or a repeated (for 14 days) treatment with amoxapine (10 mg/kg i.p. each day) or [CHEMICAL]amitriptyline[\\CHEMICAL] (10 mg/kg i.p.).",
        "label": 2,
        "major": -1,
        "len": 41
    },
    {
        "text": "This [CHEMICAL]lysine[\\CHEMICAL] is contained in the sequence [GENE]PFYAVKC[\\GENE], which is found in all known ODCs from eukaryotes.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "This [CHEMICAL]lysine[\\CHEMICAL] is contained in the sequence PFYAVKC, which is found in all known [GENE]ODCs[\\GENE] from eukaryotes.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "This lysine is contained in the sequence [CHEMICAL]PFYAVKC[\\CHEMICAL], which is found in all known [GENE]ODCs[\\GENE] from eukaryotes.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Cysteine[\\CHEMICAL] 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -[GENE]WGPTCDGL(I)D[\\GENE]-, which is present in all known eukaryote ODCs.",
        "label": 1,
        "major": -1,
        "len": 29
    },
    {
        "text": "[CHEMICAL]Cysteine[\\CHEMICAL] 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -WGPTCDGL(I)D-, which is present in all known [GENE]eukaryote ODCs[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 29
    },
    {
        "text": "Cysteine 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -[CHEMICAL]WGPTCDGL(I)D[\\CHEMICAL]-, which is present in all known [GENE]eukaryote ODCs[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 29
    },
    {
        "text": "[CHEMICAL]Nicotinic acid[\\CHEMICAL] and acipimox interfere with the biosynthesis of [GENE]LDL[\\GENE] and can also improve the clearance of VLDL/LDL.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Nicotinic acid[\\CHEMICAL] and acipimox interfere with the biosynthesis of LDL and can also improve the clearance of [GENE]VLDL[\\GENE]/LDL.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Nicotinic acid[\\CHEMICAL] and acipimox interfere with the biosynthesis of LDL and can also improve the clearance of VLDL/[GENE]LDL[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[GENE]Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase[\\GENE] (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding [CHEMICAL]3-keto-4-ene-steroids[\\CHEMICAL] and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase ([GENE]3 beta-HSD[\\GENE]) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding [CHEMICAL]3-keto-4-ene-steroids[\\CHEMICAL] and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "[GENE]Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase[\\GENE] (3 beta-HSD) purified from human placenta transforms C-21 ([CHEMICAL]pregnenolone[\\CHEMICAL] and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase ([GENE]3 beta-HSD[\\GENE]) purified from human placenta transforms C-21 ([CHEMICAL]pregnenolone[\\CHEMICAL] and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "[GENE]Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase[\\GENE] (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and [CHEMICAL]17 alpha-hydroxy pregnenolone[\\CHEMICAL]) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase ([GENE]3 beta-HSD[\\GENE]) purified from human placenta transforms C-21 (pregnenolone and [CHEMICAL]17 alpha-hydroxy pregnenolone[\\CHEMICAL]) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "[GENE]Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase[\\GENE] (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 ([CHEMICAL]dehydroepiandrosterone[\\CHEMICAL] and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase ([GENE]3 beta-HSD[\\GENE]) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 ([CHEMICAL]dehydroepiandrosterone[\\CHEMICAL] and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "[GENE]Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase[\\GENE] (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and [CHEMICAL]androst-5-ene-3 beta, 17 beta-diol[\\CHEMICAL]) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase ([GENE]3 beta-HSD[\\GENE]) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and [CHEMICAL]androst-5-ene-3 beta, 17 beta-diol[\\CHEMICAL]) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "), [GENE]MAO-B[\\GENE] by [CHEMICAL](-)deprenyl[\\CHEMICAL] (1 mg/kg i.p.",
        "label": 4,
        "major": -1,
        "len": 7
    },
    {
        "text": "), both [GENE]MAO-A[\\GENE] and MAO-B by [CHEMICAL]nialamide[\\CHEMICAL] (75 mg/kg i.p.)",
        "label": 4,
        "major": -1,
        "len": 10
    },
    {
        "text": "), both MAO-A and [GENE]MAO-B[\\GENE] by [CHEMICAL]nialamide[\\CHEMICAL] (75 mg/kg i.p.)",
        "label": 4,
        "major": -1,
        "len": 10
    },
    {
        "text": "or peripheral neuronal [GENE]MAO[\\GENE] by [CHEMICAL]debrisoquin[\\CHEMICAL] (40 mg/kg i.p.).",
        "label": 4,
        "major": -1,
        "len": 9
    },
    {
        "text": "The results suggest that most of the [CHEMICAL]HVA[\\CHEMICAL] in plasma is derived from deamination of DA by [GENE]MAO-A[\\GENE] in peripheral neurons; that DOPAC in plasma is derived from cells outside the central nervous system; that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity.",
        "label": 9,
        "major": -1,
        "len": 71
    },
    {
        "text": "The results suggest that most of the HVA in plasma is derived from deamination of [CHEMICAL]DA[\\CHEMICAL] by [GENE]MAO-A[\\GENE] in peripheral neurons; that DOPAC in plasma is derived from cells outside the central nervous system; that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity.",
        "label": 9,
        "major": -1,
        "len": 71
    },
    {
        "text": "The [CHEMICAL]C[\\CHEMICAL]-terminal half of [GENE]TSG-6[\\GENE] contains a so-called CUB domain, characteristic for developmentally regulated proteins.",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]SB 200646[\\CHEMICAL], which demonstrates some selectivity for [GENE]5-HT receptors[\\GENE] in rat stomach fundus, should provide a useful ligand for confirmation of this view and allow discrimination of 5-HT2B function both in vitro and in vivo.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "[CHEMICAL]SB 200646[\\CHEMICAL], which demonstrates some selectivity for 5-HT receptors in rat stomach fundus, should provide a useful ligand for confirmation of this view and allow discrimination of [GENE]5-HT2B[\\GENE] function both in vitro and in vivo.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Under these conditions, blockade of [GENE]monoamine oxidase[\\GENE] with [CHEMICAL]pargyline[\\CHEMICAL] (100 microM for 15 min) caused a leftward displacement of concentration-effect curves for both 5-methoxytryptamine (5-MeO-T) and tryptamine.",
        "label": 4,
        "major": -1,
        "len": 27
    },
    {
        "text": "Phorbol esters and [CHEMICAL]norepinephrine[\\CHEMICAL] destabilize [GENE]alpha 1B-adrenergic receptor[\\GENE] mRNA in vascular smooth muscle cells.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "Although there is a high probability that the action of aldosterone to cause cardiac fibrosis in this experimental model is an effect via non-epithelial MR, the locus of aldosterone action remains to be established, as do the molecular mechanisms linking [GENE]MR[\\GENE] occupancy by [CHEMICAL]aldosterone[\\CHEMICAL] and collagen deposition.",
        "label": 2,
        "major": -1,
        "len": 47
    },
    {
        "text": "Although there is a high probability that the action of [CHEMICAL]aldosterone[\\CHEMICAL] to cause cardiac fibrosis in this experimental model is an effect via non-epithelial [GENE]MR[\\GENE], the locus of aldosterone action remains to be established, as do the molecular mechanisms linking MR occupancy by aldosterone and collagen deposition.",
        "label": 2,
        "major": -1,
        "len": 47
    },
    {
        "text": "The results also confirmed previous reports that [CHEMICAL]amezinium[\\CHEMICAL] is highly selective for [GENE]MAO-A[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "By contrast, the closely related [GENE]bovine ether-a-go-go channel[\\GENE] (BEAG) is 100-fold less sensitive to [CHEMICAL]dofetilide[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "By contrast, the closely related bovine ether-a-go-go channel ([GENE]BEAG[\\GENE]) is 100-fold less sensitive to [CHEMICAL]dofetilide[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "[GENE]HERG[\\GENE]/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, [CHEMICAL]E4031[\\CHEMICAL], and MK-499, at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "HERG/[GENE]IKr[\\GENE] channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, [CHEMICAL]E4031[\\CHEMICAL], and MK-499, at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "[GENE]HERG[\\GENE]/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and [CHEMICAL]MK-499[\\CHEMICAL], at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "HERG/[GENE]IKr[\\GENE] channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and [CHEMICAL]MK-499[\\CHEMICAL], at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "Molecular determinants of [CHEMICAL]dofetilide[\\CHEMICAL] block of [GENE]HERG[\\GENE] K+ channels.",
        "label": 4,
        "major": -1,
        "len": 9
    },
    {
        "text": "Molecular determinants of [CHEMICAL]dofetilide[\\CHEMICAL] block of HERG [GENE]K+ channels[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 9
    },
    {
        "text": "[GENE]HERG[\\GENE]/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic [CHEMICAL]methanesulfonanilide[\\CHEMICAL] drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "HERG/[GENE]IKr[\\GENE] channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic [CHEMICAL]methanesulfonanilide[\\CHEMICAL] drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "[GENE]HERG[\\GENE]/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as [CHEMICAL]dofetilide[\\CHEMICAL], E4031, and MK-499, at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "HERG/[GENE]IKr[\\GENE] channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as [CHEMICAL]dofetilide[\\CHEMICAL], E4031, and MK-499, at submicromolar concentrations.",
        "label": 4,
        "major": -1,
        "len": 31
    },
    {
        "text": "[CHEMICAL]Cocaine[\\CHEMICAL] block of [GENE]human cardiac (hH1)[\\GENE] and rat skeletal (mu1) muscle sodium channels was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Cocaine[\\CHEMICAL] block of human cardiac (hH1) and [GENE]rat skeletal (mu1) muscle sodium channels[\\GENE] was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "State-dependent [CHEMICAL]cocaine[\\CHEMICAL] block of [GENE]sodium channel[\\GENE] isoforms, chimeras, and channels coexpressed with the beta1 subunit.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]Disodium cromoglycate[\\CHEMICAL] affected neither the rightward shift of [GENE]beta 2-adrenoceptor[\\GENE]-mediated responses nor the small rightward shift in beta 1-adrenoceptor-mediated exercise tachycardia after 2 weeks' administration of terbutaline.",
        "label": 10,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Disodium cromoglycate[\\CHEMICAL] affected neither the rightward shift of beta 2-adrenoceptor-mediated responses nor the small rightward shift in [GENE]beta 1-adrenoceptor[\\GENE]-mediated exercise tachycardia after 2 weeks' administration of terbutaline.",
        "label": 10,
        "major": -1,
        "len": 27
    },
    {
        "text": "CONCLUSIONS: [CHEMICAL]Argatroban[\\CHEMICAL], as compared with heparin, appears to enhance reperfusion with [GENE]TPA[\\GENE] in patients with AMI, particularly in those patients with delayed presentation.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "[CHEMICAL]Losartan[\\CHEMICAL], EXP, and irbesartan caused a rightward parallel shift without any major effects on the maximal response to [GENE]Ang II[\\GENE].",
        "label": 10,
        "major": -1,
        "len": 20
    },
    {
        "text": "Losartan, [CHEMICAL]EXP[\\CHEMICAL], and irbesartan caused a rightward parallel shift without any major effects on the maximal response to [GENE]Ang II[\\GENE].",
        "label": 10,
        "major": -1,
        "len": 20
    },
    {
        "text": "Losartan, EXP, and [CHEMICAL]irbesartan[\\CHEMICAL] caused a rightward parallel shift without any major effects on the maximal response to [GENE]Ang II[\\GENE].",
        "label": 10,
        "major": -1,
        "len": 20
    },
    {
        "text": "Before dosing and 24 h after the seventh dose of each regimen, heparinized whole blood samples were incubated with lipopolysaccharide (10 microgram/ml) for 24 h at 37 degrees C, and [CHEMICAL]prostaglandin E2[\\CHEMICAL] was measured in plasma as an index of monocyte [GENE]COX-2[\\GENE] activity.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "A role of cytosolic [GENE]NQO1[\\GENE] in protection of cells from oxidative stress, cytotoxicity, and mutagenicity of [CHEMICAL]quinones[\\CHEMICAL] was established.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "In addition, the stereospecificity required at [GENE]opioid receptors[\\GENE] appears to be retained at the nociceptin receptor, since [CHEMICAL](+)-quadazocine[\\CHEMICAL] is inactive at both receptors.",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "In addition, the stereospecificity required at opioid receptors appears to be retained at the [GENE]nociceptin receptor[\\GENE], since [CHEMICAL](+)-quadazocine[\\CHEMICAL] is inactive at both receptors.",
        "label": 10,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] and thymidine kinase are key enzymes involved in the de novo and salvage pathways for [CHEMICAL]pyrimidine nucleotide[\\CHEMICAL] synthesis, respectively.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "Thymidylate synthase and [GENE]thymidine kinase[\\GENE] are key enzymes involved in the de novo and salvage pathways for [CHEMICAL]pyrimidine nucleotide[\\CHEMICAL] synthesis, respectively.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "The selective [GENE]alpha(1)-adrenoceptor[\\GENE] ligands [CHEMICAL]prazosin[\\CHEMICAL] and doxazosin (each 3 microM) had no effect on noradrenaline responses.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The selective [GENE]alpha(1)-adrenoceptor[\\GENE] ligands prazosin and [CHEMICAL]doxazosin[\\CHEMICAL] (each 3 microM) had no effect on noradrenaline responses.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "A positron emission tomography study of [CHEMICAL]quetiapine[\\CHEMICAL] in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high [GENE]dopamine D2 receptor[\\GENE] occupancy.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of [CHEMICAL]eicosapentaenoic acid[\\CHEMICAL] (EPA) blocked [GENE]Delta-5-desaturase[\\GENE] activity, the terminal enzymatic step in AA synthesis.",
        "label": 4,
        "major": -1,
        "len": 25
    },
    {
        "text": "Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of eicosapentaenoic acid ([CHEMICAL]EPA[\\CHEMICAL]) blocked [GENE]Delta-5-desaturase[\\GENE] activity, the terminal enzymatic step in AA synthesis.",
        "label": 4,
        "major": -1,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Nicorandil[\\CHEMICAL] 20 micromol/L reversed only 50% of the effect of [GENE]ATX-II[\\GENE] and failed to completely suppress TdP in the LQT3 model (5/6 to 3/6).",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "In contrast to [GENE]UCP-3[\\GENE], UCP-2 mRNA levels were only slightly modified by [CHEMICAL]bezafibrate[\\CHEMICAL] in adipocytes.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "In contrast to UCP-3, [GENE]UCP-2[\\GENE] mRNA levels were only slightly modified by [CHEMICAL]bezafibrate[\\CHEMICAL] in adipocytes.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "The ensemble of results suggests that the ability of [CHEMICAL]Sch B[\\CHEMICAL] pretreatment to enhance hepatocellular [GENE]DTD[\\GENE] activity may at least in part be attributed to the protection against menadione hepatotoxicity.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "To mechanistically evaluate this regional selectivity, we assessed [GENE]cyclo-oxygenase-2[\\GENE] (COX-2) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and [CHEMICAL]AOM[\\CHEMICAL]-treated rats.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "To mechanistically evaluate this regional selectivity, we assessed cyclo-oxygenase-2 ([GENE]COX-2[\\GENE]) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and [CHEMICAL]AOM[\\CHEMICAL]-treated rats.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "Potent [GENE]alpha(2A)-adrenoceptor[\\GENE]-mediated vasoconstriction by [CHEMICAL]brimonidine[\\CHEMICAL] in porcine ciliary arteries.",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "[GENE]DHFS[\\GENE] is present exclusively in the mitochondria, making this compartment the sole site of synthesis of [CHEMICAL]dihydrofolate[\\CHEMICAL] in the plant cell.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "Because [GENE]rhoA[\\GENE] requires [CHEMICAL]GGPP[\\CHEMICAL] for its function, this links the microarray and biochemical data and identifies rhoA as a potential mediator of the anticancer properties of lovastatin.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Because rhoA requires GGPP for its function, this links the microarray and biochemical data and identifies [GENE]rhoA[\\GENE] as a potential mediator of the anticancer properties of [CHEMICAL]lovastatin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Cilostazol[\\CHEMICAL] undergoes intensive and finally complete hepatic metabolism via the [GENE]cytochrome P450[\\GENE] systems.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "BACKGROUND: The novel antiepileptic drug [CHEMICAL]retigabine[\\CHEMICAL] is the first selective M-current potassium channel opener for [GENE]KCNQ2/3[\\GENE] and KCNQ3/5 channels.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "BACKGROUND: The novel antiepileptic drug [CHEMICAL]retigabine[\\CHEMICAL] is the first selective M-current potassium channel opener for KCNQ2/3 and [GENE]KCNQ3/5[\\GENE] channels.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "BACKGROUND: The novel antiepileptic drug [CHEMICAL]retigabine[\\CHEMICAL] is the first selective [GENE]M-current potassium channel[\\GENE] opener for KCNQ2/3 and KCNQ3/5 channels.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL](S,S)-[(11)C]-MeNER[\\CHEMICAL] has the potential to be the first successful PET ligand to image [GENE]NET[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "The four [CHEMICAL]lysine[\\CHEMICAL] residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of [GENE]OTCase[\\GENE] to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "label": 1,
        "major": -1,
        "len": 51
    },
    {
        "text": "The four lysine residues located in the SMG loop, [CHEMICAL]Lys[\\CHEMICAL]-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of [GENE]OTCase[\\GENE] to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "label": 1,
        "major": -1,
        "len": 51
    },
    {
        "text": "The four lysine residues located in the SMG loop, Lys-260, [CHEMICAL]Lys[\\CHEMICAL]-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of [GENE]OTCase[\\GENE] to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "label": 1,
        "major": -1,
        "len": 51
    },
    {
        "text": "The four lysine residues located in the SMG loop, Lys-260, Lys-263, [CHEMICAL]Lys[\\CHEMICAL]-265, and Lys-268, also play an important role in mediating the sensitivity of [GENE]OTCase[\\GENE] to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "label": 1,
        "major": -1,
        "len": 51
    },
    {
        "text": "The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and [CHEMICAL]Lys[\\CHEMICAL]-268, also play an important role in mediating the sensitivity of [GENE]OTCase[\\GENE] to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "label": 1,
        "major": -1,
        "len": 51
    },
    {
        "text": "The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of [GENE]OTCase[\\GENE] to [CHEMICAL]ornithine[\\CHEMICAL] and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "label": 4,
        "major": -1,
        "len": 51
    },
    {
        "text": "CONCLUSIONS: Our data suggest that [GENE]beta(1)-adrenergic receptor[\\GENE] polymorphisms are important determinants of antihypertensive response to [CHEMICAL]metoprolol[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "[GENE]Beta 1-adrenergic receptor[\\GENE] polymorphisms and antihypertensive response to [CHEMICAL]metoprolol[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "We sought to assess the effects of the [GENE]angiotensin type 1 (AT1) receptor[\\GENE] blocker [CHEMICAL]eprosartan[\\CHEMICAL] on HRV and BRG.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "CONCLUSION: [CHEMICAL]Nandrolone phenylpropionate[\\CHEMICAL] up-regulated the density of AR in liver tissue, whereas it had no significant effects on the density of [GENE]AR[\\GENE] in testis and ovary tissues.",
        "label": 10,
        "major": -1,
        "len": 27
    },
    {
        "text": "The density of [GENE]AR[\\GENE] in testis and ovary tissues showed no significant difference between [CHEMICAL]NP[\\CHEMICAL] group and control group at every time-point (P > 0.05).",
        "label": 10,
        "major": -1,
        "len": 25
    },
    {
        "text": "CONCLUSION: [CHEMICAL]Nandrolone phenylpropionate[\\CHEMICAL] up-regulated the density of [GENE]AR[\\GENE] in liver tissue, whereas it had no significant effects on the density of AR in testis and ovary tissues.",
        "label": 3,
        "major": -1,
        "len": 27
    },
    {
        "text": "RESULTS: The density of [GENE]AR[\\GENE] in liver tissue in [CHEMICAL]NP[\\CHEMICAL] group was higher than that in control group (P < 0.05).",
        "label": 3,
        "major": -1,
        "len": 21
    },
    {
        "text": "This represents a novel mechanism of action for [CHEMICAL]hydralazine[\\CHEMICAL] and presents [GENE]HIF[\\GENE] as a potential target for treatment of ischemic disease.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[GENE]Collagen prolyl hydroxylase[\\GENE] is a known target of [CHEMICAL]hydralazine[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "CONCLUSIONS: The most interesting findings were the high mRNA expression of [GENE]P2Y12[\\GENE] receptors in lymphocytes potentially explaining the anti-inflammatory effects of [CHEMICAL]clopidogrel[\\CHEMICAL], P2Y13 receptors in monocytes and a previously unrecognised expression of P2X4 in lymphocytes and monocytes.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Effects of [CHEMICAL]minocycline[\\CHEMICAL] on [GENE]Fas[\\GENE]-mediated fulminant hepatitis in mice.",
        "label": 2,
        "major": -1,
        "len": 9
    },
    {
        "text": "Moreover, [CHEMICAL]minocycline[\\CHEMICAL] efficiently suppressed the release of [GENE]cytochrome c[\\GENE] from mitochondria of the liver tissues from Jo2-challenged mice.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Of these two enzymes, [GENE]cystathionine-gamma-lyase[\\GENE] (CSE) is believed to be the key enzyme that forms [CHEMICAL]H2S[\\CHEMICAL] in the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "Of these two enzymes, cystathionine-gamma-lyase ([GENE]CSE[\\GENE]) is believed to be the key enzyme that forms [CHEMICAL]H2S[\\CHEMICAL] in the cardiovascular system.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "After 3 weeks' bupropion treatment we studied the change in [GENE]DAT[\\GENE] activity, which corresponds to the occupancy of [CHEMICAL]bupropion[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "The average occupancy of [CHEMICAL]bupropion[\\CHEMICAL] on [GENE]DAT[\\GENE] was similar to the international findings at 20.84% in 9 depressed patients.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "After 3 weeks' [CHEMICAL]bupropion[\\CHEMICAL] treatment we studied the change in [GENE]DAT[\\GENE] activity, which corresponds to the occupancy of bupropion.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "A [GENE]G-protein coupled receptor[\\GENE] to [CHEMICAL]niacin[\\CHEMICAL] (nicotinic acid) was identified recently but the physiological/pharmacological role of the receptor remains poorly defined.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "A [GENE]G-protein coupled receptor[\\GENE] to niacin ([CHEMICAL]nicotinic acid[\\CHEMICAL]) was identified recently but the physiological/pharmacological role of the receptor remains poorly defined.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Niacin[\\CHEMICAL] mediates lipolysis in adipose tissue through its [GENE]G-protein coupled receptor HM74A[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Vitamin E[\\CHEMICAL] supplementation alters [GENE]HDL[\\GENE]-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Vitamin E[\\CHEMICAL] supplementation alters HDL-cholesterol concentration and [GENE]paraoxonase[\\GENE] activity in rabbits fed high-cholesterol diet: comparison with probucol.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "However, plasma high-density lipoprotein-cholesterol (HDL-C) and HDL-C/total-C ratio levels and plasma [GENE]paraoxonase[\\GENE] activity were only significantly higher in [CHEMICAL]vitamin E[\\CHEMICAL] group after 8 weeks.",
        "label": 3,
        "major": -1,
        "len": 24
    },
    {
        "text": "However, plasma [GENE]high-density lipoprotein[\\GENE]-cholesterol (HDL-C) and HDL-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in [CHEMICAL]vitamin E[\\CHEMICAL] group after 8 weeks.",
        "label": 3,
        "major": -1,
        "len": 24
    },
    {
        "text": "However, plasma high-density lipoprotein-cholesterol ([GENE]HDL[\\GENE]-C) and HDL-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in [CHEMICAL]vitamin E[\\CHEMICAL] group after 8 weeks.",
        "label": 3,
        "major": -1,
        "len": 24
    },
    {
        "text": "However, plasma high-density lipoprotein-cholesterol (HDL-C) and [GENE]HDL[\\GENE]-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in [CHEMICAL]vitamin E[\\CHEMICAL] group after 8 weeks.",
        "label": 3,
        "major": -1,
        "len": 24
    },
    {
        "text": "Hepatic mRNA expressions of [GENE]apo B-100[\\GENE] and apo C-III were significantly lower in [CHEMICAL]probucol[\\CHEMICAL] group than in other groups.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "Hepatic mRNA expressions of apo B-100 and [GENE]apo C-III[\\GENE] were significantly lower in [CHEMICAL]probucol[\\CHEMICAL] group than in other groups.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "Hence, re-expression of the p75NTR appears to partially reverse de-differentiation of prostate cancer cells by up-regulating the expression of [GENE]CRABPI[\\GENE] for localized sequestration of [CHEMICAL]retinoids[\\CHEMICAL] that are available to newly up-regulated RAR-beta, RXR-alpha, and RXR-beta.",
        "label": 3,
        "major": -1,
        "len": 35
    },
    {
        "text": "The Arg389Gly beta1-adrenoceptor polymorphism and [CHEMICAL]catecholamine[\\CHEMICAL] effects on plasma-[GENE]renin[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "To probe into the \"logic\" of this enigma, we have started comparative studies among evolutionarily distant organisms, such as mouse and Saccharomyces cerevisiae, and we are now looking for [CHEMICAL]biotin[\\CHEMICAL] effects on specific genes and proteins, such as [GENE]HCS[\\GENE] and hexokinases, and on their proteomes.",
        "label": 2,
        "major": -1,
        "len": 45
    },
    {
        "text": "To probe into the \"logic\" of this enigma, we have started comparative studies among evolutionarily distant organisms, such as mouse and Saccharomyces cerevisiae, and we are now looking for [CHEMICAL]biotin[\\CHEMICAL] effects on specific genes and proteins, such as HCS and [GENE]hexokinases[\\GENE], and on their proteomes.",
        "label": 2,
        "major": -1,
        "len": 45
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with [CHEMICAL]5-fluorouracil[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Several variables associated to [GENE]thymidylate synthase[\\GENE] (TS), the biological target of 5-fluorouracil ([CHEMICAL]5FU[\\CHEMICAL]) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer (CRC) patients.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Several variables associated to thymidylate synthase ([GENE]TS[\\GENE]), the biological target of 5-fluorouracil ([CHEMICAL]5FU[\\CHEMICAL]) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer (CRC) patients.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Several variables associated to [GENE]thymidylate synthase[\\GENE] (TS), the biological target of [CHEMICAL]5-fluorouracil[\\CHEMICAL] (5FU) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer (CRC) patients.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Several variables associated to thymidylate synthase ([GENE]TS[\\GENE]), the biological target of [CHEMICAL]5-fluorouracil[\\CHEMICAL] (5FU) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer (CRC) patients.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "Low [GENE]TS[\\GENE] expression levels, cytoplasmic expression pattern and C SNP arose as variables associated to longer progression-free survival (PFS) in patients treated with [CHEMICAL]5FU[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Simvastatin[\\CHEMICAL] regulates non-neuronal cholinergic activity in T lymphocytes via [GENE]CD11a[\\GENE]-mediated pathways.",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "[GENE]VGLUT1[\\GENE] is localized in transcytotic vesicles and accumulates [CHEMICAL]L-glutamate[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 9
    },
    {
        "text": "A follow-up study of the expression of [GENE]D6D[\\GENE] and D5D genes in Chinese who live in European countries with high [CHEMICAL]SFA[\\CHEMICAL] and MUFA diets would be of interest.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "A follow-up study of the expression of D6D and [GENE]D5D[\\GENE] genes in Chinese who live in European countries with high [CHEMICAL]SFA[\\CHEMICAL] and MUFA diets would be of interest.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "A follow-up study of the expression of [GENE]D6D[\\GENE] and D5D genes in Chinese who live in European countries with high SFA and [CHEMICAL]MUFA[\\CHEMICAL] diets would be of interest.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "A follow-up study of the expression of D6D and [GENE]D5D[\\GENE] genes in Chinese who live in European countries with high SFA and [CHEMICAL]MUFA[\\CHEMICAL] diets would be of interest.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of [CHEMICAL]linoleic acid[\\CHEMICAL] (LA) and alpha-linolenic acid (LNA) and the expression of PBMC [GENE]D6D[\\GENE] and D5D genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of [CHEMICAL]linoleic acid[\\CHEMICAL] (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and [GENE]D5D[\\GENE] genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid ([CHEMICAL]LA[\\CHEMICAL]) and alpha-linolenic acid (LNA) and the expression of PBMC [GENE]D6D[\\GENE] and D5D genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid ([CHEMICAL]LA[\\CHEMICAL]) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and [GENE]D5D[\\GENE] genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and [CHEMICAL]alpha-linolenic acid[\\CHEMICAL] (LNA) and the expression of PBMC [GENE]D6D[\\GENE] and D5D genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and [CHEMICAL]alpha-linolenic acid[\\CHEMICAL] (LNA) and the expression of PBMC D6D and [GENE]D5D[\\GENE] genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid ([CHEMICAL]LNA[\\CHEMICAL]) and the expression of PBMC [GENE]D6D[\\GENE] and D5D genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid ([CHEMICAL]LNA[\\CHEMICAL]) and the expression of PBMC D6D and [GENE]D5D[\\GENE] genes.",
        "label": 4,
        "major": -1,
        "len": 48
    },
    {
        "text": "Our data suggest that [CHEMICAL]l-arginine[\\CHEMICAL] is taken up by Sertoli cells and peritubular cells, principally via system y(+)L ([GENE]SLC3A2[\\GENE]/SLC7A6) and system y(+) (SLC7A1 and SLC7A2), with system B(0+) making a minor contribution.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to [GENE]retinal dehydrogenase 2[\\GENE] (raldh2), the key enzyme for [CHEMICAL]retinoic acid[\\CHEMICAL] synthesis.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to retinal dehydrogenase 2 ([GENE]raldh2[\\GENE]), the key enzyme for [CHEMICAL]retinoic acid[\\CHEMICAL] synthesis.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]P2Y12[\\GENE] has been shown to be the target of the [CHEMICAL]thienopyridine[\\CHEMICAL] drugs, ticlopidine and clopidogrel.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "[GENE]P2Y12[\\GENE] has been shown to be the target of the thienopyridine drugs, [CHEMICAL]ticlopidine[\\CHEMICAL] and clopidogrel.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "[GENE]P2Y12[\\GENE] has been shown to be the target of the thienopyridine drugs, ticlopidine and [CHEMICAL]clopidogrel[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent tyrosine kinase Pyk2, the non-receptor tyrosine kinase c-Src and the focal adhesion protein/[GENE]steroid receptor co-factor[\\GENE], Hic-5.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent tyrosine kinase Pyk2, the non-receptor tyrosine kinase c-Src and the focal adhesion protein/steroid receptor co-factor, [GENE]Hic-5[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent [GENE]tyrosine kinase[\\GENE] Pyk2, the non-receptor tyrosine kinase c-Src and the focal adhesion protein/steroid receptor co-factor, Hic-5.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent tyrosine kinase [GENE]Pyk2[\\GENE], the non-receptor tyrosine kinase c-Src and the focal adhesion protein/steroid receptor co-factor, Hic-5.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent tyrosine kinase Pyk2, the [GENE]non-receptor tyrosine kinase[\\GENE] c-Src and the focal adhesion protein/steroid receptor co-factor, Hic-5.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent tyrosine kinase Pyk2, the non-receptor tyrosine kinase [GENE]c-Src[\\GENE] and the focal adhesion protein/steroid receptor co-factor, Hic-5.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "This mechanism involves the [CHEMICAL]calcium[\\CHEMICAL]-dependent tyrosine kinase Pyk2, the non-receptor tyrosine kinase c-Src and the [GENE]focal adhesion protein[\\GENE]/steroid receptor co-factor, Hic-5.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "In response to [CHEMICAL]METH[\\CHEMICAL], AMPH, or POHA exposure, the accumulation of cAMP by HEK-293 cells stably expressing different species of [GENE]TAAR1[\\GENE] was concentration- and isomer-dependent.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "In response to METH, [CHEMICAL]AMPH[\\CHEMICAL], or POHA exposure, the accumulation of cAMP by HEK-293 cells stably expressing different species of [GENE]TAAR1[\\GENE] was concentration- and isomer-dependent.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "In response to METH, AMPH, or [CHEMICAL]POHA[\\CHEMICAL] exposure, the accumulation of cAMP by HEK-293 cells stably expressing different species of [GENE]TAAR1[\\GENE] was concentration- and isomer-dependent.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "[GENE]Trace amine-associated receptor 1[\\GENE] displays species-dependent stereoselectivity for isomers of methamphetamine, [CHEMICAL]amphetamine[\\CHEMICAL], and para-hydroxyamphetamine.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "[GENE]Trace amine-associated receptor 1[\\GENE] displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and [CHEMICAL]para-hydroxyamphetamine[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "[GENE]Trace amine-associated receptor 1[\\GENE] displays species-dependent stereoselectivity for isomers of [CHEMICAL]methamphetamine[\\CHEMICAL], amphetamine, and para-hydroxyamphetamine.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "EC50 values for [CHEMICAL]S-(+)-METH[\\CHEMICAL] were 0.89, 0.92, and 4.44 microM for [GENE]rTAAR1[\\GENE], mTAAR1, and h-rChTAAR1, respectively.",
        "label": 3,
        "major": -1,
        "len": 16
    },
    {
        "text": "EC50 values for [CHEMICAL]S-(+)-METH[\\CHEMICAL] were 0.89, 0.92, and 4.44 microM for rTAAR1, [GENE]mTAAR1[\\GENE], and h-rChTAAR1, respectively.",
        "label": 3,
        "major": -1,
        "len": 16
    },
    {
        "text": "EC50 values for [CHEMICAL]S-(+)-METH[\\CHEMICAL] were 0.89, 0.92, and 4.44 microM for rTAAR1, mTAAR1, and [GENE]h-rChTAAR1[\\GENE], respectively.",
        "label": 3,
        "major": -1,
        "len": 16
    },
    {
        "text": "Furthermore, because S-(+)-isomers of [CHEMICAL]METH[\\CHEMICAL] and AMPH are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of [GENE]TAAR1[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "Furthermore, because S-(+)-isomers of METH and [CHEMICAL]AMPH[\\CHEMICAL] are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of [GENE]TAAR1[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "The kinetic parameters for the [CHEMICAL]CO2[\\CHEMICAL] hydration reaction proved [GENE]hCA VI[\\GENE] to possess a kcat of 3.4 x 10(5) s-1 and kcat/KM of 4.9 x 10(7) M-1 s-1 (at pH 7.5 and 20 degrees C).",
        "label": 9,
        "major": -1,
        "len": 35
    },
    {
        "text": "These data define [CHEMICAL]PFD[\\CHEMICAL] or PFD-related agents as promising agents for human cancers associated with enhanced [GENE]TGF-beta[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "These data define PFD or [CHEMICAL]PFD[\\CHEMICAL]-related agents as promising agents for human cancers associated with enhanced [GENE]TGF-beta[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "We used immunofluorescence microscopy and [CHEMICAL]digitonin[\\CHEMICAL] permeabilization assays to determine the subcellular location of endogenous [GENE]BAAT[\\GENE] in primary human and rat hepatocytes.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Photolytic release of free [CHEMICAL]alanine[\\CHEMICAL] results in the generation of significant transient current components in HEK293 cells expressing the [GENE]ASCT2[\\GENE], SNAT1, and SNAT2 proteins.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Photolytic release of free [CHEMICAL]alanine[\\CHEMICAL] results in the generation of significant transient current components in HEK293 cells expressing the ASCT2, [GENE]SNAT1[\\GENE], and SNAT2 proteins.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Photolytic release of free [CHEMICAL]alanine[\\CHEMICAL] results in the generation of significant transient current components in HEK293 cells expressing the ASCT2, SNAT1, and [GENE]SNAT2[\\GENE] proteins.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "These data indicate that neuroprotection provided by [CHEMICAL]estrogen[\\CHEMICAL] against MPP(+) toxicity is mediated by [GENE]ERalpha[\\GENE] and involves an interplay among at least two cell types.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Using immunohistochemistry, the authors analyzed changes in [GENE]CREB[\\GENE] phosphorylation in the NAc after 5 days of [CHEMICAL]cocaine[\\CHEMICAL], a short or long drug-free period, and a subsequent challenge injection.",
        "label": 3,
        "major": -1,
        "len": 28
    },
    {
        "text": "The carboxylation of glutamic acid residues to [CHEMICAL]gamma-carboxyglutamic acid[\\CHEMICAL] (Gla) by the [GENE]vitamin K-dependent gamma-glutamyl carboxylase[\\GENE] (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The carboxylation of glutamic acid residues to [CHEMICAL]gamma-carboxyglutamic acid[\\CHEMICAL] (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase ([GENE]gamma-carboxylase[\\GENE]) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid ([CHEMICAL]Gla[\\CHEMICAL]) by the [GENE]vitamin K-dependent gamma-glutamyl carboxylase[\\GENE] (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid ([CHEMICAL]Gla[\\CHEMICAL]) by the vitamin K-dependent gamma-glutamyl carboxylase ([GENE]gamma-carboxylase[\\GENE]) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The carboxylation of [CHEMICAL]glutamic acid[\\CHEMICAL] residues to gamma-carboxyglutamic acid (Gla) by the [GENE]vitamin K-dependent gamma-glutamyl carboxylase[\\GENE] (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The carboxylation of [CHEMICAL]glutamic acid[\\CHEMICAL] residues to gamma-carboxyglutamic acid (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase ([GENE]gamma-carboxylase[\\GENE]) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "The 2.0-A resolution structure of [GENE]Thermus thermophilus PRODH[\\GENE] reveals a distorted (betaalpha)(8) barrel catalytic core domain and a hydrophobic alpha-helical domain located above the [CHEMICAL]carboxyl[\\CHEMICAL]-terminal ends of the strands of the barrel.",
        "label": 1,
        "major": -1,
        "len": 32
    },
    {
        "text": "The [GENE]phosphodiesterase (PDE) 4[\\GENE] is the predominant [CHEMICAL]cyclic AMP[\\CHEMICAL] degrading enzyme in a variety of inflammatory cells including eosinophils, neutrophils, macrophages, T cells and monocytes.",
        "label": 9,
        "major": -1,
        "len": 25
    },
    {
        "text": "For the isolated PKCalpha C2 domain in the presence of physiological Ca2+ levels, the target lipids [CHEMICAL]phosphatidylserine[\\CHEMICAL] (PS) and phosphatidylinositol-4,5-bisphosphate (PIP2) are together sufficient to recruit the [GENE]PKCalpha C2 domai[\\GENE]n to a lipid mixture mimicking the plasma membrane inner leaflet.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "For the isolated PKCalpha C2 domain in the presence of physiological Ca2+ levels, the target lipids phosphatidylserine ([CHEMICAL]PS[\\CHEMICAL]) and phosphatidylinositol-4,5-bisphosphate (PIP2) are together sufficient to recruit the [GENE]PKCalpha C2 domai[\\GENE]n to a lipid mixture mimicking the plasma membrane inner leaflet.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "For the isolated PKCalpha C2 domain in the presence of physiological Ca2+ levels, the target lipids phosphatidylserine (PS) and [CHEMICAL]phosphatidylinositol-4,5-bisphosphate[\\CHEMICAL] (PIP2) are together sufficient to recruit the [GENE]PKCalpha C2 domai[\\GENE]n to a lipid mixture mimicking the plasma membrane inner leaflet.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "For the isolated PKCalpha C2 domain in the presence of physiological Ca2+ levels, the target lipids phosphatidylserine (PS) and phosphatidylinositol-4,5-bisphosphate ([CHEMICAL]PIP2[\\CHEMICAL]) are together sufficient to recruit the [GENE]PKCalpha C2 domai[\\GENE]n to a lipid mixture mimicking the plasma membrane inner leaflet.",
        "label": 2,
        "major": -1,
        "len": 40
    },
    {
        "text": "Treatment with [CHEMICAL]rosiglitazone[\\CHEMICAL] or cholestyramine had no effect on [GENE]BAT[\\GENE] activity in any subcellular compartment.",
        "label": 10,
        "major": -1,
        "len": 15
    },
    {
        "text": "Treatment with rosiglitazone or [CHEMICAL]cholestyramine[\\CHEMICAL] had no effect on [GENE]BAT[\\GENE] activity in any subcellular compartment.",
        "label": 10,
        "major": -1,
        "len": 15
    },
    {
        "text": "Because of their low asparagine synthetase ([GENE]ASNS[\\GENE]) expression and [CHEMICAL]asparagine[\\CHEMICAL] biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Because of their low [GENE]asparagine synthetase[\\GENE] (ASNS) expression and [CHEMICAL]asparagine[\\CHEMICAL] biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Variants in the [GENE]IMPDH2[\\GENE] gene may account for the large inter-individual variability in baseline enzyme activity, immunosuppressive efficacy and side effects in transplant recipients receiving [CHEMICAL]mycophenolic acid[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Estrogen[\\CHEMICAL] protects against mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of [GENE]glutaredoxin[\\GENE] in the CNS.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "However, GlyT2 was more effective than GlyT1, probably because GlyT2 is unable to operate in the reverse mode, which gives it an advantage in maintaining the high cytosolic [CHEMICAL]glycine[\\CHEMICAL] concentration required for efficient vesicular loading by [GENE]VIAAT[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 37
    },
    {
        "text": "Consequently, other cation species may compete with [CHEMICAL]Na+[\\CHEMICAL] to regulate the time [GENE]KARs[\\GENE] remain in the open state.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Isothiocyanates[\\CHEMICAL], thought to be responsible for the chemopreventive properties of this food group, are conjugated to glutathione by [GENE]glutathione S-transferases[\\GENE] (GSTs) before urinary excretion.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Isothiocyanates[\\CHEMICAL], thought to be responsible for the chemopreventive properties of this food group, are conjugated to glutathione by glutathione S-transferases ([GENE]GSTs[\\GENE]) before urinary excretion.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[GENE]LTC4 synthase[\\GENE] (LTC4S), the pivotal enzyme for the biosynthesis of [CHEMICAL]LTC4[\\CHEMICAL] (ref.",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "LTC4 synthase ([GENE]LTC4S[\\GENE]), the pivotal enzyme for the biosynthesis of [CHEMICAL]LTC4[\\CHEMICAL] (ref.",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "Caution is necessary only when it is coadministered with drugs metabolised by [GENE]CYP2D6[\\GENE], such as [CHEMICAL]metoprolol[\\CHEMICAL], or administered to the elderly or patients with severe hepatic or renal impairment.",
        "label": 9,
        "major": -1,
        "len": 29
    },
    {
        "text": "The mRNA level of [GENE]AQP5[\\GENE] was scarcely affected by CTD and [CHEMICAL]cevimeline hydrochloride[\\CHEMICAL] administration.",
        "label": 10,
        "major": -1,
        "len": 14
    },
    {
        "text": "Identification of [CHEMICAL]N[\\CHEMICAL]-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, [GENE]adrenomedullin[\\GENE], and amylin receptor function.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "Identification of [CHEMICAL]N[\\CHEMICAL]-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and [GENE]amylin receptor[\\GENE] function.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "Identification of [CHEMICAL]N[\\CHEMICAL]-terminal receptor activity-modifying protein residues important for [GENE]calcitonin gene-related peptide[\\GENE], adrenomedullin, and amylin receptor function.",
        "label": 1,
        "major": -1,
        "len": 17
    },
    {
        "text": "Likewise, no [CHEMICAL]fatty acids[\\CHEMICAL] bound to [GENE]holo-alpha-lactalbumin[\\GENE], isolated using nondenaturing conditions, were detected by gas chromatography.",
        "label": 10,
        "major": -1,
        "len": 16
    },
    {
        "text": "Oxytocin (OT) and [CHEMICAL]vasopressin[\\CHEMICAL] (AVP) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP [GENE]V(1a)[\\GENE] (vasopressor), V(1b) (pituitary), V(2) (renal) receptors and a fifth putative AVP V(1c)?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and [CHEMICAL]vasopressin[\\CHEMICAL] (AVP) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), [GENE]V(1b)[\\GENE] (pituitary), V(2) (renal) receptors and a fifth putative AVP V(1c)?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and [CHEMICAL]vasopressin[\\CHEMICAL] (AVP) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), V(1b) (pituitary), [GENE]V(2)[\\GENE] (renal) receptors and a fifth putative AVP V(1c)?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and [CHEMICAL]vasopressin[\\CHEMICAL] (AVP) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), V(1b) (pituitary), V(2) (renal) receptors and a fifth putative AVP [GENE]V(1c)[\\GENE]?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and vasopressin ([CHEMICAL]AVP[\\CHEMICAL]) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP [GENE]V(1a)[\\GENE] (vasopressor), V(1b) (pituitary), V(2) (renal) receptors and a fifth putative AVP V(1c)?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and vasopressin ([CHEMICAL]AVP[\\CHEMICAL]) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), [GENE]V(1b)[\\GENE] (pituitary), V(2) (renal) receptors and a fifth putative AVP V(1c)?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and vasopressin ([CHEMICAL]AVP[\\CHEMICAL]) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), V(1b) (pituitary), [GENE]V(2)[\\GENE] (renal) receptors and a fifth putative AVP V(1c)?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Oxytocin (OT) and vasopressin ([CHEMICAL]AVP[\\CHEMICAL]) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), V(1b) (pituitary), V(2) (renal) receptors and a fifth putative AVP [GENE]V(1c)[\\GENE]?",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "It is approved by the FDA for use in combination with [CHEMICAL]capecitabine[\\CHEMICAL] for the treatment of [GENE]HER2[\\GENE]-positive MBC that has progressed with standard treatment.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "This study identified four clinically approved antihypertensive drugs ([CHEMICAL]efonidipine[\\CHEMICAL], felodipine, isradipine, and nitrendipine) as potent [GENE]T-channel[\\GENE] blockers (IC(50) < 3 microM).",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "This study identified four clinically approved antihypertensive drugs (efonidipine, [CHEMICAL]felodipine[\\CHEMICAL], isradipine, and nitrendipine) as potent [GENE]T-channel[\\GENE] blockers (IC(50) < 3 microM).",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, [CHEMICAL]isradipine[\\CHEMICAL], and nitrendipine) as potent [GENE]T-channel[\\GENE] blockers (IC(50) < 3 microM).",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and [CHEMICAL]nitrendipine[\\CHEMICAL]) as potent [GENE]T-channel[\\GENE] blockers (IC(50) < 3 microM).",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Chlorthalidone[\\CHEMICAL] bound within the [GENE]CA II[\\GENE] active site is in an enolic (lactimic) tautomeric form, with the enolic OH also participating in two strong hydrogen bonds with Asn67 and a water molecule.",
        "label": 2,
        "major": -1,
        "len": 32
    },
    {
        "text": "These data indicate that [CHEMICAL]sergliflozin etabonate[\\CHEMICAL] could improve glycemic control without its use resulting in [GENE]insulin[\\GENE] secretion, hypoglycemia, and body weight gain, and may provide a unique approach to the treatment of diabetes.",
        "label": 10,
        "major": -1,
        "len": 33
    },
    {
        "text": "The results lend support that [CHEMICAL](18)F-AV-45[\\CHEMICAL] may be a useful PET agent for detecting [GENE]Abeta[\\GENE] plaques in the living human brain.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL](E)-4-(2-(6-(2-(2-(2-(18)F-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methy l benzenamine[\\CHEMICAL] ((18)F-AV-45) is such as an agent currently in phase III clinical studies for PET of [GENE]Abeta[\\GENE] plaques in the brain.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "(E)-4-(2-(6-(2-(2-(2-(18)F-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methy l benzenamine ([CHEMICAL](18)F-AV-45[\\CHEMICAL]) is such as an agent currently in phase III clinical studies for PET of [GENE]Abeta[\\GENE] plaques in the brain.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Preclinical properties of [CHEMICAL]18F-AV-45[\\CHEMICAL]: a PET agent for [GENE]Abeta[\\GENE] plaques in the brain.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "[GENE]Alpha-2B adrenergic receptor[\\GENE] mediated hemodynamic profile of [CHEMICAL]etomidate[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 8
    },
    {
        "text": "[CHEMICAL]Cabozantinib[\\CHEMICAL] may provide clinical benefit by simultaneously targeting multiple pathways of importance in MTC, including [GENE]MET[\\GENE], VEGFR2, and RET.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Cabozantinib[\\CHEMICAL] may provide clinical benefit by simultaneously targeting multiple pathways of importance in MTC, including MET, [GENE]VEGFR2[\\GENE], and RET.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Cabozantinib[\\CHEMICAL] may provide clinical benefit by simultaneously targeting multiple pathways of importance in MTC, including MET, VEGFR2, and [GENE]RET[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including [GENE]Fnta[\\GENE], Pon1, Pparg, Aldh1b1, Apoa4, Abcg5, Gpam, Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, [GENE]Pon1[\\GENE], Pparg, Aldh1b1, Apoa4, Abcg5, Gpam, Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, [GENE]Pparg[\\GENE], Aldh1b1, Apoa4, Abcg5, Gpam, Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, [GENE]Aldh1b1[\\GENE], Apoa4, Abcg5, Gpam, Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, [GENE]Apoa4[\\GENE], Abcg5, Gpam, Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, Apoa4, [GENE]Abcg5[\\GENE], Gpam, Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, Apoa4, Abcg5, [GENE]Gpam[\\GENE], Acaca, Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, Apoa4, Abcg5, Gpam, [GENE]Acaca[\\GENE], Cd36, Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, Apoa4, Abcg5, Gpam, Acaca, [GENE]Cd36[\\GENE], Fdft1, and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, Apoa4, Abcg5, Gpam, Acaca, Cd36, [GENE]Fdft1[\\GENE], and Fasn, relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] supplementation altered expression profiles of several lipid metabolism-related genes, including Fnta, Pon1, Pparg, Aldh1b1, Apoa4, Abcg5, Gpam, Acaca, Cd36, Fdft1, and [GENE]Fasn[\\GENE], relative to those in HFD control mice.",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "These findings suggest that oral consumption of [CHEMICAL]nicotine[\\CHEMICAL] enhances the efficacy of [GENE]nicotinic acetylcholine receptors[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 15
    },
    {
        "text": "Overall, the present study, using a different and more sensitive statistical model than the parent study, revealed a statistically significant dose-dependent correlation between cumulative exposure to [CHEMICAL]Hg[\\CHEMICAL] from dental amalgams and urinary levels of [GENE]GST-\u03b1[\\GENE], after covariate adjustment; where as, a nonsignificant relationship was observed with urinary levels of GST-\u03c0.",
        "label": 2,
        "major": -1,
        "len": 50
    },
    {
        "text": "Overall, the present study, using a different and more sensitive statistical model than the parent study, revealed a statistically significant dose-dependent correlation between cumulative exposure to [CHEMICAL]Hg[\\CHEMICAL] from dental amalgams and urinary levels of GST-\u03b1, after covariate adjustment; where as, a nonsignificant relationship was observed with urinary levels of [GENE]GST-\u03c0[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 50
    },
    {
        "text": "It was hypothesized that because Hg accumulates in the proximal tubules (PTs), [GENE]glutathione-S-transferases (GST)-\u03b1[\\GENE] (suggestive of kidney damage at the level of PT) would be expected to be more related to [CHEMICAL]Hg[\\CHEMICAL] exposure than GST-\u03c0 (suggestive of kidney damage at the level of the distal tubules).",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "It was hypothesized that because Hg accumulates in the proximal tubules (PTs), glutathione-S-transferases (GST)-\u03b1 (suggestive of kidney damage at the level of PT) would be expected to be more related to [CHEMICAL]Hg[\\CHEMICAL] exposure than [GENE]GST-\u03c0[\\GENE] (suggestive of kidney damage at the level of the distal tubules).",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "Furthermore, elevations in blood neutrophil count, serum [GENE]monocyte chemoattractant protein-1[\\GENE], and other markers of inflammation corresponded to [CHEMICAL]GDC-0152[\\CHEMICAL] exposure and toxicity and thus may have utility as safety biomarkers.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Recent studies, however, have demonstrated a promising potential treatment option with the help of the serum enzyme [GENE]butyrylcholinesterase[\\GENE] (BChE), which is capable of breaking down naturally occurring [CHEMICAL](-)-cocaine[\\CHEMICAL] before the drug can influence the reward centers of the brain or affect other areas of the body.",
        "label": 9,
        "major": -1,
        "len": 46
    },
    {
        "text": "Recent studies, however, have demonstrated a promising potential treatment option with the help of the serum enzyme butyrylcholinesterase ([GENE]BChE[\\GENE]), which is capable of breaking down naturally occurring [CHEMICAL](-)-cocaine[\\CHEMICAL] before the drug can influence the reward centers of the brain or affect other areas of the body.",
        "label": 9,
        "major": -1,
        "len": 46
    },
    {
        "text": "This prompted the design of variants of [GENE]BChE[\\GENE] which exhibit significantly improved catalytic activity against [CHEMICAL](-)-cocaine[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "In an effort to understand the shedding process of AChE, we have used several pharmacological treatments, which showed that it is likely to be mediated in part by an EDTA- and batimastat-sensitive, but [CHEMICAL]GM6001[\\CHEMICAL]-insensitive [GENE]metalloprotease[\\GENE], with the possible additional involvement of a thiol isomerase.",
        "label": 10,
        "major": -1,
        "len": 44
    },
    {
        "text": "In an effort to understand the shedding process of [GENE]AChE[\\GENE], we have used several pharmacological treatments, which showed that it is likely to be mediated in part by an [CHEMICAL]EDTA[\\CHEMICAL]- and batimastat-sensitive, but GM6001-insensitive metalloprotease, with the possible additional involvement of a thiol isomerase.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "In an effort to understand the shedding process of [GENE]AChE[\\GENE], we have used several pharmacological treatments, which showed that it is likely to be mediated in part by an EDTA- and [CHEMICAL]batimastat[\\CHEMICAL]-sensitive, but GM6001-insensitive metalloprotease, with the possible additional involvement of a thiol isomerase.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "In an effort to understand the shedding process of AChE, we have used several pharmacological treatments, which showed that it is likely to be mediated in part by an EDTA- and [CHEMICAL]batimastat[\\CHEMICAL]-sensitive, but GM6001-insensitive [GENE]metalloprotease[\\GENE], with the possible additional involvement of a thiol isomerase.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Although acetylcholinesterase ([GENE]AChE[\\GENE]) is primarily a hydrolytic enzyme, metabolising the neurotransmitter [CHEMICAL]acetylcholine[\\CHEMICAL] in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "Although [GENE]acetylcholinesterase[\\GENE] (AChE) is primarily a hydrolytic enzyme, metabolising the neurotransmitter [CHEMICAL]acetylcholine[\\CHEMICAL] in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] unregulated [GENE]ELL[\\GENE] (eleven-nineteen lysine-rich leukaemia) 3 mRNA expression before F7 up-regulation.",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] unregulated ELL ([GENE]eleven-nineteen lysine-rich leukaemia) 3[\\GENE] mRNA expression before F7 up-regulation.",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] unregulated ELL (eleven-nineteen lysine-rich leukaemia) 3 mRNA expression before [GENE]F7[\\GENE] up-regulation.",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] also enhanced recruitment of [GENE]CDK9[\\GENE] (cyclin-dependent kinase 9) and AFF4 to F7.",
        "label": 3,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] also enhanced recruitment of CDK9 ([GENE]cyclin-dependent kinase 9[\\GENE]) and AFF4 to F7.",
        "label": 3,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] also enhanced recruitment of CDK9 (cyclin-dependent kinase 9) and [GENE]AFF4[\\GENE] to F7.",
        "label": 3,
        "major": -1,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Ribavirin[\\CHEMICAL] also enhanced recruitment of CDK9 (cyclin-dependent kinase 9) and AFF4 to [GENE]F7[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 13
    },
    {
        "text": "It was reported previously that [GENE]FVII[\\GENE] gene (F7) expression was up-regulated by [CHEMICAL]ribavirin[\\CHEMICAL] treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.",
        "label": 3,
        "major": -1,
        "len": 27
    },
    {
        "text": "It was reported previously that FVII gene ([GENE]F7[\\GENE]) expression was up-regulated by [CHEMICAL]ribavirin[\\CHEMICAL] treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.",
        "label": 3,
        "major": -1,
        "len": 27
    },
    {
        "text": "Using site-directed mutagenesis, we identified three serines (Ser833, [CHEMICAL]Ser[\\CHEMICAL]836, and Ser840) within the membrane proximal region of the [GENE]GluK5[\\GENE] C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and [CHEMICAL]Ser[\\CHEMICAL]840) within the membrane proximal region of the [GENE]GluK5[\\GENE] C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the [GENE]GluK5[\\GENE] [CHEMICAL]C[\\CHEMICAL]-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using site-directed mutagenesis, we identified three [CHEMICAL]serines[\\CHEMICAL] (Ser833, Ser836, and Ser840) within the membrane proximal region of the [GENE]GluK5[\\GENE] C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "Using site-directed mutagenesis, we identified three serines ([CHEMICAL]Ser[\\CHEMICAL]833, Ser836, and Ser840) within the membrane proximal region of the [GENE]GluK5[\\GENE] C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "However, recent evidence suggests that the action of [CHEMICAL]FTY720[\\CHEMICAL] involves [GENE]S1PRs[\\GENE] expressed by cells resident in the CNS, including neurons.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]GHRP-6[\\CHEMICAL] is a [GENE]growth hormone[\\GENE] secretagogue that also enhances tissue viability in different organs.",
        "label": 3,
        "major": -1,
        "len": 14
    },
    {
        "text": "Cultured rat DRG neurons endogenously expressed [GENE]rCtr1[\\GENE] protein on their neuronal cell body plasma membranes and cytoplasm, and displayed substantial capacity for taking up [CHEMICAL]copper[\\CHEMICAL], but were resistant to copper toxicity.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Contributions of [GENE]rat Ctr1[\\GENE] to the uptake and toxicity of [CHEMICAL]copper[\\CHEMICAL] and platinum anticancer drugs in dorsal root ganglion neurons.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "Contributions of [GENE]rat Ctr1[\\GENE] to the uptake and toxicity of copper and [CHEMICAL]platinum[\\CHEMICAL] anticancer drugs in dorsal root ganglion neurons.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "The two subtypes of [GENE]mammalian G protein-coupled melatonin receptors[\\GENE] are primarily responsible for mediating the actions of [CHEMICAL]melatonin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "In sum, identification of [GENE]PIM-1[\\GENE] as an ER\u03b1 target gene adds a novel potential mechanism by which [CHEMICAL]estrogens[\\CHEMICAL] can contribute to breast cancer cell proliferation and carcinogenesis.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "In sum, identification of PIM-1 as an [GENE]ER\u03b1[\\GENE] target gene adds a novel potential mechanism by which [CHEMICAL]estrogens[\\CHEMICAL] can contribute to breast cancer cell proliferation and carcinogenesis.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "In contrast, [CHEMICAL]flunisolide[\\CHEMICAL] was only metabolized via CYP3A4, with no significant turnover by [GENE]CYP3A5[\\GENE] or CYP3A7.",
        "label": 10,
        "major": -1,
        "len": 16
    },
    {
        "text": "In contrast, [CHEMICAL]flunisolide[\\CHEMICAL] was only metabolized via CYP3A4, with no significant turnover by CYP3A5 or [GENE]CYP3A7[\\GENE].",
        "label": 10,
        "major": -1,
        "len": 16
    },
    {
        "text": "In this work, the metabolism of four frequently prescribed inhaled GCs, [CHEMICAL]triamcinolone acetonide[\\CHEMICAL], flunisolide, budesonide, and fluticasone propionate, by the [GENE]CYP3A[\\GENE] family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "label": 9,
        "major": -1,
        "len": 39
    },
    {
        "text": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, [CHEMICAL]flunisolide[\\CHEMICAL], budesonide, and fluticasone propionate, by the [GENE]CYP3A[\\GENE] family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "label": 9,
        "major": -1,
        "len": 39
    },
    {
        "text": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, [CHEMICAL]budesonide[\\CHEMICAL], and fluticasone propionate, by the [GENE]CYP3A[\\GENE] family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "label": 9,
        "major": -1,
        "len": 39
    },
    {
        "text": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and [CHEMICAL]fluticasone propionate[\\CHEMICAL], by the [GENE]CYP3A[\\GENE] family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "label": 9,
        "major": -1,
        "len": 39
    },
    {
        "text": "[GENE]CYP3A5[\\GENE], which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize [CHEMICAL]triamcinolone acetonide[\\CHEMICAL], budesonide, and fluticasone propionate.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]CYP3A5[\\GENE], which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, [CHEMICAL]budesonide[\\CHEMICAL], and fluticasone propionate.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]CYP3A5[\\GENE], which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, budesonide, and [CHEMICAL]fluticasone propionate[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "In contrast, [CHEMICAL]flunisolide[\\CHEMICAL] was only metabolized via [GENE]CYP3A4[\\GENE], with no significant turnover by CYP3A5 or CYP3A7.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]NAC[\\CHEMICAL] also suppressed the p-[GENE]JNK[\\GENE] and p-p38, but failed to reverse the effects of ISO.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]NAC[\\CHEMICAL] also suppressed the p-JNK and [GENE]p-p38[\\GENE], but failed to reverse the effects of ISO.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "Here, we show that [GENE]rTRPV1[\\GENE], rTRPV2, rTRPV3, and mTRPV4, as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, [GENE]rTRPV2[\\GENE], rTRPV3, and mTRPV4, as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, [GENE]rTRPV3[\\GENE], and mTRPV4, as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, rTRPV3, and [GENE]mTRPV4[\\GENE], as well as hTRPM8, and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, rTRPV3, and mTRPV4, as well as [GENE]hTRPM8[\\GENE], and rTRPM3, which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we show that rTRPV1, rTRPV2, rTRPV3, and mTRPV4, as well as hTRPM8, and [GENE]rTRPM3[\\GENE], which are expressed in dorsal root ganglion neurons, are insensitive toward [CHEMICAL]apomorphine[\\CHEMICAL] treatment.",
        "label": 10,
        "major": -1,
        "len": 28
    },
    {
        "text": "Previous report demonstrated that [CHEMICAL]thyroid hormone[\\CHEMICAL] (TH) negatively regulates [GENE]mouse SCD-1 gene promoter[\\GENE] before SREBP-1c was revealed.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "Exchange of domains between the two isoforms indicates that the C1b domain and the [CHEMICAL]N[\\CHEMICAL]-terminus of the [GENE]C1a domain[\\GENE] are important for directing selective regulation of AC7 by the G(13) pathway.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "Regulation of multiple [GENE]adenylyl cyclases[\\GENE] (AC) provides unique inputs to mediate the synthesis of [CHEMICAL]cAMP[\\CHEMICAL], a ubiquitous second messenger that controls many aspects of cellular function.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Regulation of multiple adenylyl cyclases ([GENE]AC[\\GENE]) provides unique inputs to mediate the synthesis of [CHEMICAL]cAMP[\\CHEMICAL], a ubiquitous second messenger that controls many aspects of cellular function.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "During base excision repair of this mispair, [GENE]DNA polymerase (pol) \u03b2[\\GENE] is confronted with gap filling opposite [CHEMICAL]8-oxoG[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Structural studies with [GENE]R283K[\\GENE] pol \u03b2 show that the binary DNA complex has [CHEMICAL]8-oxoG[\\CHEMICAL] in equilibrium between anti- and syn-forms.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Structural studies with R283K [GENE]pol \u03b2[\\GENE] show that the binary DNA complex has [CHEMICAL]8-oxoG[\\CHEMICAL] in equilibrium between anti- and syn-forms.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "These results suggest that [CHEMICAL]ganglioside[\\CHEMICAL]-bound [GENE]A\u03b2[\\GENE] (GA\u03b2), which acts as an endogenous seed for A\u03b2 fibril formation in AD brains, is generated on ASIGN on synaptosomal membranes.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "These results suggest that [CHEMICAL]ganglioside[\\CHEMICAL]-bound A\u03b2 (G[GENE]A\u03b2[\\GENE]), which acts as an endogenous seed for A\u03b2 fibril formation in AD brains, is generated on ASIGN on synaptosomal membranes.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Tamoxifen[\\CHEMICAL] represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating [GENE]c-Myc[\\GENE] in endometrial carcinoma cell lines.",
        "label": 3,
        "major": -1,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Tamoxifen[\\CHEMICAL] represses [GENE]miR-200[\\GENE] microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines.",
        "label": 4,
        "major": -1,
        "len": 16
    },
    {
        "text": "Methylation of [GENE]histone H3[\\GENE] on [CHEMICAL]lysine[\\CHEMICAL] 4 by the lysine methyltransferase SET1 protein is needed for normal clock gene expression.",
        "label": 1,
        "major": -1,
        "len": 20
    },
    {
        "text": "A., Ventura, F. V., Houten, S. M. [GENE]Carnitine palmitoyltransferase 2[\\GENE] and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of [CHEMICAL]acylcarnitines[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "A., Ventura, F. V., Houten, S. M. Carnitine palmitoyltransferase 2 and [GENE]carnitine/acylcarnitine translocase[\\GENE] are involved in the mitochondrial synthesis and export of [CHEMICAL]acylcarnitines[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]Carnitine palmitoyltransferase 2[\\GENE] and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of [CHEMICAL]acylcarnitines[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Carnitine palmitoyltransferase 2 and [GENE]carnitine/acylcarnitine translocase[\\GENE] are involved in the mitochondrial synthesis and export of [CHEMICAL]acylcarnitines[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "This shows that [GENE]CPT2[\\GENE] and CACT are crucial for mitochondrial [CHEMICAL]acylcarnitine[\\CHEMICAL] formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R. J.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "This shows that CPT2 and [GENE]CACT[\\GENE] are crucial for mitochondrial [CHEMICAL]acylcarnitine[\\CHEMICAL] formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R. J.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Almorexant[\\CHEMICAL] effects on [GENE]CYP3A4[\\GENE] activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of [GENE]CYP1A2[\\GENE], CYP2C9, CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: [CHEMICAL]caffeine[\\CHEMICAL], chlorzoxazone, tolbutamide, metoprolol and midazolam, respectively.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, [GENE]CYP2C9[\\GENE], CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, [CHEMICAL]chlorzoxazone[\\CHEMICAL], tolbutamide, metoprolol and midazolam, respectively.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, [GENE]CYP2E1[\\GENE], CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, [CHEMICAL]tolbutamide[\\CHEMICAL], metoprolol and midazolam, respectively.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, [GENE]CYP2D6[\\GENE] and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, [CHEMICAL]metoprolol[\\CHEMICAL] and midazolam, respectively.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, CYP2D6 and [GENE]CYP3A4[\\GENE], which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, metoprolol and [CHEMICAL]midazolam[\\CHEMICAL], respectively.",
        "label": 2,
        "major": -1,
        "len": 44
    },
    {
        "text": "Similarly, mature [GENE]BMP-2[\\GENE] was also cleaved to a truncated peptide within its [CHEMICAL]N[\\CHEMICAL]-terminal region (Arg(289)\u2193Lys(290)).",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "Similarly, mature [GENE]BMP-2[\\GENE] was also cleaved to a truncated peptide within its N-terminal region ([CHEMICAL]Arg[\\CHEMICAL](289)\u2193Lys(290)).",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "Similarly, mature [GENE]BMP-2[\\GENE] was also cleaved to a truncated peptide within its N-terminal region (Arg(289)\u2193[CHEMICAL]Lys[\\CHEMICAL](290)).",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "Evidence also outlines a role for [GENE]oxytocin[\\GENE] in the prosocial effects of [CHEMICAL]3,4-methylenedioxymethamphetamine[\\CHEMICAL] (MDMA, Ecstasy) in both rodents and humans.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Evidence also outlines a role for [GENE]oxytocin[\\GENE] in the prosocial effects of 3,4-methylenedioxymethamphetamine ([CHEMICAL]MDMA[\\CHEMICAL], Ecstasy) in both rodents and humans.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Evidence also outlines a role for [GENE]oxytocin[\\GENE] in the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA, [CHEMICAL]Ecstasy[\\CHEMICAL]) in both rodents and humans.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Clinical trials should now investigate the effectiveness of [GENE]oxytocin[\\GENE] as a novel intervention for psychostimulant addiction and should aim to determine its specific role in the therapeutic properties of [CHEMICAL]MDMA[\\CHEMICAL] that are currently being investigated.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "The myosin-18A\u03b1 isoform, additionally, has an [CHEMICAL]N[\\CHEMICAL]-terminal [GENE]PDZ domain[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 9
    },
    {
        "text": "We apply DFTB in a QM/MM framework to perform vibrational analysis of buried [CHEMICAL]aspartic acids[\\CHEMICAL] in [GENE]bacteriorhodopsin[\\GENE] and channelrhodopsin-2.",
        "label": 1,
        "major": -1,
        "len": 19
    },
    {
        "text": "We apply DFTB in a QM/MM framework to perform vibrational analysis of buried [CHEMICAL]aspartic acids[\\CHEMICAL] in bacteriorhodopsin and [GENE]channelrhodopsin-2[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 19
    },
    {
        "text": "The normal 46,XY genital virilization depends on androgen receptor gene expression, which is tissue specific, and requires normal [GENE]androgen receptor[\\GENE] mRNA levels in [CHEMICAL]androgen[\\CHEMICAL] sensitive tissues.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Androgen[\\CHEMICAL] action is exerted through the [GENE]androgen receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 8
    },
    {
        "text": "Dexamethasone suppressed IL-11 gene transcription enhanced by PTH(1-34) without affecting \u0394FosB expression or Smad1 phosphorylation, and [CHEMICAL]dexamethasone[\\CHEMICAL]-[GENE]GC receptor[\\GENE] complex was bound to JunD, which forms heterodimers with \u0394FosB.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "Dexamethasone suppressed IL-11 gene transcription enhanced by PTH(1-34) without affecting \u0394FosB expression or Smad1 phosphorylation, and [CHEMICAL]dexamethasone[\\CHEMICAL]-GC receptor complex was bound to [GENE]JunD[\\GENE], which forms heterodimers with \u0394FosB.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "Dexamethasone suppressed IL-11 gene transcription enhanced by PTH(1-34) without affecting \u0394FosB expression or Smad1 phosphorylation, and [CHEMICAL]dexamethasone[\\CHEMICAL]-GC receptor complex was bound to JunD, which forms heterodimers with [GENE]\u0394FosB[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "[CHEMICAL]Dexamethasone[\\CHEMICAL] suppressed [GENE]IL-11[\\GENE] gene transcription enhanced by PTH(1-34) without affecting \u0394FosB expression or Smad1 phosphorylation, and dexamethasone-GC receptor complex was bound to JunD, which forms heterodimers with \u0394FosB.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "Number and area of preneoplastic foci positive for [GENE]glutathione S-transferase placental form[\\GENE] (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with [CHEMICAL]HEP[\\CHEMICAL] or HCB alone.",
        "label": 3,
        "major": -1,
        "len": 34
    },
    {
        "text": "Number and area of preneoplastic foci positive for glutathione S-transferase placental form ([GENE]GST-P[\\GENE]) were consistently higher in these groups than the sum of individual values in the groups treated with [CHEMICAL]HEP[\\CHEMICAL] or HCB alone.",
        "label": 3,
        "major": -1,
        "len": 34
    },
    {
        "text": "Number and area of preneoplastic foci positive for [GENE]glutathione S-transferase placental form[\\GENE] (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or [CHEMICAL]HCB[\\CHEMICAL] alone.",
        "label": 3,
        "major": -1,
        "len": 34
    },
    {
        "text": "Number and area of preneoplastic foci positive for glutathione S-transferase placental form ([GENE]GST-P[\\GENE]) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or [CHEMICAL]HCB[\\CHEMICAL] alone.",
        "label": 3,
        "major": -1,
        "len": 34
    },
    {
        "text": "On the basis of these findings, we conclude that [CHEMICAL]HEP[\\CHEMICAL] and HCB have additive and synergistic effects on the development of [GENE]GST-P[\\GENE]-positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides.",
        "label": 3,
        "major": -1,
        "len": 44
    },
    {
        "text": "On the basis of these findings, we conclude that HEP and [CHEMICAL]HCB[\\CHEMICAL] have additive and synergistic effects on the development of [GENE]GST-P[\\GENE]-positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides.",
        "label": 3,
        "major": -1,
        "len": 44
    },
    {
        "text": "Moreover, [CHEMICAL]Paeoniflorin[\\CHEMICAL] promoted the nuclear translocation of [GENE]nuclear factor erythroid 2 related factor-2[\\GENE] (Nrf-2).",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Moreover, [CHEMICAL]Paeoniflorin[\\CHEMICAL] promoted the nuclear translocation of nuclear factor erythroid 2 related factor-2 ([GENE]Nrf-2[\\GENE]).",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "In conclusion, [CHEMICAL]BPA[\\CHEMICAL] has adverse effects on phosphorylation of Akt, [GENE]GLUT4[\\GENE] translocation and (14)C-glucose oxidation.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "In conclusion, [CHEMICAL]BPA[\\CHEMICAL] has adverse effects on phosphorylation of [GENE]Akt[\\GENE], GLUT4 translocation and (14)C-glucose oxidation.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "Cerebrovascular Dilation via Selective Targeting of the [CHEMICAL]Cholane[\\CHEMICAL] Steroid-Recognition Site in the [GENE]BK Channel \u03b21-Subunit[\\GENE] by a Novel Nonsteroidal Agent.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Cerebrovascular Dilation via Selective Targeting of the Cholane [CHEMICAL]Steroid[\\CHEMICAL]-Recognition Site in the [GENE]BK Channel \u03b21-Subunit[\\GENE] by a Novel Nonsteroidal Agent.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Finally, carotid artery-infusion of [CHEMICAL]HENA[\\CHEMICAL] (45 \u03bcM) dilated the pial cerebral arterioles via selective [GENE]BK-channel[\\GENE] targeting.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "HENA failed to dilate the arteries from the KCNMB1 knockout mouse, underscoring [GENE]BK \u03b21[\\GENE]'s role in [CHEMICAL]HENA[\\CHEMICAL] action.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "This methodology was subsequently used to assess the relative contribution of [GENE]OATP1B1[\\GENE] uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), [CHEMICAL]pitavastatin[\\CHEMICAL] (84%-98%) and lopinavir (64%-89%).",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "This methodology was subsequently used to assess the relative contribution of [GENE]OATP1B1[\\GENE] uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), pitavastatin (84%-98%) and [CHEMICAL]lopinavir[\\CHEMICAL] (64%-89%).",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "This methodology was subsequently used to assess the relative contribution of [GENE]OATP1B1[\\GENE] uptake in human hepatocytes for [CHEMICAL]olmesartan[\\CHEMICAL] (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), pitavastatin (84%-98%) and lopinavir (64%-89%).",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "This methodology was subsequently used to assess the relative contribution of [GENE]OATP1B1[\\GENE] uptake in human hepatocytes for olmesartan (42%-62%), [CHEMICAL]valsartan[\\CHEMICAL] (28%-81%), rosuvastatin (64%-72%), pitavastatin (84%-98%) and lopinavir (64%-89%).",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "This methodology was subsequently used to assess the relative contribution of [GENE]OATP1B1[\\GENE] uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), [CHEMICAL]rosuvastatin[\\CHEMICAL] (64%-72%), pitavastatin (84%-98%) and lopinavir (64%-89%).",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "Plasma glucose, active [GENE]GLP-1[\\GENE] (7-36) amide concentration and insulin levels were measured after [CHEMICAL]glucose[\\CHEMICAL] loading.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Plasma glucose, active GLP-1 (7-36) amide concentration and [GENE]insulin[\\GENE] levels were measured after [CHEMICAL]glucose[\\CHEMICAL] loading.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Moreover, limited cleavage of SNAP-25 was conferred onto the protease from BoNT/E when fused to the [CHEMICAL]N[\\CHEMICAL]-terminus of [GENE]BoNT/A[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Tetrodotoxin[\\CHEMICAL]-sensitive spontaneous cholinergic neurotransmission was blocked >80% by 1\u00a0pM BoNT/A despite cleaving <20% of the [GENE]SNAP-25[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "GTLE pretreatment completely reversed the damaging effects of [CHEMICAL]AlCl3[\\CHEMICAL] on AA and [GENE]superoxide dismutase[\\GENE] activity, markedly corrected COX and AChE activities, and moderately improved TGC.",
        "label": 4,
        "major": -1,
        "len": 25
    },
    {
        "text": "GTLE pretreatment completely reversed the damaging effects of [CHEMICAL]AlCl3[\\CHEMICAL] on AA and superoxide dismutase activity, markedly corrected [GENE]COX[\\GENE] and AChE activities, and moderately improved TGC.",
        "label": 4,
        "major": -1,
        "len": 25
    },
    {
        "text": "GTLE pretreatment completely reversed the damaging effects of [CHEMICAL]AlCl3[\\CHEMICAL] on AA and superoxide dismutase activity, markedly corrected COX and [GENE]AChE[\\GENE] activities, and moderately improved TGC.",
        "label": 4,
        "major": -1,
        "len": 25
    },
    {
        "text": "Here, we report the first crystal structure of [GENE]KIF4[\\GENE] complexed with the non-hydrolyzable [CHEMICAL]ATP[\\CHEMICAL] analog, AMPPNP (adenylyl imidodiphosphate), at 1.7\u00c5 resolution.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Here, we report the first crystal structure of [GENE]KIF4[\\GENE] complexed with the non-hydrolyzable ATP analog, [CHEMICAL]AMPPNP[\\CHEMICAL] (adenylyl imidodiphosphate), at 1.7\u00c5 resolution.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Here, we report the first crystal structure of [GENE]KIF4[\\GENE] complexed with the non-hydrolyzable ATP analog, AMPPNP ([CHEMICAL]adenylyl imidodiphosphate[\\CHEMICAL]), at 1.7\u00c5 resolution.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Studies mainly in osteoporosis rodent models and limited data in postmenopausal women suggest that [CHEMICAL]N[\\CHEMICAL]-terminal [GENE]PTHrP[\\GENE] peptides might be considered a promising bone anabolic therapy.",
        "label": 1,
        "major": -1,
        "len": 25
    },
    {
        "text": "These studies show that [GENE]CYP3A4[\\GENE] and CYP3A5 metabolize [CHEMICAL]BDP[\\CHEMICAL] to inactive metabolites and suggest that differences in the expression or function of these enzymes in the lung and/or liver could influence BDP disposition in humans.",
        "label": 9,
        "major": -1,
        "len": 35
    },
    {
        "text": "These studies show that CYP3A4 and [GENE]CYP3A5[\\GENE] metabolize [CHEMICAL]BDP[\\CHEMICAL] to inactive metabolites and suggest that differences in the expression or function of these enzymes in the lung and/or liver could influence BDP disposition in humans.",
        "label": 9,
        "major": -1,
        "len": 35
    },
    {
        "text": "It is possible that variations in [GENE]cytochrome P450 3A[\\GENE] enzyme-mediated metabolism of [CHEMICAL]BDP[\\CHEMICAL] may contribute to this phenomenon.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "This hypothesis was explored by evaluating the contributions of CYP3A4, 3A5, 3A7, and [GENE]esterase[\\GENE] enzymes in the metabolism of [CHEMICAL]BDP[\\CHEMICAL] in vitro and relating metabolism to changes in CYP3A enzyme mRNA expression via the glucocorticoid receptor in lung and liver cells.",
        "label": 9,
        "major": -1,
        "len": 41
    },
    {
        "text": "Metabolism of [CHEMICAL]Beclomethasone Dipropionate[\\CHEMICAL] by [GENE]Cytochrome P450 3A[\\GENE] Enzymes.",
        "label": 9,
        "major": -1,
        "len": 9
    },
    {
        "text": "Genomic variation in the [GENE]MAP3K5[\\GENE] gene is associated with \u03b2-thalassemia disease severity and [CHEMICAL]hydroxyurea[\\CHEMICAL] treatment efficacy.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Enhancement of [GENE]GLUT4[\\GENE] expression by [CHEMICAL]fisetin[\\CHEMICAL] was further confirmed in differentiated 3T3-L1 adipocytes.",
        "label": 3,
        "major": -1,
        "len": 13
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 ([CHEMICAL]VU0467903[\\CHEMICAL]), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent [GENE]mAChR[\\GENE] selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 2,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, [CHEMICAL]ML326[\\CHEMICAL] (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent [GENE]mAChR[\\GENE] selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 2,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar [GENE]M5[\\GENE] PAM, ML326 ([CHEMICAL]VU0467903[\\CHEMICAL]), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 ([CHEMICAL]VU0467903[\\CHEMICAL]), (human and rat [GENE]M5[\\GENE] EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "This Letter describes the further chemical optimization of the [GENE]M5[\\GENE] PAM MLPCN probes [CHEMICAL]ML129[\\CHEMICAL] and ML172.",
        "label": 7,
        "major": -1,
        "len": 16
    },
    {
        "text": "This Letter describes the further chemical optimization of the [GENE]M5[\\GENE] PAM MLPCN probes ML129 and [CHEMICAL]ML172[\\CHEMICAL].",
        "label": 7,
        "major": -1,
        "len": 16
    },
    {
        "text": "Discovery of [CHEMICAL]ML326[\\CHEMICAL]: The first sub-micromolar, selective [GENE]M5[\\GENE] PAM.",
        "label": 7,
        "major": -1,
        "len": 9
    },
    {
        "text": "An HTS campaign identified several weak M5 PAMs ([GENE]M5[\\GENE] EC50 >10\u03bcM) with a structurally related [CHEMICAL]isatin[\\CHEMICAL] core that possessed a southern phenethyl ether linkage.",
        "label": 7,
        "major": -1,
        "len": 24
    },
    {
        "text": "An HTS campaign identified several weak M5 PAMs ([GENE]M5[\\GENE] EC50 >10\u03bcM) with a structurally related isatin core that possessed a southern [CHEMICAL]phenethyl ether[\\CHEMICAL] linkage.",
        "label": 7,
        "major": -1,
        "len": 24
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the [CHEMICAL]phenethyl ether[\\CHEMICAL] linkage onto the ML129/ML172 cores led to the first sub-micromolar [GENE]M5[\\GENE] PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the [CHEMICAL]ML129[\\CHEMICAL]/ML172 cores led to the first sub-micromolar [GENE]M5[\\GENE] PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/[CHEMICAL]ML172[\\CHEMICAL] cores led to the first sub-micromolar [GENE]M5[\\GENE] PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar [GENE]M5[\\GENE] PAM, [CHEMICAL]ML326[\\CHEMICAL] (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, [CHEMICAL]ML326[\\CHEMICAL] (VU0467903), (human and rat [GENE]M5[\\GENE] EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30\u03bcM) and a robust 20-fold leftward shift of the ACh CRC.",
        "label": 7,
        "major": -1,
        "len": 59
    },
    {
        "text": "Meanwhile, the alterations of cyclin A and B1, [GENE]p-CDK1[\\GENE] and p-cdc25c levels were also observed in response to [CHEMICAL]DICO[\\CHEMICAL] treatment.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Meanwhile, the alterations of cyclin A and B1, p-CDK1 and [GENE]p-cdc25c[\\GENE] levels were also observed in response to [CHEMICAL]DICO[\\CHEMICAL] treatment.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]S[\\CHEMICAL]-nitrosation of [GENE]glutathione transferase P1-1[\\GENE] is controlled by the conformation of a dynamic active-site helix.",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "C47 of [GENE]GSTP1-1[\\GENE] is [CHEMICAL]S[\\CHEMICAL]-nitrosated in two steps, with the chemical step limited by a pre-equilibrium between the open and closed conformations of helix \u03b12 at the active site.",
        "label": 1,
        "major": -1,
        "len": 29
    },
    {
        "text": "[GENE]Cytochrome P450 2E1[\\GENE] (CYP 450 2E1), activity was determined as hydroxylation of [CHEMICAL]aniline[\\CHEMICAL] in liver microsomes.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "Cytochrome P450 2E1 ([GENE]CYP 450 2E1[\\GENE]), activity was determined as hydroxylation of [CHEMICAL]aniline[\\CHEMICAL] in liver microsomes.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory [GENE]interleukins[\\GENE], IL-6 and IL-8, caused by a mixture of [CHEMICAL]oxysterols[\\CHEMICAL] representative of a high cholesterol diet.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, [GENE]IL-6[\\GENE] and IL-8, caused by a mixture of [CHEMICAL]oxysterols[\\CHEMICAL] representative of a high cholesterol diet.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and [GENE]IL-8[\\GENE], caused by a mixture of [CHEMICAL]oxysterols[\\CHEMICAL] representative of a high cholesterol diet.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory [GENE]interleukins[\\GENE], IL-6 and IL-8, caused by a mixture of oxysterols representative of a high [CHEMICAL]cholesterol[\\CHEMICAL] diet.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, [GENE]IL-6[\\GENE] and IL-8, caused by a mixture of oxysterols representative of a high [CHEMICAL]cholesterol[\\CHEMICAL] diet.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and [GENE]IL-8[\\GENE], caused by a mixture of oxysterols representative of a high [CHEMICAL]cholesterol[\\CHEMICAL] diet.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the African-American cohort, after excluding Y186C carriers, homozygous carriers of [GENE]C29R[\\GENE] showed 27% higher DPD activity as compared with noncarriers (609\u2009\u00b1\u2009152 and 480\u2009\u00b1\u2009152 pmol [CHEMICAL]5-FU[\\CHEMICAL] min(-1) mg(-1), respectively; P = 0.013).Clinical Pharmacology & Therapeutics (2013); advance online publication 1 May 2013. doi:10.1038/clpt.2013.69.",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "In the African-American cohort, after excluding Y186C carriers, homozygous carriers of C29R showed 27% higher [GENE]DPD[\\GENE] activity as compared with noncarriers (609\u2009\u00b1\u2009152 and 480\u2009\u00b1\u2009152 pmol [CHEMICAL]5-FU[\\CHEMICAL] min(-1) mg(-1), respectively; P = 0.013).Clinical Pharmacology & Therapeutics (2013); advance online publication 1 May 2013. doi:10.1038/clpt.2013.69.",
        "label": 2,
        "major": -1,
        "len": 43
    },
    {
        "text": "The responses to [CHEMICAL]5-FU[\\CHEMICAL], with respect to both toxicity and efficacy, vary among racial groups, potentially because of variability in the activity levels of the enzyme [GENE]dihydropyrimidine dehydrogenase[\\GENE] (DPD, encoded by the DPYD gene).",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The responses to [CHEMICAL]5-FU[\\CHEMICAL], with respect to both toxicity and efficacy, vary among racial groups, potentially because of variability in the activity levels of the enzyme dihydropyrimidine dehydrogenase ([GENE]DPD[\\GENE], encoded by the DPYD gene).",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The responses to [CHEMICAL]5-FU[\\CHEMICAL], with respect to both toxicity and efficacy, vary among racial groups, potentially because of variability in the activity levels of the enzyme dihydropyrimidine dehydrogenase (DPD, encoded by the [GENE]DPYD[\\GENE] gene).",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The [GENE]DPYD[\\GENE]-Y186C variant was unique to individuals of African ancestry, and DPD activity was 46% lower in carriers as compared with noncarriers (279\u2009\u00b1\u200935 vs. 514\u2009\u00b1\u2009168 pmol [CHEMICAL]5-FU[\\CHEMICAL] min(-1) mg(-1); P = 0.00029).",
        "label": 2,
        "major": -1,
        "len": 32
    },
    {
        "text": "The DPYD-[GENE]Y186C[\\GENE] variant was unique to individuals of African ancestry, and DPD activity was 46% lower in carriers as compared with noncarriers (279\u2009\u00b1\u200935 vs. 514\u2009\u00b1\u2009168 pmol [CHEMICAL]5-FU[\\CHEMICAL] min(-1) mg(-1); P = 0.00029).",
        "label": 2,
        "major": -1,
        "len": 32
    },
    {
        "text": "The DPYD-Y186C variant was unique to individuals of African ancestry, and [GENE]DPD[\\GENE] activity was 46% lower in carriers as compared with noncarriers (279\u2009\u00b1\u200935 vs. 514\u2009\u00b1\u2009168 pmol [CHEMICAL]5-FU[\\CHEMICAL] min(-1) mg(-1); P = 0.00029).",
        "label": 2,
        "major": -1,
        "len": 32
    },
    {
        "text": "[CHEMICAL]Arsenic[\\CHEMICAL] deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of [GENE]p62[\\GENE], Keap1, and LC3.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Arsenic[\\CHEMICAL] deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of p62, [GENE]Keap1[\\GENE], and LC3.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Arsenic[\\CHEMICAL] deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of p62, Keap1, and [GENE]LC3[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]UGT2B10[\\GENE] was inactive in the glucuronidation of [CHEMICAL]desipramine[\\CHEMICAL], nortriptyline, carbamazepine and afloqualone.",
        "label": 10,
        "major": -1,
        "len": 12
    },
    {
        "text": "[GENE]UGT2B10[\\GENE] was inactive in the glucuronidation of desipramine, [CHEMICAL]nortriptyline[\\CHEMICAL], carbamazepine and afloqualone.",
        "label": 10,
        "major": -1,
        "len": 12
    },
    {
        "text": "[GENE]UGT2B10[\\GENE] was inactive in the glucuronidation of desipramine, nortriptyline, [CHEMICAL]carbamazepine[\\CHEMICAL] and afloqualone.",
        "label": 10,
        "major": -1,
        "len": 12
    },
    {
        "text": "[GENE]UGT2B10[\\GENE] was inactive in the glucuronidation of desipramine, nortriptyline, carbamazepine and [CHEMICAL]afloqualone[\\CHEMICAL].",
        "label": 10,
        "major": -1,
        "len": 12
    },
    {
        "text": "This group of drugs contains [CHEMICAL]secondary or primary amines[\\CHEMICAL], and these results suggest that [GENE]UGT2B10[\\GENE] preferably conjugates tertiary amines.",
        "label": 10,
        "major": -1,
        "len": 19
    },
    {
        "text": "This group of drugs contains secondary or primary amines, and these results suggest that [GENE]UGT2B10[\\GENE] preferably conjugates [CHEMICAL]tertiary amines[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]Cynomolgus FMO1[\\GENE], FMO2, FMO3, and FMO5 metabolized [CHEMICAL]benzydamine[\\CHEMICAL], and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, [GENE]FMO2[\\GENE], FMO3, and FMO5 metabolized [CHEMICAL]benzydamine[\\CHEMICAL], and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, [GENE]FMO3[\\GENE], and FMO5 metabolized [CHEMICAL]benzydamine[\\CHEMICAL], and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and [GENE]FMO5[\\GENE] metabolized [CHEMICAL]benzydamine[\\CHEMICAL], and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and [GENE]FMO1[\\GENE]/FMO3 and FMO3 also metabolized [CHEMICAL]methimazole[\\CHEMICAL] and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/[GENE]FMO3[\\GENE] and FMO3 also metabolized [CHEMICAL]methimazole[\\CHEMICAL] and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and [GENE]FMO3[\\GENE] also metabolized [CHEMICAL]methimazole[\\CHEMICAL] and trimethylamine, respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and [GENE]FMO1[\\GENE]/FMO3 and FMO3 also metabolized methimazole and [CHEMICAL]trimethylamine[\\CHEMICAL], respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/[GENE]FMO3[\\GENE] and FMO3 also metabolized methimazole and [CHEMICAL]trimethylamine[\\CHEMICAL], respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and [GENE]FMO3[\\GENE] also metabolized methimazole and [CHEMICAL]trimethylamine[\\CHEMICAL], respectively.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "[GENE]Cynomolgus FMO6[\\GENE] metabolized [CHEMICAL]benzydamine[\\CHEMICAL] only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Cynomolgus FMO6 metabolized [CHEMICAL]benzydamine[\\CHEMICAL] only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus [GENE]FMO1[\\GENE], FMO2, FMO3, and FMO5 which were all functional.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Cynomolgus FMO6 metabolized [CHEMICAL]benzydamine[\\CHEMICAL] only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, [GENE]FMO2[\\GENE], FMO3, and FMO5 which were all functional.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Cynomolgus FMO6 metabolized [CHEMICAL]benzydamine[\\CHEMICAL] only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, [GENE]FMO3[\\GENE], and FMO5 which were all functional.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Cynomolgus FMO6 metabolized [CHEMICAL]benzydamine[\\CHEMICAL] only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and [GENE]FMO5[\\GENE] which were all functional.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "The [GENE]2B4[\\GENE]-[CHEMICAL]paroxetine[\\CHEMICAL] structure is nearly superimposable on a previously solved closed structure in a ligand free state.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "An X-ray crystal structure of [GENE]cytochrome P450 2B4[\\GENE] in complex with the drug [CHEMICAL]paroxetine[\\CHEMICAL] was solved at 2.14 \u00c5 resolution.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in glucosinolates, which upon [GENE]myrosinase[\\GENE] hydrolysis release the corresponding [CHEMICAL]isothiocyanates[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in [CHEMICAL]glucosinolates[\\CHEMICAL], which upon [GENE]myrosinase[\\GENE] hydrolysis release the corresponding isothiocyanates.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Involvement of [GENE]p-CREB[\\GENE] and phase II detoxifying enzyme system in neuroprotection mediated by the flavonoid [CHEMICAL]calycopterin[\\CHEMICAL] isolated from Dracocephalum kotschyi.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Involvement of p-CREB and [GENE]phase II detoxifying enzyme[\\GENE] system in neuroprotection mediated by the flavonoid [CHEMICAL]calycopterin[\\CHEMICAL] isolated from Dracocephalum kotschyi.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "In H2O2-treated cells, [CHEMICAL]calycopterin[\\CHEMICAL] also suppressed [GENE]cytochrome C[\\GENE] release to cytosol that is necessary for maintaining mitochondrial homeostasis in survived cells.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "The results suggest that individuals with high Vmax [GENE]beta 2-ADH[\\GENE] and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with [CHEMICAL]acetaldehyde[\\CHEMICAL] accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial [GENE]ALDH2[\\GENE], accounting for approximately 45% of the Chinese population, may end up with [CHEMICAL]acetaldehyde[\\CHEMICAL] accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "These findings indicate that human pulmonary [CHEMICAL]ethanol[\\CHEMICAL]-metabolizing activities differ significantly with respect to genetic polymorphism at both the [GENE]ADH2[\\GENE] and the ALDH2 loci.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "These findings indicate that human pulmonary [CHEMICAL]ethanol[\\CHEMICAL]-metabolizing activities differ significantly with respect to genetic polymorphism at both the ADH2 and the [GENE]ALDH2[\\GENE] loci.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "The results suggest that individuals with high Vmax [GENE]beta 2-ADH[\\GENE] and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during [CHEMICAL]alcohol[\\CHEMICAL] consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial [GENE]ALDH2[\\GENE], accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during [CHEMICAL]alcohol[\\CHEMICAL] consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.",
        "label": 9,
        "major": -1,
        "len": 47
    },
    {
        "text": "Among all the organophosphates tested, the combination of a methyl group and a negatively charged [CHEMICAL]oxygen[\\CHEMICAL] attached to the P atom, CH3P(O)(O-)-[GENE]AChE[\\GENE], conferred the greatest protection to the active site of aged or nonaged organophosphoryl conjugates of acetylcholinesterase.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "Among all the organophosphates tested, the combination of a methyl group and a negatively charged oxygen attached to the [CHEMICAL]P[\\CHEMICAL] atom, CH3P(O)(O-)-[GENE]AChE[\\GENE], conferred the greatest protection to the active site of aged or nonaged organophosphoryl conjugates of acetylcholinesterase.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "Among all the organophosphates tested, the combination of a methyl group and a negatively charged oxygen attached to the P atom, [CHEMICAL]CH3P(O)(O-)[\\CHEMICAL]-[GENE]AChE[\\GENE], conferred the greatest protection to the active site of aged or nonaged organophosphoryl conjugates of acetylcholinesterase.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "Among all the organophosphates tested, the combination of a methyl group and a negatively charged oxygen attached to the P atom, CH3P(O)(O-)-AChE, conferred the greatest protection to the active site of aged or nonaged [CHEMICAL]organophosphoryl[\\CHEMICAL] conjugates of [GENE]acetylcholinesterase[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "Among all the [CHEMICAL]organophosphates[\\CHEMICAL] tested, the combination of a methyl group and a negatively charged oxygen attached to the P atom, CH3P(O)(O-)-[GENE]AChE[\\GENE], conferred the greatest protection to the active site of aged or nonaged organophosphoryl conjugates of acetylcholinesterase.",
        "label": 2,
        "major": -1,
        "len": 38
    },
    {
        "text": "Monoclonal antibody 25B1 appears to be directed against a conformational epitope located in close proximity to the catalytic center of the enzyme and was found to be most suitable for studying the stabilization of the active site of [GENE]acetylcholinesterase[\\GENE] against denaturation by heat or [CHEMICAL]guanidine[\\CHEMICAL] following phosphorylation by organophosphorus anticholinesterase compounds.",
        "label": 4,
        "major": -1,
        "len": 51
    },
    {
        "text": "[CHEMICAL]Carvedilol[\\CHEMICAL] had no effect on the pressor response elicited by [GENE]angiotensin II[\\GENE], indicating a lack of nonspecific vasodilator activity.",
        "label": 10,
        "major": -1,
        "len": 19
    },
    {
        "text": "Thus, [CHEMICAL]carvedilol[\\CHEMICAL] blocks both beta 1 and beta 2 adrenoceptors at antihypertensive doses, with modest selectivity being observed for the [GENE]beta 1 adrenoceptor[\\GENE] subtype.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "We have named this activity 11 beta HSD2 to distinguish it from the [CHEMICAL]NADP[\\CHEMICAL]-dependent [GENE]11 beta HSD[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "These results demonstrate the presence of a dehydrogenase activity separate from the [CHEMICAL]nicotinamide-adenine dinucleotide phosphate[\\CHEMICAL] (NADP)-dependent [GENE]11 beta hydroxysteroid dehydrogenase[\\GENE] recently purified and cloned from rat liver.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "These results demonstrate the presence of a dehydrogenase activity separate from the nicotinamide-adenine dinucleotide phosphate ([CHEMICAL]NADP[\\CHEMICAL])-dependent [GENE]11 beta hydroxysteroid dehydrogenase[\\GENE] recently purified and cloned from rat liver.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "The uncharged [CHEMICAL]estramustine[\\CHEMICAL] bound to both tubulin and MAPs, but no effects were seen on microtubule assembly, the composition of coassembled [GENE]MAPs[\\GENE] or the microtubule morphology.",
        "label": 10,
        "major": -1,
        "len": 26
    },
    {
        "text": "The uncharged [CHEMICAL]estramustine[\\CHEMICAL] bound to both [GENE]tubulin[\\GENE] and MAPs, but no effects were seen on microtubule assembly, the composition of coassembled MAPs or the microtubule morphology.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The uncharged [CHEMICAL]estramustine[\\CHEMICAL] bound to both tubulin and [GENE]MAPs[\\GENE], but no effects were seen on microtubule assembly, the composition of coassembled MAPs or the microtubule morphology.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "These findings suggest that ceruletide specifically suppresses the barrel rotation evoked by [CHEMICAL]SMS 201-995[\\CHEMICAL] in a long-lasting manner possibly acting through [GENE]CCK-A receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "These findings suggest that [CHEMICAL]ceruletide[\\CHEMICAL] specifically suppresses the barrel rotation evoked by SMS 201-995 in a long-lasting manner possibly acting through [GENE]CCK-A receptor[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 23
    },
    {
        "text": "Results from R-PIA and [CHEMICAL]N6-(S-phenylisopropyl)adenosine[\\CHEMICAL] experiments showed nearly a 40-fold greater potency of R-vs. S-diastereoisomer, suggesting predominance of [GENE]adenosine A1[\\GENE] subtype.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "However, [CHEMICAL]5'-(N-cyclopropyl)-carboxamidoadenosine[\\CHEMICAL] data indicate complexity of the mechanism(s) and point toward an additional involvement of a yet unknown subtype of [GENE]adenosine A2[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "[CHEMICAL]13cisRA[\\CHEMICAL]-dosed animals showed no change in [GENE]prothrombin[\\GENE] times.",
        "label": 10,
        "major": -1,
        "len": 8
    },
    {
        "text": "For all [CHEMICAL]retinoid[\\CHEMICAL]-dosed groups maintained on the purified diet, changes in [GENE]prothrombin[\\GENE] times occured as early as 1 week.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "When menadione was omitted from the diet, however, [CHEMICAL]4HPR[\\CHEMICAL]-dosed animals had elevated [GENE]prothrombin[\\GENE] times.",
        "label": 3,
        "major": -1,
        "len": 14
    },
    {
        "text": "The test procedure was verified with respect to intestinal [CHEMICAL]lactose[\\CHEMICAL] hydrolysis by demonstrating a linear relationship between lactose/lactulose excretion and log jejunal mucosal [GENE]lactase[\\GENE] activity by in vitro assay (R2 = 0.95) in a further group of subjects.",
        "label": 9,
        "major": -1,
        "len": 38
    },
    {
        "text": "The test procedure was verified with respect to intestinal lactose hydrolysis by demonstrating a linear relationship between [CHEMICAL]lactose[\\CHEMICAL]/lactulose excretion and log jejunal mucosal [GENE]lactase[\\GENE] activity by in vitro assay (R2 = 0.95) in a further group of subjects.",
        "label": 9,
        "major": -1,
        "len": 38
    },
    {
        "text": "The test procedure was verified with respect to intestinal lactose hydrolysis by demonstrating a linear relationship between lactose/[CHEMICAL]lactulose[\\CHEMICAL] excretion and log jejunal mucosal [GENE]lactase[\\GENE] activity by in vitro assay (R2 = 0.95) in a further group of subjects.",
        "label": 9,
        "major": -1,
        "len": 38
    },
    {
        "text": "Differential [CHEMICAL]lactose[\\CHEMICAL]/lactulose/L-rhamnose absorption provides a non-invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal [GENE]lactase[\\GENE] deficiency.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Differential lactose/[CHEMICAL]lactulose[\\CHEMICAL]/L-rhamnose absorption provides a non-invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal [GENE]lactase[\\GENE] deficiency.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "Differential lactose/lactulose/[CHEMICAL]L-rhamnose[\\CHEMICAL] absorption provides a non-invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal [GENE]lactase[\\GENE] deficiency.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Adenosine[\\CHEMICAL] analogs in particular the N6-substituted compounds are more potent at [GENE]A1 receptors[\\GENE] than at A2 receptors.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Adenosine[\\CHEMICAL] analogs in particular the N6-substituted compounds are more potent at A1 receptors than at [GENE]A2 receptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Adenosine analogs in particular the [CHEMICAL]N6[\\CHEMICAL]-substituted compounds are more potent at [GENE]A1 receptors[\\GENE] than at A2 receptors.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Adenosine analogs in particular the [CHEMICAL]N6[\\CHEMICAL]-substituted compounds are more potent at A1 receptors than at [GENE]A2 receptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Certain of the [CHEMICAL]adenosine[\\CHEMICAL] conjugates are highly selective for [GENE]A1 receptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "Isolation and characterization of labeled peptides from [CHEMICAL]phenoxybenzamine[\\CHEMICAL]-modified [GENE]calmodulins[\\GENE] indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained phenoxybenzamine label.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Isolation and characterization of labeled peptides from phenoxybenzamine-modified [GENE]calmodulins[\\GENE] indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained [CHEMICAL]phenoxybenzamine[\\CHEMICAL] label.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Adducts of [GENE]calmodulin[\\GENE] and [CHEMICAL]phenoxybenzamine[\\CHEMICAL] were separated by high-performance liquid chromatography into four major fractions: two containing 0.6 and 1.2 mol of drug per mol of protein and two different fractions each containing 2.0 mol/mol.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "In plasma membranes prepared from these isolated brown fat cells by [CHEMICAL]borate[\\CHEMICAL] extraction there was a similar enrichment of activity of SSAO and of the plasma membrane marker enzyme, [GENE]phosphodiesterase I[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "[GENE]Amine oxidase[\\GENE] activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive ([CHEMICAL]clorgyline[\\CHEMICAL]-resistant) activity at the fat cell membrane.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[GENE]Amine oxidase[\\GENE] activities in brown adipose tissue of the rat: identification of [CHEMICAL]semicarbazide[\\CHEMICAL]-sensitive (clorgyline-resistant) activity at the fat cell membrane.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "In plasma membranes prepared from these isolated brown fat cells by [CHEMICAL]borate[\\CHEMICAL] extraction there was a similar enrichment of activity of [GENE]SSAO[\\GENE] and of the plasma membrane marker enzyme, phosphodiesterase I.",
        "label": 3,
        "major": -1,
        "len": 31
    },
    {
        "text": "The compound is more [GENE]beta-lactamase[\\GENE] stable than [CHEMICAL]ampicillin[\\CHEMICAL] and has no major delay in entry into the periplasmic space as do some penicillins.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "From these results, it is proposed that [GENE]tyrosine hydroxylase[\\GENE] activity determines [CHEMICAL]p-HPAA[\\CHEMICAL] concentrations by regulating p-tyrosine availability.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "From these results, it is proposed that [GENE]tyrosine hydroxylase[\\GENE] activity determines p-HPAA concentrations by regulating [CHEMICAL]p-tyrosine[\\CHEMICAL] availability.",
        "label": 9,
        "major": -1,
        "len": 17
    },
    {
        "text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ([CHEMICAL]CN-Cbl[\\CHEMICAL]) bound to [GENE]transcobalamin II[\\GENE] (transcobalamin, TC).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ([CHEMICAL]CN-Cbl[\\CHEMICAL]) bound to transcobalamin II ([GENE]transcobalamin[\\GENE], TC).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ([CHEMICAL]CN-Cbl[\\CHEMICAL]) bound to transcobalamin II (transcobalamin, [GENE]TC[\\GENE]).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Intracellular protein-bound [CHEMICAL][57Co]Cbl[\\CHEMICAL] fractionated with [GENE]methionine synthase[\\GENE] (MS) and methylmalonyl-CoA mutase (MU) activity.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Intracellular protein-bound [CHEMICAL][57Co]Cbl[\\CHEMICAL] fractionated with methionine synthase ([GENE]MS[\\GENE]) and methylmalonyl-CoA mutase (MU) activity.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Intracellular protein-bound [CHEMICAL][57Co]Cbl[\\CHEMICAL] fractionated with methionine synthase (MS) and [GENE]methylmalonyl-CoA mutase[\\GENE] (MU) activity.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Intracellular protein-bound [CHEMICAL][57Co]Cbl[\\CHEMICAL] fractionated with methionine synthase (MS) and methylmalonyl-CoA mutase ([GENE]MU[\\GENE]) activity.",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [CHEMICAL][57Co]cyanocobalamin[\\CHEMICAL] (CN-Cbl) bound to [GENE]transcobalamin II[\\GENE] (transcobalamin, TC).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [CHEMICAL][57Co]cyanocobalamin[\\CHEMICAL] (CN-Cbl) bound to transcobalamin II ([GENE]transcobalamin[\\GENE], TC).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [CHEMICAL][57Co]cyanocobalamin[\\CHEMICAL] (CN-Cbl) bound to transcobalamin II (transcobalamin, [GENE]TC[\\GENE]).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "With the exception of [CHEMICAL]risperidone[\\CHEMICAL], all the antipsychotic drugs tested failed to show selectivity for either of the [GENE]alpha 1-adrenoceptor[\\GENE] subtypes.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Risperidone[\\CHEMICAL] was 120-fold more selective for the [GENE]alpha 1B-adrenoceptor[\\GENE] with respect to the alpha 1A-adrenoceptor (Ki values: 2.3 +/- 1.2 nM and 283.6 +/- 174.1 nM respectively).",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Risperidone[\\CHEMICAL] was 120-fold more selective for the alpha 1B-adrenoceptor with respect to the [GENE]alpha 1A-adrenoceptor[\\GENE] (Ki values: 2.3 +/- 1.2 nM and 283.6 +/- 174.1 nM respectively).",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "The subtypes of [GENE]alpha 1-adrenoceptor[\\GENE] mediating contractions to exogenous [CHEMICAL]noradrenaline[\\CHEMICAL] (NA) in rat aorta have been examined in both biochemical and functional studies.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "The subtypes of [GENE]alpha 1-adrenoceptor[\\GENE] mediating contractions to exogenous noradrenaline ([CHEMICAL]NA[\\CHEMICAL]) in rat aorta have been examined in both biochemical and functional studies.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "[CHEMICAL]5-Methylurapidil[\\CHEMICAL] and phentolamine were confirmed as selective for the [GENE]alpha 1A-adrenoceptors[\\GENE], whereas spiperone was alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "5-Methylurapidil and [CHEMICAL]phentolamine[\\CHEMICAL] were confirmed as selective for the [GENE]alpha 1A-adrenoceptors[\\GENE], whereas spiperone was alpha 1B-selective.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The drug had a potent cytotoxic effect on RIN cells expressing [GENE]GLUT2[\\GENE], but had no effect on cells lacking GLUT2 expression, as indicated by histological analysis and measurement of the blood [CHEMICAL]glucose[\\CHEMICAL] levels of treated animals.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "In summary, these results show that the excitatory effect of [CHEMICAL]histamine[\\CHEMICAL] on immunohistochemically identified vasopressin neurons in the supraoptic nucleus is due in part to the [GENE]H1-receptor[\\GENE]-mediated enhancement of the depolarizing afterpotential independent of any change in the afterhyperpolarizing potential or membrane potential.",
        "label": 3,
        "major": -1,
        "len": 43
    },
    {
        "text": "[CHEMICAL]Glutathione[\\CHEMICAL]-independent prostaglandin D synthase [[GENE]prostaglandin-H2 D-isomerase[\\GENE]; (5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, EC 5.3.99.2] is an enzyme responsible for biosynthesis of prostaglandin D2 in the central nervous system.",
        "label": 10,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Glutathione[\\CHEMICAL]-independent prostaglandin D synthase [prostaglandin-H2 D-isomerase; [GENE](5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase[\\GENE], EC 5.3.99.2] is an enzyme responsible for biosynthesis of prostaglandin D2 in the central nervous system.",
        "label": 10,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Glutathione[\\CHEMICAL]-independent prostaglandin D synthase [prostaglandin-H2 D-isomerase; (5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, [GENE]EC 5.3.99.2[\\GENE]] is an enzyme responsible for biosynthesis of prostaglandin D2 in the central nervous system.",
        "label": 10,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Glutathione[\\CHEMICAL]-independent [GENE]prostaglandin D synthase[\\GENE] [prostaglandin-H2 D-isomerase; (5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, EC 5.3.99.2] is an enzyme responsible for biosynthesis of prostaglandin D2 in the central nervous system.",
        "label": 10,
        "major": -1,
        "len": 26
    },
    {
        "text": "Glutathione-independent prostaglandin D synthase [[GENE]prostaglandin-H2 D-isomerase[\\GENE]; (5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, EC 5.3.99.2] is an enzyme responsible for biosynthesis of [CHEMICAL]prostaglandin D2[\\CHEMICAL] in the central nervous system.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Glutathione-independent prostaglandin D synthase [prostaglandin-H2 D-isomerase; [GENE](5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase[\\GENE], EC 5.3.99.2] is an enzyme responsible for biosynthesis of [CHEMICAL]prostaglandin D2[\\CHEMICAL] in the central nervous system.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Glutathione-independent prostaglandin D synthase [prostaglandin-H2 D-isomerase; (5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, [GENE]EC 5.3.99.2[\\GENE]] is an enzyme responsible for biosynthesis of [CHEMICAL]prostaglandin D2[\\CHEMICAL] in the central nervous system.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "Glutathione-independent [GENE]prostaglandin D synthase[\\GENE] [prostaglandin-H2 D-isomerase; (5Z,13E)-(15S)-9 alpha,11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, EC 5.3.99.2] is an enzyme responsible for biosynthesis of [CHEMICAL]prostaglandin D2[\\CHEMICAL] in the central nervous system.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "This cDNA clone, designated [GENE]EAA3a[\\GENE], shares a 90% [CHEMICAL]nucleotide[\\CHEMICAL] identity with the previously reported rat GluR5-2b cDNA splice variant and differed from human GluR5-1d in the amino and carboxy terminal regions.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "This cDNA clone, designated EAA3a, shares a 90% [CHEMICAL]nucleotide[\\CHEMICAL] identity with the previously reported [GENE]rat GluR5-2b[\\GENE] cDNA splice variant and differed from human GluR5-1d in the amino and carboxy terminal regions.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "This cDNA clone, designated EAA3a, shares a 90% nucleotide identity with the previously reported rat GluR5-2b cDNA splice variant and differed from [GENE]human GluR5-1d[\\GENE] in the [CHEMICAL]amino[\\CHEMICAL] and carboxy terminal regions.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "This cDNA clone, designated EAA3a, shares a 90% nucleotide identity with the previously reported rat GluR5-2b cDNA splice variant and differed from [GENE]human GluR5-1d[\\GENE] in the amino and [CHEMICAL]carboxy[\\CHEMICAL] terminal regions.",
        "label": 1,
        "major": -1,
        "len": 31
    },
    {
        "text": "PC3 is a type I proinsulin-processing enzyme that initiates the sequential processing of [GENE]proinsulin[\\GENE] to insulin by cleaving the proinsulin molecule on the [CHEMICAL]COOH[\\CHEMICAL]-terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and C-peptide.",
        "label": 1,
        "major": -1,
        "len": 35
    },
    {
        "text": "PC3 is a type I proinsulin-processing enzyme that initiates the sequential processing of proinsulin to insulin by cleaving the [GENE]proinsulin[\\GENE] molecule on the [CHEMICAL]COOH[\\CHEMICAL]-terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and C-peptide.",
        "label": 1,
        "major": -1,
        "len": 35
    },
    {
        "text": "PC3 is a type I proinsulin-processing enzyme that initiates the sequential processing of [GENE]proinsulin[\\GENE] to insulin by cleaving the proinsulin molecule on the COOH-terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and [CHEMICAL]C[\\CHEMICAL]-peptide.",
        "label": 1,
        "major": -1,
        "len": 35
    },
    {
        "text": "PC3 is a type I proinsulin-processing enzyme that initiates the sequential processing of proinsulin to insulin by cleaving the [GENE]proinsulin[\\GENE] molecule on the COOH-terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and [CHEMICAL]C[\\CHEMICAL]-peptide.",
        "label": 1,
        "major": -1,
        "len": 35
    },
    {
        "text": "After 7 days of [CHEMICAL]DMI[\\CHEMICAL] administration the number of [GENE]beta-adrenoceptors[\\GENE] was lower in frontal and occipital cortex and hippocampus.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "Coexpression of the flip and flop splice variants of [GENE]GluR-A[\\GENE], in the absence of GluR-B, revealed that heteromeric AMPA receptors with intermediate sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL], similar to responses observed for the combinations GluR-AoBi or GluR-AiBo, could be generated independently of the presence of the GluR-B subunit.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "Coexpression of the flip and flop splice variants of GluR-A, in the absence of GluR-B, revealed that heteromeric AMPA receptors with intermediate sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL], similar to responses observed for the combinations [GENE]GluR-AoBi[\\GENE] or GluR-AiBo, could be generated independently of the presence of the GluR-B subunit.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "Coexpression of the flip and flop splice variants of GluR-A, in the absence of GluR-B, revealed that heteromeric AMPA receptors with intermediate sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL], similar to responses observed for the combinations GluR-AoBi or [GENE]GluR-AiBo[\\GENE], could be generated independently of the presence of the GluR-B subunit.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "Coexpression of the flip and flop splice variants of GluR-A, in the absence of GluR-B, revealed that heteromeric AMPA receptors with intermediate sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL], similar to responses observed for the combinations GluR-AoBi or GluR-AiBo, could be generated independently of the presence of the [GENE]GluR-B[\\GENE] subunit.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "The kinetics of onset of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor desensitization by glutamate, and the extent of attenuation of [GENE]AMPA receptor[\\GENE] desensitization by [CHEMICAL]cyclothiazide[\\CHEMICAL], showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "The complex patterns of sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL] seen in hippocampal neurons could be reconstituted by assembly of recombinant [GENE]AMPA receptor[\\GENE] subunits generated from cDNAs encoding the flip (i) and flop (o) splice variants of the GluR-A and GluR-B subunits.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "The complex patterns of sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL] seen in hippocampal neurons could be reconstituted by assembly of recombinant AMPA receptor subunits generated from cDNAs encoding the flip (i) and flop (o) splice variants of the [GENE]GluR-A[\\GENE] and GluR-B subunits.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "The complex patterns of sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL] seen in hippocampal neurons could be reconstituted by assembly of recombinant AMPA receptor subunits generated from cDNAs encoding the flip (i) and flop (o) splice variants of the GluR-A and [GENE]GluR-B[\\GENE] subunits.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "[GENE]AMPA receptor[\\GENE] heterogeneity in rat hippocampal neurons revealed by differential sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 13
    },
    {
        "text": "The kinetics of onset of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid [GENE](AMPA) receptor[\\GENE] desensitization by [CHEMICAL]glutamate[\\CHEMICAL], and the extent of attenuation of AMPA receptor desensitization by cyclothiazide, showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "Coexpression of the flip and flop splice variants of GluR-A, in the absence of GluR-B, revealed that heteromeric [GENE]AMPA receptors[\\GENE] with intermediate sensitivity to [CHEMICAL]cyclothiazide[\\CHEMICAL], similar to responses observed for the combinations GluR-AoBi or GluR-AiBo, could be generated independently of the presence of the GluR-B subunit.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "The predicted structure of [GENE]PHBP[\\GENE] showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its N-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three [GENE]epidermal growth factor (EGF) domains[\\GENE], a kringle domain and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its N-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a [GENE]kringle domain[\\GENE] and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its N-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a [GENE]serine protease domain[\\GENE], from its [CHEMICAL]N[\\CHEMICAL]-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its N-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although [GENE]HGFA[\\GENE] has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although HGFA has a [GENE]fibronectin type II domain[\\GENE], an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although HGFA has a fibronectin type II domain, an [GENE]EGF domain[\\GENE], a fibronectin type I domain, an EGF domain, a kringle domain, and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a [GENE]fibronectin type I domain[\\GENE], an EGF domain, a kringle domain, and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an [GENE]EGF domain[\\GENE], a kringle domain, and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a [GENE]kringle domain[\\GENE], and a serine protease domain, from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "The predicted structure of PHBP showed three epidermal growth factor (EGF) domains, a kringle domain and a serine protease domain, from its N-terminus, although HGFA has a fibronectin type II domain, an EGF domain, a fibronectin type I domain, an EGF domain, a kringle domain, and a [GENE]serine protease domain[\\GENE], from its [CHEMICAL]N[\\CHEMICAL]-terminus.",
        "label": 1,
        "major": -1,
        "len": 53
    },
    {
        "text": "Thus, [GENE]PHBP[\\GENE] was a heterodimer composed of 50-kDa and 17-kDa subunits, bridged by a [CHEMICAL]disulfide[\\CHEMICAL] linkage.",
        "label": 1,
        "major": -1,
        "len": 16
    },
    {
        "text": "It appears likely that the [GENE]histamine H2 receptor[\\GENE] blocked by cimetidine obviated the pulmonary vasodilator effect of [CHEMICAL]tolazoline[\\CHEMICAL] therapy.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "It appears likely that the [GENE]histamine H2 receptor[\\GENE] blocked by [CHEMICAL]cimetidine[\\CHEMICAL] obviated the pulmonary vasodilator effect of tolazoline therapy.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Cyclothiazide[\\CHEMICAL] (330 microM) shifted the concentration-response curve for the effects of GYKI 52466 on [GENE]AMPA receptor[\\GENE]-mediated e.p.s.c.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Cyclothiazide (330 microM) shifted the concentration-response curve for the effects of [CHEMICAL]GYKI 52466[\\CHEMICAL] on [GENE]AMPA receptor[\\GENE]-mediated e.p.s.c.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Likewise, [CHEMICAL]GYKI 52466[\\CHEMICAL] (30-100 microM)) shifted the concentration-response curve for the effects of cyclothiazide on [GENE]AMPA receptor[\\GENE]-mediated e.p.s.c.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Likewise, GYKI 52466 (30-100 microM)) shifted the concentration-response curve for the effects of [CHEMICAL]cyclothiazide[\\CHEMICAL] on [GENE]AMPA receptor[\\GENE]-mediated e.p.s.c.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Cyclothiazide[\\CHEMICAL] prolonged the decay time constant of [GENE]AMPA receptor[\\GENE]-mediated e.p.s.cs (EC50 35.7 +/- 6.5 microM) with less pronounced effects in slowing e.p.s.c.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "The [GENE]nuclear gene transcription factors[\\GENE] RAR beta and RAR gamma mediate the retinoid activity of [CHEMICAL]adapalene[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The nuclear gene transcription factors [GENE]RAR beta[\\GENE] and RAR gamma mediate the retinoid activity of [CHEMICAL]adapalene[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "The nuclear gene transcription factors RAR beta and [GENE]RAR gamma[\\GENE] mediate the retinoid activity of [CHEMICAL]adapalene[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Among the other [CHEMICAL]bisphosphonates[\\CHEMICAL] studied, alendronate was more potent and selective for [GENE]PTPmeg1[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "Among the other bisphosphonates studied, [CHEMICAL]alendronate[\\CHEMICAL] was more potent and selective for [GENE]PTPmeg1[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 13
    },
    {
        "text": "The [GENE]EP1[\\GENE] receptor bound [CHEMICAL]17-phenyl-PGE2[\\CHEMICAL], sulprostone and iloprost in addition to PGE2 and PGE1, with Ki values of 14-36 nM.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "In addition, three [GENE]IP[\\GENE] ligands, [CHEMICAL]iloprost[\\CHEMICAL], carbacyclin and isocarbacyclin, and one TP ligand, STA2, bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors, respectively.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "In addition, three [GENE]IP[\\GENE] ligands, iloprost, [CHEMICAL]carbacyclin[\\CHEMICAL] and isocarbacyclin, and one TP ligand, STA2, bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors, respectively.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "In addition, three [GENE]IP[\\GENE] ligands, iloprost, carbacyclin and [CHEMICAL]isocarbacyclin[\\CHEMICAL], and one TP ligand, STA2, bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors, respectively.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "In addition, three IP ligands, iloprost, carbacyclin and isocarbacyclin, and one [GENE]TP[\\GENE] ligand, [CHEMICAL]STA2[\\CHEMICAL], bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors, respectively.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "The [GENE]EP1[\\GENE] receptor bound 17-phenyl-PGE2, [CHEMICAL]sulprostone[\\CHEMICAL] and iloprost in addition to PGE2 and PGE1, with Ki values of 14-36 nM.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The [GENE]EP1[\\GENE] receptor bound 17-phenyl-PGE2, sulprostone and [CHEMICAL]iloprost[\\CHEMICAL] in addition to PGE2 and PGE1, with Ki values of 14-36 nM.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The [GENE]EP1[\\GENE] receptor bound 17-phenyl-PGE2, sulprostone and iloprost in addition to [CHEMICAL]PGE2[\\CHEMICAL] and PGE1, with Ki values of 14-36 nM.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The [GENE]FP receptor[\\GENE] bound [CHEMICAL]PGF2[\\CHEMICAL] alpha and fluprostenol with Ki values of 3-4 nM.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "The [GENE]FP receptor[\\GENE] bound PGF2 alpha and [CHEMICAL]fluprostenol[\\CHEMICAL] with Ki values of 3-4 nM.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "The [GENE]EP1[\\GENE] receptor bound 17-phenyl-PGE2, sulprostone and iloprost in addition to PGE2 and [CHEMICAL]PGE1[\\CHEMICAL], with Ki values of 14-36 nM.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "Thymidine kinase from Herpes simplex virus type 1 ([GENE]TK[\\GENE]) was crystallized in an [CHEMICAL]N[\\CHEMICAL]-terminally truncated but fully active form.",
        "label": 1,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]Thymidine kinase[\\GENE] from Herpes simplex virus type 1 (TK) was crystallized in an [CHEMICAL]N[\\CHEMICAL]-terminally truncated but fully active form.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Blockage of the [GENE]HERG human cardiac K+ channel[\\GENE] by the gastrointestinal prokinetic agent [CHEMICAL]cisapride[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "We conclude that [CHEMICAL]cisapride[\\CHEMICAL] is a potent blocker of [GENE]HERG[\\GENE] channels expressed in HEK293 cells.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "We tested the hypothesis that [CHEMICAL]cisapride[\\CHEMICAL] blocks [GENE]HERG[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 8
    },
    {
        "text": "We expressed cardiac or [GENE]smooth muscle alpha1C[\\GENE] subunits in combination with beta2a and alpha2/delta subunits in human embryonic kidney cells, and used 2 mM [CHEMICAL]Ca2+[\\CHEMICAL] as the permeant ion.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The [CHEMICAL]sulfonylurea glibenclamide[\\CHEMICAL] caused release of prebound 8-azido-[alpha-32P]ATP from [GENE]SUR1[\\GENE] in the presence of MgADP or MgATP in a concentration-dependent manner.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The sulfonylurea glibenclamide caused release of prebound [CHEMICAL]8-azido-[alpha-32P]ATP[\\CHEMICAL] from [GENE]SUR1[\\GENE] in the presence of MgADP or MgATP in a concentration-dependent manner.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Although electrophysiological studies provide clues to the complex control of [GENE]KATP channels[\\GENE] by [CHEMICAL]ATP[\\CHEMICAL], MgADP, and pharmacological agents, the molecular mechanism of KATP-channel regulation remains unclear.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Although electrophysiological studies provide clues to the complex control of [GENE]KATP channels[\\GENE] by ATP, [CHEMICAL]MgADP[\\CHEMICAL], and pharmacological agents, the molecular mechanism of KATP-channel regulation remains unclear.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The sulfonylurea glibenclamide caused release of prebound 8-azido-[alpha-32P]ATP from [GENE]SUR1[\\GENE] in the presence of [CHEMICAL]MgADP[\\CHEMICAL] or MgATP in a concentration-dependent manner.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The sulfonylurea glibenclamide caused release of prebound 8-azido-[alpha-32P]ATP from [GENE]SUR1[\\GENE] in the presence of MgADP or [CHEMICAL]MgATP[\\CHEMICAL] in a concentration-dependent manner.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "), attenuated the antitussive effects of [CHEMICAL]codeine[\\CHEMICAL] or SB 227122, indicating that the antitussive activity of both compounds is [GENE]opioid receptor[\\GENE]-mediated.",
        "label": 5,
        "major": -1,
        "len": 21
    },
    {
        "text": "), attenuated the antitussive effects of codeine or [CHEMICAL]SB 227122[\\CHEMICAL], indicating that the antitussive activity of both compounds is [GENE]opioid receptor[\\GENE]-mediated.",
        "label": 5,
        "major": -1,
        "len": 21
    },
    {
        "text": "Therefore, we conclude that the tissue and sub-cellular localization of [GENE]calcium channel[\\GENE] subunits as well as their specific associations are essential parameters to understand the in vivo effects of [CHEMICAL]Mibefradil[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Salicylic acid[\\CHEMICAL] promotes dissociation of (125)I-[GENE]ET-1[\\GENE] ETA receptor complexes both in the absence and the presence of unlabeled ET-1.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Salicylic acid[\\CHEMICAL] promotes dissociation of (125)I-ET-1 [GENE]ETA receptor[\\GENE] complexes both in the absence and the presence of unlabeled ET-1.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Salicylic acid promotes dissociation of [CHEMICAL](125)I[\\CHEMICAL]-[GENE]ET-1[\\GENE] ETA receptor complexes both in the absence and the presence of unlabeled ET-1.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Salicylic acid promotes dissociation of [CHEMICAL](125)I[\\CHEMICAL]-ET-1 [GENE]ETA receptor[\\GENE] complexes both in the absence and the presence of unlabeled ET-1.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "It has no influence on the rate of association of [CHEMICAL](125)I[\\CHEMICAL]-[GENE]ET-1[\\GENE] to ETA receptors.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "It has no influence on the rate of association of [CHEMICAL](125)I[\\CHEMICAL]-ET-1 to [GENE]ETA receptors[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "This study shows that [CHEMICAL]aspirin[\\CHEMICAL] and sodium salicylate, its major blood metabolite, reverse contractile actions of [GENE]endothelin-1[\\GENE] (ET-1) in isolated rat aorta and human mammary arteries.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "This study shows that [CHEMICAL]aspirin[\\CHEMICAL] and sodium salicylate, its major blood metabolite, reverse contractile actions of endothelin-1 ([GENE]ET-1[\\GENE]) in isolated rat aorta and human mammary arteries.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "This study shows that aspirin and [CHEMICAL]sodium salicylate[\\CHEMICAL], its major blood metabolite, reverse contractile actions of [GENE]endothelin-1[\\GENE] (ET-1) in isolated rat aorta and human mammary arteries.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "This study shows that aspirin and [CHEMICAL]sodium salicylate[\\CHEMICAL], its major blood metabolite, reverse contractile actions of endothelin-1 ([GENE]ET-1[\\GENE]) in isolated rat aorta and human mammary arteries.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Salicylic acid[\\CHEMICAL] promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled [GENE]ET-1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Salicylic acid promotes dissociation of [CHEMICAL](125)I[\\CHEMICAL]-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled [GENE]ET-1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "The cytosolic fractions from liver and colon tissues of NQO1-/- mice showed similar amounts of DNA cross-linking upon exposure to [CHEMICAL]MMC[\\CHEMICAL], as observed in [GENE]NQO1[\\GENE]+/+ mice.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "These data directly demonstrate that [GENE]NKCC1[\\GENE] is the major [CHEMICAL]Cl(-)[\\CHEMICAL] uptake mechanism across the basolateral membrane of acinar cells and is critical for driving saliva secretion in vivo.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "This finding, together with the more favorable accumulation of 3H-NMPB in cerebral cortex, hippocampus, and striatum, leads us to conclude that [CHEMICAL]3H-NMPB[\\CHEMICAL], or its positron emitting counterpart, should be the more favorable radiotracer for the estimation of [GENE]mAch receptor[\\GENE] occupancy by cholinergic drugs in the brain.",
        "label": 2,
        "major": -1,
        "len": 46
    },
    {
        "text": "However, inter-helical distances calculated and determined by EPR for [GENE]PGHS-2[\\GENE] complexed with [CHEMICAL]arachidonic acid[\\CHEMICAL], flurbiprofen, and SC-58125 were in close agreement with those obtained from the cognate crystal structures.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "However, inter-helical distances calculated and determined by EPR for [GENE]PGHS-2[\\GENE] complexed with arachidonic acid, [CHEMICAL]flurbiprofen[\\CHEMICAL], and SC-58125 were in close agreement with those obtained from the cognate crystal structures.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "However, inter-helical distances calculated and determined by EPR for [GENE]PGHS-2[\\GENE] complexed with arachidonic acid, flurbiprofen, and [CHEMICAL]SC-58125[\\CHEMICAL] were in close agreement with those obtained from the cognate crystal structures.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Various drugs used in the treatment of IBD, such as glucocorticoids, [CHEMICAL]5-aminosalicylic acid[\\CHEMICAL], and sulfasalazine, interfere with [GENE]NF-kappaB[\\GENE]/Rel signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Various drugs used in the treatment of IBD, such as glucocorticoids, [CHEMICAL]5-aminosalicylic acid[\\CHEMICAL], and sulfasalazine, interfere with NF-kappaB/[GENE]Rel[\\GENE] signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Various drugs used in the treatment of IBD, such as glucocorticoids, 5-aminosalicylic acid, and [CHEMICAL]sulfasalazine[\\CHEMICAL], interfere with [GENE]NF-kappaB[\\GENE]/Rel signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Various drugs used in the treatment of IBD, such as glucocorticoids, 5-aminosalicylic acid, and [CHEMICAL]sulfasalazine[\\CHEMICAL], interfere with NF-kappaB/[GENE]Rel[\\GENE] signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Accordingly, self-administration of a group of local anesthetics that are [GENE]DAT[\\GENE] ligands was compared to their effects as [CHEMICAL]DA[\\CHEMICAL] uptake blockers in vitro in brain tissue.",
        "label": 9,
        "major": -1,
        "len": 26
    },
    {
        "text": "In conclusion, OMCD tubules from [CHEMICAL]deoxycorticosterone pivalate[\\CHEMICAL]-treated rats secrete Cl- into the luminal fluid through [GENE]NKCC1[\\GENE]-mediated Cl- uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete [CHEMICAL]Cl-[\\CHEMICAL] into the luminal fluid through [GENE]NKCC1[\\GENE]-mediated Cl- uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete Cl- into the luminal fluid through [GENE]NKCC1[\\GENE]-mediated [CHEMICAL]Cl-[\\CHEMICAL] uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete Cl- into the luminal fluid through [GENE]NKCC1[\\GENE]-mediated Cl- uptake across the basolateral membrane in series with [CHEMICAL]Cl-[\\CHEMICAL] efflux across the apical membrane.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "The physiological role of [GENE]NKCC1[\\GENE]-mediated [CHEMICAL]Cl-[\\CHEMICAL] uptake remains to be determined.",
        "label": 9,
        "major": -1,
        "len": 11
    },
    {
        "text": "The anti-emetic and pharmacological profile of [CHEMICAL]AS-8112[\\CHEMICAL] ((R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methy lamino-3-pyridinecarboxamide.2 fumarate), a novel and potent dopamine D2, D3 and [GENE]5-hydroxytryptamine-3 (5-HT3) receptors[\\GENE] ligand, was investigated in the present study.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "The anti-emetic and pharmacological profile of AS-8112 ([CHEMICAL](R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methy lamino-3-pyridinecarboxamide.2 fumarate[\\CHEMICAL]), a novel and potent dopamine D2, D3 and [GENE]5-hydroxytryptamine-3 (5-HT3) receptors[\\GENE] ligand, was investigated in the present study.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "Moreover, certain basic residues of this site, particularly [CHEMICAL]Arg[\\CHEMICAL](165) and Lys(169), play a key role in factor Va and/or prothrombin recognition by [GENE]factor Xa[\\GENE] in the prothrombinase complex.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "Moreover, certain basic residues of this site, particularly Arg(165) and [CHEMICAL]Lys[\\CHEMICAL](169), play a key role in factor Va and/or prothrombin recognition by [GENE]factor Xa[\\GENE] in the prothrombinase complex.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "Rofecoxib has greater selectivity for [GENE]COX-2[\\GENE] than [CHEMICAL]celecoxib[\\CHEMICAL], meloxicam, diclofenac and indomethacin.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "Rofecoxib has greater selectivity for [GENE]COX-2[\\GENE] than celecoxib, [CHEMICAL]meloxicam[\\CHEMICAL], diclofenac and indomethacin.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "Rofecoxib has greater selectivity for [GENE]COX-2[\\GENE] than celecoxib, meloxicam, [CHEMICAL]diclofenac[\\CHEMICAL] and indomethacin.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "Rofecoxib has greater selectivity for [GENE]COX-2[\\GENE] than celecoxib, meloxicam, diclofenac and [CHEMICAL]indomethacin[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Rofecoxib[\\CHEMICAL] has greater selectivity for [GENE]COX-2[\\GENE] than celecoxib, meloxicam, diclofenac and indomethacin.",
        "label": 4,
        "major": -1,
        "len": 12
    },
    {
        "text": "Different forms of therapy, [CHEMICAL]potassium[\\CHEMICAL] and magnesium substitution, spironolactone and indomethacin failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized [GENE]IGF-I[\\GENE] levels in the three patients with short stature.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Different forms of therapy, potassium and [CHEMICAL]magnesium[\\CHEMICAL] substitution, spironolactone and indomethacin failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized [GENE]IGF-I[\\GENE] levels in the three patients with short stature.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Different forms of therapy, potassium and magnesium substitution, [CHEMICAL]spironolactone[\\CHEMICAL] and indomethacin failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized [GENE]IGF-I[\\GENE] levels in the three patients with short stature.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Different forms of therapy, potassium and magnesium substitution, spironolactone and [CHEMICAL]indomethacin[\\CHEMICAL] failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized [GENE]IGF-I[\\GENE] levels in the three patients with short stature.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "To elucidate the target genes regulated by these compounds, we treated Zucker diabetic fatty rats (ZDF) for 15 days with a PPAR-alpha-specific compound, fenofibrate, a [GENE]PPAR-gamma[\\GENE]-specific ligand, [CHEMICAL]rosiglitazone[\\CHEMICAL], and a PPAR-alpha/-gamma coagonist, GW2331, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "To elucidate the target genes regulated by these compounds, we treated Zucker diabetic fatty rats (ZDF) for 15 days with a [GENE]PPAR-alpha[\\GENE]-specific compound, [CHEMICAL]fenofibrate[\\CHEMICAL], a PPAR-gamma-specific ligand, rosiglitazone, and a PPAR-alpha/-gamma coagonist, GW2331, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction.",
        "label": 2,
        "major": -1,
        "len": 49
    },
    {
        "text": "As with GABA, the metabolism of [CHEMICAL]alanine[\\CHEMICAL] involves a [GENE]pyridoxal phosphate-dependent transaminase[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Olopatadine[\\CHEMICAL] exerted no significant effects on action potential duration in isolated guinea pig ventricular myocytes, myocardium and [GENE]human ether-a-go-go-related gene channel[\\GENE].",
        "label": 10,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Corticosteroids[\\CHEMICAL] act, at least in part, by recruitment of [GENE]histone deacetylases[\\GENE] (HDACs) to the site of active inflammatory gene transcription.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Corticosteroids[\\CHEMICAL] act, at least in part, by recruitment of histone deacetylases ([GENE]HDACs[\\GENE]) to the site of active inflammatory gene transcription.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "We show both in vitro and in vivo that low-dose [CHEMICAL]theophylline[\\CHEMICAL] enhances [GENE]HDAC[\\GENE] activity in epithelial cells and macrophages.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "Identification and characterization of a novel [CHEMICAL]flavin[\\CHEMICAL]-containing [GENE]spermine oxidase[\\GENE] of mammalian cell origin.",
        "label": 1,
        "major": -1,
        "len": 13
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with [CHEMICAL]epsilon-amino[\\CHEMICAL] groups of lysine residues in proteins.",
        "label": 1,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of [CHEMICAL]lysine[\\CHEMICAL] residues in proteins.",
        "label": 1,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to [CHEMICAL]pyruvate[\\CHEMICAL], ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, [CHEMICAL]ammonia[\\CHEMICAL], and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an [CHEMICAL]alpha-chloroenethiolate[\\CHEMICAL] (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an alpha-chloroenethiolate (with [CHEMICAL]DCVC[\\CHEMICAL]) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an [CHEMICAL]alpha-difluoroalkylthiolate[\\CHEMICAL] (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with [CHEMICAL]TFEC[\\CHEMICAL]) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "Most halogenated [CHEMICAL]cysteine S-conjugates[\\CHEMICAL] are metabolized by cysteine S-conjugate [GENE]beta-lyases[\\GENE] to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.",
        "label": 9,
        "major": -1,
        "len": 42
    },
    {
        "text": "These two alleles were shown previously to be associated with [CHEMICAL]ivermectin[\\CHEMICAL] susceptibility (HG1A) and resistance ([GENE]HG1E[\\GENE]), respectively.",
        "label": 10,
        "major": -1,
        "len": 17
    },
    {
        "text": "These two alleles were shown previously to be associated with [CHEMICAL]ivermectin[\\CHEMICAL] susceptibility ([GENE]HG1A[\\GENE]) and resistance (HG1E), respectively.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, ivermectin potentiated the [CHEMICAL]GABA[\\CHEMICAL]-evoked current of the [GENE]GAB-1[\\GENE]/HG1A receptor, but attenuated the GABA response of the GAB-1/HG1E receptor.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, ivermectin potentiated the [CHEMICAL]GABA[\\CHEMICAL]-evoked current of the GAB-1/[GENE]HG1A[\\GENE] receptor, but attenuated the GABA response of the GAB-1/HG1E receptor.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, ivermectin potentiated the GABA-evoked current of the GAB-1/HG1A receptor, but attenuated the [CHEMICAL]GABA[\\CHEMICAL] response of the [GENE]GAB-1[\\GENE]/HG1E receptor.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, ivermectin potentiated the GABA-evoked current of the GAB-1/HG1A receptor, but attenuated the [CHEMICAL]GABA[\\CHEMICAL] response of the GAB-1/[GENE]HG1E[\\GENE] receptor.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "We demonstrated that the coexpressed [GENE]HG1[\\GENE] and GAB-1 receptors are [CHEMICAL]GABA[\\CHEMICAL]-responsive, and provide evidence for the possible involvement of GABA receptors in the mechanism of ivermectin resistance.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "We demonstrated that the coexpressed HG1 and [GENE]GAB-1[\\GENE] receptors are [CHEMICAL]GABA[\\CHEMICAL]-responsive, and provide evidence for the possible involvement of GABA receptors in the mechanism of ivermectin resistance.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "We demonstrated that the coexpressed HG1 and GAB-1 receptors are GABA-responsive, and provide evidence for the possible involvement of [GENE]GABA receptors[\\GENE] in the mechanism of [CHEMICAL]ivermectin[\\CHEMICAL] resistance.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, [CHEMICAL]ivermectin[\\CHEMICAL] potentiated the GABA-evoked current of the [GENE]GAB-1[\\GENE]/HG1A receptor, but attenuated the GABA response of the GAB-1/HG1E receptor.",
        "label": 3,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, [CHEMICAL]ivermectin[\\CHEMICAL] potentiated the GABA-evoked current of the GAB-1/[GENE]HG1A[\\GENE] receptor, but attenuated the GABA response of the GAB-1/HG1E receptor.",
        "label": 3,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, [CHEMICAL]ivermectin[\\CHEMICAL] potentiated the GABA-evoked current of the GAB-1/HG1A receptor, but attenuated the GABA response of the [GENE]GAB-1[\\GENE]/HG1E receptor.",
        "label": 4,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, when coapplied with 10 micro m GABA, [CHEMICAL]ivermectin[\\CHEMICAL] potentiated the GABA-evoked current of the GAB-1/HG1A receptor, but attenuated the GABA response of the GAB-1/[GENE]HG1E[\\GENE] receptor.",
        "label": 4,
        "major": -1,
        "len": 26
    },
    {
        "text": "These findings demonstrate that the addition of spacer linkages to bivalent [CHEMICAL]yohimbine[\\CHEMICAL] molecules provides a successful approach to the development of ligands that are potent and highly selective for the [GENE]alpha2C-adrenoceptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Initial studies showed that [CHEMICAL]yohimbine[\\CHEMICAL] was about 4- and 15-fold more selective for the [GENE]human alpha2C-adrenoceptor[\\GENE] in comparison with the alpha2A- and alpha2B-adrenoceptors, respectively.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Yohimbine[\\CHEMICAL] dimers exhibiting selectivity for the [GENE]human alpha 2C-adrenoceptor[\\GENE] subtype.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "It is suggested that HSP expression at the time of [CHEMICAL]H2O2[\\CHEMICAL] exposure protects astrocytes from oxidative injury and apoptotic cell death by means of pro-survival [GENE]Akt[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, while [GENE]Akt[\\GENE] phosphorylation was prevented by CHX, Erk1/2 phosphorylation was further enhanced by [CHEMICAL]CHX[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "In human plasma the [GENE]BrBK[\\GENE] half-life values in the absence or in the presence of [CHEMICAL]GW660511X[\\CHEMICAL] (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.",
        "label": 2,
        "major": -1,
        "len": 45
    },
    {
        "text": "In human plasma the [GENE]BrBK[\\GENE] half-life values in the absence or in the presence of GW660511X (3.8 microM) or [CHEMICAL]omapatrilat[\\CHEMICAL] (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.",
        "label": 2,
        "major": -1,
        "len": 45
    },
    {
        "text": "Acetylcholinesterase ([GENE]AChE[\\GENE]) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain [CHEMICAL]acetylcholine[\\CHEMICAL] (ACh) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Acetylcholinesterase (AChE) predominates in the healthy brain, with [GENE]butyrylcholinesterase[\\GENE] (BuChE) considered to play a minor role in regulating brain [CHEMICAL]acetylcholine[\\CHEMICAL] (ACh) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase ([GENE]BuChE[\\GENE]) considered to play a minor role in regulating brain [CHEMICAL]acetylcholine[\\CHEMICAL] (ACh) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Acetylcholinesterase[\\GENE] (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain [CHEMICAL]acetylcholine[\\CHEMICAL] (ACh) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Acetylcholinesterase ([GENE]AChE[\\GENE]) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine ([CHEMICAL]ACh[\\CHEMICAL]) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Acetylcholinesterase (AChE) predominates in the healthy brain, with [GENE]butyrylcholinesterase[\\GENE] (BuChE) considered to play a minor role in regulating brain acetylcholine ([CHEMICAL]ACh[\\CHEMICAL]) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase ([GENE]BuChE[\\GENE]) considered to play a minor role in regulating brain acetylcholine ([CHEMICAL]ACh[\\CHEMICAL]) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Acetylcholinesterase[\\GENE] (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine ([CHEMICAL]ACh[\\CHEMICAL]) levels.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "A low toxicity maintenance regime, using [CHEMICAL]eicosapentaenoic acid[\\CHEMICAL] and readily available drugs, for mantle cell lymphoma and other malignancies with excess [GENE]cyclin D1[\\GENE] levels.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Agents which have recently been shown to block [GENE]cyclin D1[\\GENE] translation by regulating calcium levels are the [CHEMICAL]unsaturated essential fatty acid[\\CHEMICAL], eicosapentaenoic acid (EPA), the antidiabetic thiazolidinediones, and the antifungal agent, clotrimazole.",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "Agents which have recently been shown to block [GENE]cyclin D1[\\GENE] translation by regulating calcium levels are the unsaturated essential fatty acid, [CHEMICAL]eicosapentaenoic acid[\\CHEMICAL] (EPA), the antidiabetic thiazolidinediones, and the antifungal agent, clotrimazole.",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "Agents which have recently been shown to block [GENE]cyclin D1[\\GENE] translation by regulating calcium levels are the unsaturated essential fatty acid, eicosapentaenoic acid ([CHEMICAL]EPA[\\CHEMICAL]), the antidiabetic thiazolidinediones, and the antifungal agent, clotrimazole.",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "Agents which have recently been shown to block [GENE]cyclin D1[\\GENE] translation by regulating calcium levels are the unsaturated essential fatty acid, eicosapentaenoic acid (EPA), the antidiabetic [CHEMICAL]thiazolidinediones[\\CHEMICAL], and the antifungal agent, clotrimazole.",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "Agents which have recently been shown to block [GENE]cyclin D1[\\GENE] translation by regulating calcium levels are the unsaturated essential fatty acid, eicosapentaenoic acid (EPA), the antidiabetic thiazolidinediones, and the antifungal agent, [CHEMICAL]clotrimazole[\\CHEMICAL].",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "The observation that [GENE]Ras[\\GENE]-transformed cells can be sensitized to killing by ionizing radiation with [CHEMICAL]GW572016[\\CHEMICAL] demonstrates that EGFR KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras-driven autocrine signaling through EGFR.",
        "label": 4,
        "major": -1,
        "len": 37
    },
    {
        "text": "The observation that Ras-transformed cells can be sensitized to killing by ionizing radiation with [CHEMICAL]GW572016[\\CHEMICAL] demonstrates that [GENE]EGFR[\\GENE] KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras-driven autocrine signaling through EGFR.",
        "label": 4,
        "major": -1,
        "len": 37
    },
    {
        "text": "[CHEMICAL][(131)I]MIBG[\\CHEMICAL] uptake in PC12 cells, which express the [GENE]NET[\\GENE] endogenously, was 20- to 28-fold lower than in transduced cells.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "In vivo, A431[GENE]NET[\\GENE] tumors demonstrated a 33-fold higher [CHEMICAL][(123)I]MIBG[\\CHEMICAL] uptake than parental tumors.",
        "label": 9,
        "major": -1,
        "len": 13
    },
    {
        "text": "Responses to [CHEMICAL]isoproterenol[\\CHEMICAL] were largely mediated through the [GENE]beta1AR[\\GENE] in control myocytes.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "Pertussis toxin normalised [CHEMICAL]isoproterenol[\\CHEMICAL] responses in NCX cells, indicating that [GENE]beta2AR[\\GENE] effects were mediated by Gi.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "These studies demonstrate that [GENE]AMPK[\\GENE] activity is subject to regulation by both [CHEMICAL]glucose[\\CHEMICAL] and metformin in pancreatic islets and clonal beta-cells.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "These studies demonstrate that [GENE]AMPK[\\GENE] activity is subject to regulation by both glucose and [CHEMICAL]metformin[\\CHEMICAL] in pancreatic islets and clonal beta-cells.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The results demonstrate that [CHEMICAL]DMI[\\CHEMICAL] and nisoxetine are persistently retained in cell membranes, at least partly in association with the [GENE]NET[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The results demonstrate that DMI and [CHEMICAL]nisoxetine[\\CHEMICAL] are persistently retained in cell membranes, at least partly in association with the [GENE]NET[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL](-)-[(3)H]-CGP12177[\\CHEMICAL] dissociated from the [GENE]beta(1)-adrenoceptors[\\GENE] with a fast component (k(off)=0.45 min(-1)), consistent with the L-site, and a slow component (k(off)=0.017-0.033 min(-1)), consistent with the H-site.",
        "label": 10,
        "major": -1,
        "len": 25
    },
    {
        "text": "Thus, the biological activity of [CHEMICAL]IMQ[\\CHEMICAL] appears to exceed its previously known functions, inasmuch as it boosts up significantly the [GENE]perforin[\\GENE]-granule system.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Ang II[\\GENE] level in plasma and mesenteric arteries in imidapril group was significantly lower than that in [CHEMICAL]irbesartan[\\CHEMICAL] group (P<0.05).",
        "label": 3,
        "major": -1,
        "len": 20
    },
    {
        "text": "The [GENE]c-Jun[\\GENE] absorbed light value/GAPDH absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY, [CHEMICAL]imidapril[\\CHEMICAL], and irbesartan groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in imidapril group than in irbesartan group (P<0.05).",
        "label": 3,
        "major": -1,
        "len": 48
    },
    {
        "text": "The c-Jun absorbed light value/[GENE]GAPDH[\\GENE] absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY, [CHEMICAL]imidapril[\\CHEMICAL], and irbesartan groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in imidapril group than in irbesartan group (P<0.05).",
        "label": 3,
        "major": -1,
        "len": 48
    },
    {
        "text": "The [GENE]c-Jun[\\GENE] absorbed light value/GAPDH absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY, imidapril, and [CHEMICAL]irbesartan[\\CHEMICAL] groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in imidapril group than in irbesartan group (P<0.05).",
        "label": 3,
        "major": -1,
        "len": 48
    },
    {
        "text": "The c-Jun absorbed light value/[GENE]GAPDH[\\GENE] absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY, imidapril, and [CHEMICAL]irbesartan[\\CHEMICAL] groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in imidapril group than in irbesartan group (P<0.05).",
        "label": 3,
        "major": -1,
        "len": 48
    },
    {
        "text": "[GENE]Ang II[\\GENE] level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group, and was higher in [CHEMICAL]irbesartan[\\CHEMICAL] group and lower in imidapril group.",
        "label": 3,
        "major": -1,
        "len": 32
    },
    {
        "text": "The ratio of [GENE]TGF-beta1[\\GENE] absorbed light value to GAPDH absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group, [CHEMICAL]imidapril[\\CHEMICAL] group, and irbesartan group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01).",
        "label": 3,
        "major": -1,
        "len": 42
    },
    {
        "text": "The ratio of TGF-beta1 absorbed light value to [GENE]GAPDH[\\GENE] absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group, [CHEMICAL]imidapril[\\CHEMICAL] group, and irbesartan group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01).",
        "label": 3,
        "major": -1,
        "len": 42
    },
    {
        "text": "The ratio of [GENE]TGF-beta1[\\GENE] absorbed light value to GAPDH absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group, imidapril group, and [CHEMICAL]irbesartan[\\CHEMICAL] group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01).",
        "label": 3,
        "major": -1,
        "len": 42
    },
    {
        "text": "The ratio of TGF-beta1 absorbed light value to [GENE]GAPDH[\\GENE] absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group, imidapril group, and [CHEMICAL]irbesartan[\\CHEMICAL] group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01).",
        "label": 3,
        "major": -1,
        "len": 42
    },
    {
        "text": "[GENE]Ang II[\\GENE] level in plasma and mesenteric arteries in [CHEMICAL]imidapril[\\CHEMICAL] group was significantly lower than that in irbesartan group (P<0.05).",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "[GENE]Ang II[\\GENE] level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group, and was higher in irbesartan group and lower in [CHEMICAL]imidapril[\\CHEMICAL] group.",
        "label": 4,
        "major": -1,
        "len": 32
    },
    {
        "text": "Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain [GENE]histamine H1-receptor[\\GENE] occupancy using [CHEMICAL]11C-doxepin[\\CHEMICAL] positron emission tomography.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "This study compared the sedative profiles of the second-generation [CHEMICAL]antihistamines[\\CHEMICAL], fexofenadine and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of [GENE]histamine H1-receptor[\\GENE] occupancy (H1RO) in the brain.",
        "label": 2,
        "major": -1,
        "len": 53
    },
    {
        "text": "This study compared the sedative profiles of the second-generation antihistamines, [CHEMICAL]fexofenadine[\\CHEMICAL] and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of [GENE]histamine H1-receptor[\\GENE] occupancy (H1RO) in the brain.",
        "label": 2,
        "major": -1,
        "len": 53
    },
    {
        "text": "This study compared the sedative profiles of the second-generation antihistamines, fexofenadine and [CHEMICAL]cetirizine[\\CHEMICAL], using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of [GENE]histamine H1-receptor[\\GENE] occupancy (H1RO) in the brain.",
        "label": 2,
        "major": -1,
        "len": 53
    },
    {
        "text": "Central effects of [CHEMICAL]fexofenadine[\\CHEMICAL] and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain [GENE]histamine H1-receptor[\\GENE] occupancy using 11C-doxepin positron emission tomography.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Central effects of fexofenadine and [CHEMICAL]cetirizine[\\CHEMICAL]: measurement of psychomotor performance, subjective sleepiness, and brain [GENE]histamine H1-receptor[\\GENE] occupancy using 11C-doxepin positron emission tomography.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for [CHEMICAL]5-fluorouracil[\\CHEMICAL] (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for [CHEMICAL]5-fluorouracil[\\CHEMICAL] (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil ([CHEMICAL]5-FU[\\CHEMICAL]) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil ([CHEMICAL]5-FU[\\CHEMICAL]) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, [CHEMICAL]UFT[\\CHEMICAL]/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, [CHEMICAL]UFT[\\CHEMICAL]/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/[CHEMICAL]LV[\\CHEMICAL] (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/[CHEMICAL]LV[\\CHEMICAL] (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV ([CHEMICAL]Orzel[\\CHEMICAL]), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV ([CHEMICAL]Orzel[\\CHEMICAL]), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), [CHEMICAL]capecitabine[\\CHEMICAL] (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), [CHEMICAL]capecitabine[\\CHEMICAL] (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine ([CHEMICAL]Xeloda[\\CHEMICAL]), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine ([CHEMICAL]Xeloda[\\CHEMICAL]), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and [CHEMICAL]S-1[\\CHEMICAL], primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and [CHEMICAL]S-1[\\CHEMICAL], primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "[GENE]Thymidylate synthase[\\GENE] (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of [CHEMICAL]2-deoxythymidine-5-monophosphate[\\CHEMICAL], a precursor for DNA synthesis.",
        "label": 9,
        "major": -1,
        "len": 37
    },
    {
        "text": "Thymidylate synthase ([GENE]TS[\\GENE]) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of [CHEMICAL]2-deoxythymidine-5-monophosphate[\\CHEMICAL], a precursor for DNA synthesis.",
        "label": 9,
        "major": -1,
        "len": 37
    },
    {
        "text": "[CHEMICAL]Valdecoxib[\\CHEMICAL]: assessment of [GENE]cyclooxygenase-2[\\GENE] potency and selectivity.",
        "label": 2,
        "major": -1,
        "len": 7
    },
    {
        "text": "Collectively, these data provide a mechanistic basis for the potency and in vitro selectivity of [CHEMICAL]valdecoxib[\\CHEMICAL] for [GENE]COX-2[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Valdecoxib[\\CHEMICAL] showed similar activity in the [GENE]human whole-blood COX[\\GENE] assay (COX-2 IC(50) = 0.24 microM; COX-1 IC(50) = 21.9 microM).",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Valdecoxib[\\CHEMICAL] showed similar activity in the human whole-blood COX assay ([GENE]COX-2[\\GENE] IC(50) = 0.24 microM; COX-1 IC(50) = 21.9 microM).",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Valdecoxib[\\CHEMICAL] showed similar activity in the human whole-blood COX assay (COX-2 IC(50) = 0.24 microM; [GENE]COX-1[\\GENE] IC(50) = 21.9 microM).",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "By contrast, [CHEMICAL]telmisartan[\\CHEMICAL] attenuated [GENE]11beta-hydroxysteroid dehydrogenase type 1[\\GENE] mRNA level in differentiated adipocytes.",
        "label": 3,
        "major": -1,
        "len": 13
    },
    {
        "text": "Genetic variants at the [GENE]beta(2)-adrenergic receptor[\\GENE] (beta(2)AR) may modify asthma severity and [CHEMICAL]albuterol[\\CHEMICAL] responsiveness.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Genetic variants at the beta(2)-adrenergic receptor ([GENE]beta(2)AR[\\GENE]) may modify asthma severity and [CHEMICAL]albuterol[\\CHEMICAL] responsiveness.",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "In a human whole blood assay, IC(50) values for [CHEMICAL]lumiracoxib[\\CHEMICAL] were 0.13 microM for [GENE]COX-2[\\GENE] and 67 microM for COX-1 (COX-1/COX-2 selectivity ratio 515).",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "In a human whole blood assay, IC(50) values for [CHEMICAL]lumiracoxib[\\CHEMICAL] were 0.13 microM for COX-2 and 67 microM for [GENE]COX-1[\\GENE] (COX-1/COX-2 selectivity ratio 515).",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "In a human whole blood assay, IC(50) values for [CHEMICAL]lumiracoxib[\\CHEMICAL] were 0.13 microM for COX-2 and 67 microM for COX-1 ([GENE]COX-1[\\GENE]/COX-2 selectivity ratio 515).",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "In a human whole blood assay, IC(50) values for [CHEMICAL]lumiracoxib[\\CHEMICAL] were 0.13 microM for COX-2 and 67 microM for COX-1 (COX-1/[GENE]COX-2[\\GENE] selectivity ratio 515).",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "As [CHEMICAL]thiamine[\\CHEMICAL] metabolism deficiencies have been seen in placental infarcts previously, these indicate that [GENE]PP20[\\GENE]/hTPK may have a role in placental diseases.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "As [CHEMICAL]thiamine[\\CHEMICAL] metabolism deficiencies have been seen in placental infarcts previously, these indicate that PP20/[GENE]hTPK[\\GENE] may have a role in placental diseases.",
        "label": 9,
        "major": -1,
        "len": 22
    },
    {
        "text": "[CHEMICAL]STI 571[\\CHEMICAL] (imatinib mesylate [Gleevec]) might be an effective therapy in this case, since Gleevec targets both [GENE]PDGFRA[\\GENE] and c-kit oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "[CHEMICAL]STI 571[\\CHEMICAL] (imatinib mesylate [Gleevec]) might be an effective therapy in this case, since Gleevec targets both PDGFRA and [GENE]c-kit[\\GENE] oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "STI 571 ([CHEMICAL]imatinib mesylate[\\CHEMICAL] [Gleevec]) might be an effective therapy in this case, since Gleevec targets both [GENE]PDGFRA[\\GENE] and c-kit oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "STI 571 ([CHEMICAL]imatinib mesylate[\\CHEMICAL] [Gleevec]) might be an effective therapy in this case, since Gleevec targets both PDGFRA and [GENE]c-kit[\\GENE] oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "STI 571 (imatinib mesylate [[CHEMICAL]Gleevec[\\CHEMICAL]]) might be an effective therapy in this case, since Gleevec targets both [GENE]PDGFRA[\\GENE] and c-kit oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "STI 571 (imatinib mesylate [[CHEMICAL]Gleevec[\\CHEMICAL]]) might be an effective therapy in this case, since Gleevec targets both PDGFRA and [GENE]c-kit[\\GENE] oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "STI 571 (imatinib mesylate [Gleevec]) might be an effective therapy in this case, since [CHEMICAL]Gleevec[\\CHEMICAL] targets both [GENE]PDGFRA[\\GENE] and c-kit oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "STI 571 (imatinib mesylate [Gleevec]) might be an effective therapy in this case, since [CHEMICAL]Gleevec[\\CHEMICAL] targets both PDGFRA and [GENE]c-kit[\\GENE] oncoproteins.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and [CHEMICAL]carprofen[\\CHEMICAL] (-12.9%) had lower [GENE]COX-2[\\GENE] selectivity than at IC50.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "However at IC80, [CHEMICAL]phenylbutazone[\\CHEMICAL] (+134.4%) and flunixin (+29.7%) had greater [GENE]COX-2[\\GENE] selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "However at IC80, phenylbutazone (+134.4%) and [CHEMICAL]flunixin[\\CHEMICAL] (+29.7%) had greater [GENE]COX-2[\\GENE] selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and [CHEMICAL]meloxicam[\\CHEMICAL] (-41.2%) and carprofen (-12.9%) had lower [GENE]COX-2[\\GENE] selectivity than at IC50.",
        "label": 4,
        "major": -1,
        "len": 28
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] is associated with a reversal of abnormal regulation of HIF-1alpha, VEGF, BNP, and [GENE]NGF-beta[\\GENE] in the hypertrophic myocardium.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and [GENE]NGF-beta[\\GENE] to the baseline values.",
        "label": 3,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of [GENE]HIF-1alpha[\\GENE], VEGF, BNP, and NGF-beta to the baseline values.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of HIF-1alpha, [GENE]VEGF[\\GENE], BNP, and NGF-beta to the baseline values.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] reversed both protein and mRNA of HIF-1alpha, VEGF, [GENE]BNP[\\GENE], and NGF-beta to the baseline values.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] is associated with a reversal of abnormal regulation of [GENE]HIF-1alpha[\\GENE], VEGF, BNP, and NGF-beta in the hypertrophic myocardium.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] is associated with a reversal of abnormal regulation of HIF-1alpha, [GENE]VEGF[\\GENE], BNP, and NGF-beta in the hypertrophic myocardium.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "Treatment with [CHEMICAL]carvedilol[\\CHEMICAL] is associated with a reversal of abnormal regulation of HIF-1alpha, VEGF, [GENE]BNP[\\GENE], and NGF-beta in the hypertrophic myocardium.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "Crystal structure of [GENE]pyridoxal kinase[\\GENE] in complex with [CHEMICAL]roscovitine[\\CHEMICAL] and derivatives.",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "It could also aid in the design of [CHEMICAL]roscovitine[\\CHEMICAL] derivatives displaying strict selectivity for either [GENE]PDXK[\\GENE] or CDKs.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "It could also aid in the design of [CHEMICAL]roscovitine[\\CHEMICAL] derivatives displaying strict selectivity for either PDXK or [GENE]CDKs[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "The current comprehensive losartan clinical end-point programme (4 large scale morbidity/mortality trials) should provide evidence regarding the efficacy of direct blockade of the [GENE]AT(1) receptor[\\GENE] with [CHEMICAL]losartan[\\CHEMICAL] compared to standard therapy: 1) The Losartan Heart Failure Survival Study - ELITE II, 2) The Losartan Post-Myocardial Infarction Survival Study - OPTIMAAL, 3) The Losartan Hypertension Survival Study - LIFE and 4) The Losartan Renal Protection Study - RENAAL.",
        "label": 4,
        "major": -1,
        "len": 67
    },
    {
        "text": "In the present study, age-related changes of [CHEMICAL]pyridoxal 5'-phosphate[\\CHEMICAL] (PLP) synthesizing enzymes, pyridoxal kinase ([GENE]PLK[\\GENE]) and pyridoxine 5'-phosphate oxidase (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of [CHEMICAL]pyridoxal 5'-phosphate[\\CHEMICAL] (PLP) synthesizing enzymes, pyridoxal kinase (PLK) and [GENE]pyridoxine 5'-phosphate oxidase[\\GENE] (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of [CHEMICAL]pyridoxal 5'-phosphate[\\CHEMICAL] (PLP) synthesizing enzymes, pyridoxal kinase (PLK) and pyridoxine 5'-phosphate oxidase ([GENE]PNPO[\\GENE]), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of [CHEMICAL]pyridoxal 5'-phosphate[\\CHEMICAL] (PLP) synthesizing enzymes, [GENE]pyridoxal kinase[\\GENE] (PLK) and pyridoxine 5'-phosphate oxidase (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of pyridoxal 5'-phosphate ([CHEMICAL]PLP[\\CHEMICAL]) synthesizing enzymes, pyridoxal kinase ([GENE]PLK[\\GENE]) and pyridoxine 5'-phosphate oxidase (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of pyridoxal 5'-phosphate ([CHEMICAL]PLP[\\CHEMICAL]) synthesizing enzymes, pyridoxal kinase (PLK) and [GENE]pyridoxine 5'-phosphate oxidase[\\GENE] (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of pyridoxal 5'-phosphate ([CHEMICAL]PLP[\\CHEMICAL]) synthesizing enzymes, pyridoxal kinase (PLK) and pyridoxine 5'-phosphate oxidase ([GENE]PNPO[\\GENE]), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "In the present study, age-related changes of pyridoxal 5'-phosphate ([CHEMICAL]PLP[\\CHEMICAL]) synthesizing enzymes, [GENE]pyridoxal kinase[\\GENE] (PLK) and pyridoxine 5'-phosphate oxidase (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.",
        "label": 9,
        "major": -1,
        "len": 32
    },
    {
        "text": "The [GENE]angiotensin II (A-II) type 1 (AT1) receptor[\\GENE]-mediated effects of [CHEMICAL]A-II[\\CHEMICAL] play a key role in the pathophysiology of hypertension.",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "A review of the structural and functional features of [CHEMICAL]olmesartan medoxomil[\\CHEMICAL], an [GENE]angiotensin receptor[\\GENE] blocker.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "This effect was reverted in the presence of [CHEMICAL]atropine[\\CHEMICAL] (ATR; 0.1 microM), which blocks the pre-synaptic [GENE]muscarinic M2 receptor[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "This effect was reverted in the presence of atropine ([CHEMICAL]ATR[\\CHEMICAL]; 0.1 microM), which blocks the pre-synaptic [GENE]muscarinic M2 receptor[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "To test the role of [GENE]nicotinic receptors[\\GENE] in the drugs' effects on [3H]-ACh release, [CHEMICAL]mecamylamine[\\CHEMICAL] (MEC) 100 microM was used to block such receptors.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "To test the role of [GENE]nicotinic receptors[\\GENE] in the drugs' effects on [3H]-ACh release, mecamylamine ([CHEMICAL]MEC[\\CHEMICAL]) 100 microM was used to block such receptors.",
        "label": 4,
        "major": -1,
        "len": 24
    },
    {
        "text": "When expressed heterologously in a mammalian cell line, [GENE]rabbit PAT1[\\GENE] mediates pH-dependent, [CHEMICAL]Na(+)[\\CHEMICAL]-independent uptake of proline, glycine, l-alanine and alpha-(methylamino)isobutyric acid.",
        "label": 10,
        "major": -1,
        "len": 21
    },
    {
        "text": "When expressed heterologously in a mammalian cell line, [GENE]rabbit PAT1[\\GENE] mediates pH-dependent, Na(+)-independent uptake of [CHEMICAL]proline[\\CHEMICAL], glycine, l-alanine and alpha-(methylamino)isobutyric acid.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "When expressed heterologously in a mammalian cell line, [GENE]rabbit PAT1[\\GENE] mediates pH-dependent, Na(+)-independent uptake of proline, [CHEMICAL]glycine[\\CHEMICAL], l-alanine and alpha-(methylamino)isobutyric acid.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "When expressed heterologously in a mammalian cell line, [GENE]rabbit PAT1[\\GENE] mediates pH-dependent, Na(+)-independent uptake of proline, glycine, [CHEMICAL]l-alanine[\\CHEMICAL] and alpha-(methylamino)isobutyric acid.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "When expressed heterologously in a mammalian cell line, [GENE]rabbit PAT1[\\GENE] mediates pH-dependent, Na(+)-independent uptake of proline, glycine, l-alanine and [CHEMICAL]alpha-(methylamino)isobutyric acid[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "However, there were some significant differences among [CHEMICAL]Captopril[\\CHEMICAL] (30 mg/kg or 45 mg/kg), enalapril (20 mg/kg), and N-acetylcysteine particular in the activity of [GENE]PON1[\\GENE] and ACE.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, there were some significant differences among [CHEMICAL]Captopril[\\CHEMICAL] (30 mg/kg or 45 mg/kg), enalapril (20 mg/kg), and N-acetylcysteine particular in the activity of PON1 and [GENE]ACE[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, there were some significant differences among Captopril (30 mg/kg or 45 mg/kg), [CHEMICAL]enalapril[\\CHEMICAL] (20 mg/kg), and N-acetylcysteine particular in the activity of [GENE]PON1[\\GENE] and ACE.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, there were some significant differences among Captopril (30 mg/kg or 45 mg/kg), [CHEMICAL]enalapril[\\CHEMICAL] (20 mg/kg), and N-acetylcysteine particular in the activity of PON1 and [GENE]ACE[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, there were some significant differences among Captopril (30 mg/kg or 45 mg/kg), enalapril (20 mg/kg), and [CHEMICAL]N-acetylcysteine[\\CHEMICAL] particular in the activity of [GENE]PON1[\\GENE] and ACE.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "However, there were some significant differences among Captopril (30 mg/kg or 45 mg/kg), enalapril (20 mg/kg), and [CHEMICAL]N-acetylcysteine[\\CHEMICAL] particular in the activity of PON1 and [GENE]ACE[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "In addition, [CHEMICAL]sorafenib[\\CHEMICAL] demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression, including vascular-endothelial growth factor (VEGFR)-2, [GENE]VEGFR-3[\\GENE], platelet-derived growth factor (PDGFR)-beta Flt-3, and c-KIT.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "In addition, [CHEMICAL]sorafenib[\\CHEMICAL] demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression, including vascular-endothelial growth factor (VEGFR)-2, VEGFR-3, [GENE]platelet-derived growth factor (PDGFR)-beta[\\GENE] Flt-3, and c-KIT.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "In addition, [CHEMICAL]sorafenib[\\CHEMICAL] demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression, including vascular-endothelial growth factor (VEGFR)-2, VEGFR-3, platelet-derived growth factor (PDGFR)-beta [GENE]Flt-3[\\GENE], and c-KIT.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "In addition, [CHEMICAL]sorafenib[\\CHEMICAL] demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression, including vascular-endothelial growth factor (VEGFR)-2, VEGFR-3, platelet-derived growth factor (PDGFR)-beta Flt-3, and [GENE]c-KIT[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "In addition, [CHEMICAL]sorafenib[\\CHEMICAL] demonstrated significant activity against several [GENE]receptor tyrosine kinases[\\GENE] involved in neovascularization and tumor progression, including vascular-endothelial growth factor (VEGFR)-2, VEGFR-3, platelet-derived growth factor (PDGFR)-beta Flt-3, and c-KIT.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "In addition, [CHEMICAL]sorafenib[\\CHEMICAL] demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression, including [GENE]vascular-endothelial growth factor (VEGFR)-2[\\GENE], VEGFR-3, platelet-derived growth factor (PDGFR)-beta Flt-3, and c-KIT.",
        "label": 3,
        "major": -1,
        "len": 30
    },
    {
        "text": "The dysmenorrhea pain evoked by [CHEMICAL]vasopressin[\\CHEMICAL] correlated poorly with area under the curve, which may suggest that the effect is mediated by more than one [GENE]V1a-like receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "BACKGROUND AND AIMS: [GENE]Thymidylate synthase[\\GENE] (TS) is an important enzyme for DNA synthesis and the target for [CHEMICAL]5-fluorouracil[\\CHEMICAL] (5-FU).",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "BACKGROUND AND AIMS: Thymidylate synthase ([GENE]TS[\\GENE]) is an important enzyme for DNA synthesis and the target for [CHEMICAL]5-fluorouracil[\\CHEMICAL] (5-FU).",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "BACKGROUND AND AIMS: [GENE]Thymidylate synthase[\\GENE] (TS) is an important enzyme for DNA synthesis and the target for 5-fluorouracil ([CHEMICAL]5-FU[\\CHEMICAL]).",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "BACKGROUND AND AIMS: Thymidylate synthase ([GENE]TS[\\GENE]) is an important enzyme for DNA synthesis and the target for 5-fluorouracil ([CHEMICAL]5-FU[\\CHEMICAL]).",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Removal of Pro128 from the hepatic [GENE]SDH[\\GENE] consisting of 328 residues, which is missing in the corresponding position of the isoform consisting of 329 residues, significantly changed the Michaelis constants and Kd value for pyridoxal 5'-phosphate, whereas addition of a [CHEMICAL]proline[\\CHEMICAL] residue to the isoform was without effect.",
        "label": 1,
        "major": -1,
        "len": 48
    },
    {
        "text": "Removal of Pro128 from the hepatic [GENE]SDH[\\GENE] consisting of 328 residues, which is missing in the corresponding position of the isoform consisting of 329 residues, significantly changed the Michaelis constants and Kd value for [CHEMICAL]pyridoxal 5'-phosphate[\\CHEMICAL], whereas addition of a proline residue to the isoform was without effect.",
        "label": 8,
        "major": -1,
        "len": 48
    }
]